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1.0 INTRODUCTION
The National Space Biomedical Research Institute (NSBRI) sponsors and performs fundamental
and applied space biomedical research with the mission of leading a world-class, national effort
in integrated, critical path space biomedical research that supports NASA's Human Exploration
and Development of Space (HEDS) Strategic Plan. It focuses on the enabling of long-term
human presence in, development of, and exploration of space. This will be accomplished by:
• designing, implementing, and validating effective countermeasures to address the
biological and environmental impediments to long-term human space flight;
• defining the molecular, cellular, organ-level, integrated responses and mechanistic
relationships that ultimately determine these impediments, where such activity fosters the
development of novel countermeasures;
• establishing biomedical support technologies to maximize human performance in space,
reduce biomedical hazards to an acceptable level, and deliver quality medical care;
• transferring and disseminating the biomedical advances in knowledge and technology
acquired through living and working in space to the benefit of mankind in space and on
Earth, including the treatment of patients suffering from gravity- and radiation-related
conditions on Earth; and
• ensuring open involvement of the scientific community, industry, and the public at large
in the Institute's activities and fostering a robust collaboration with NASA, particularly
through Johnson Space Center.
The National Space Biomedical Research Institute is a private, non-profit organization
established in April 1997 following competitive selection by NASA to lead a national effort to
carry out the research required to assure safe human exploration of space. It is governed by a
consortium of educational institutions (including Baylor College of Medicine, Harvard Medical
School, The Johns Hopkins University School of Medicine and the Applied Physics Laboratory,
Massachusetts Institute of Technology, Morehouse School of Medicine, Rice University, and
Texas A&M University). The Institute's headquarters are in Houston at Baylor College of
Medicine.
The NSBRI's research program is carried out at nineteen universities and government laborato-
ries in addition to the consortium institutions. At these institutions, the NSBRI's research
activities are built upon the considerable infrastructure already developed through existing
Federal programs. Ten companies and non-profit organizations serve as industrial partners of the
Institute. The management plan for the Institute is based on the model used by the National
Institutes of Health. An independent Board of Scientific Counselors is responsible for assuring
excellence in the Institute's intramural program through independent external peer review, and an
External Advisory Council, consisting of leaders in the research fields central to the Institute's
mission, is responsible for advising Institute management concerning programmatic effective-
ness. In addition, the NSBRI hasa User Panelof former and currentastronautsand flight
surgeonsresponsiblefor assuringthat the researchprogramis focussedsquarelyon astronaut
healthand safety,and an IndustryForumof representativesof spaceand biomedically-related
industriesthat assiststheInstitutein developingindustryparticipationin NSBRI andthetimely
transferof technology.
The strategicresearchagendaof the NSBRI currentlyinvolveseightteamsof research scientists
focussed on:
• Bone Loss - Addressing the loss and weakening of bone during space flight with the
inherent risks of fracture;
• Cardiovascular Alterations - Addressing tlle-inflight increase of cardiac dysrhythmias
and the postflight impairment of the cardiovascular response to orthostatic and exercise
stress;
• Human Performance - Addressing maintenance of high cognitive performance and
vigilance despite environmental or psychosocial stress and sleep disturbances;
• Immunology, Infection and Hematology - Addressing the potential for immune system
impairment and altered susceptibility to infection, increased allergic response, decreased
blood volume and postflight anemia;
• Muscle Alterations and Atrophy - Addressing the loss of skeletal muscle mass, strength
and endurance that accompanies space flight;
• Neurovestibular Adaptation - Addressing the problems of space motion sickness and
disorientation during flight and the postflight problems of balance and gaze disorders;
• Radiation Effects - Addressing the problem of increased cancer risk caused by the natural
space radiation environment; and
• Technology Development - Developing instrumentation that will enhance the research of
the other teams and transfer the technology to industry for the benefit of society.
The total current intramural research program, including all eight research areas, involves 41
projects, with an average funding per project of approximately $200,000 (Direct + Indirect
Costs).
In addition, the NSBRI has developed partnerships with both the National Science Foundation
and one of the institutes of the National Institutes of Health (National Institute on Deafness and
Other Communication Disorders, NIDCD) to jointly fund competitive extramural research grants
focussing simultaneously on health on Earth and in space while complementing the NSBRI's
intramural tasks. Peer reviews for these programs are managed by the partner, while the
NSBRI's funds for these activities presently come from private sources.
The NSBRI also has signed an agreement of affiliation with the Institute of Aerospace Medicine
of the German Aerospace Center (Deutsches Zentrum f'tir Luft- und Raumfahrt e.V., DLR)
enabling German-funded projects to become part of the NSBRI's intramural program
Finally, the NSBRI has developed a vital program of education and outreach, translating cutting-
edge research from the laboratory to the classroom and home. This important program provides
for: development of several types of classroom materials; a summer teacher training program; the
preparation of a public documentary television program on space biomedical research; and a
television series (Lifioff to Health, The Story of Medicine and Space) depicting the benefits
medicine has received from the space program.
In summary, the NSBRI has established itself as the preeminent NASA-sponsored organization
conducting the research necessary to understand the effects of the space environment on humans
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andusingthat information to developcountermeasuresto therisks of spaceflight. In the short
time that it hasbeenin existence,theNSBRI hassuccessfullyimplementeda soundmanage-
mentplan overseenby a uniqueconsortiumof someof thetopmedicalandresearchuniversities
in thecountryandhasdevelopedthe infrastructurenecessaryto managea completebiomedical
researchprogram. TheNSBRI's currentresearchprograminvolvesa coreof strongbiomedical
researchers,selectedthrough careful peer review and utilizing the modern tools of medical
science. It has involved a numberof investigatorsat NASA's JohnsonSpaceCenterin joint
activitiesandreapsthe fruit of their practicalexperience.In addition,theInstitutehasbegunto
investin the educationof schoolchildrenandin raisingpublicawarenessof thebenefitsof space
research.Finally, theNSBRI hasestablishedcloseconnectionsandjoint model programswith
otherFederalagencies,including the NIH andtheNSF, andhasdevelopedgoodrelationsand
partnershipswith non-U.S,spaceagenciesandthe internationalbiomedicalsciencecommunity,
including a programthat enablesGerman-fundedprojectsto be incorporatedinto the NSBRI's
intramuralteams.
2.0 RESEARCH PLAN
The original research plan for the NSBRI was conceived and developed by Institute management
with the eight Research Team Leaders and the original investigators involved in the preparation
of the proposal to NASA to establish the NSBRI (in mid-to-late 1996). In that winning proposal,
the following statement was made concerning the steps to be taken to establish the Institute's
research plan:
Upon award of the NSBRI, the individual investigators and teams will prepare full-
length, substantive scientific technical proposals for formal independent peer-review by
the Institute's Board of Scientific Counselors, an external group of scientists to be
managed for the NSBRI by Information Dynamics, Inc. (IDI). No Institute Core research
will be funded unless it meets appropriate standards of mission relevance, scientific
excellence, and achievability. It should take four months or less to prepare and review
the Institute task proposals and one month or less to prepare a detailed task funding plan
and review this plan with the Institute's External Advisory Council. Thus, if NASA's
stated selection schedule is maintained, the Institute Core research program will be
implemented by September 1997.
In fact, even though the selection schedule was modified slightly, the plan, exactly as presented
in the proposal, was carried out and the Institute's research program began on schedule in
October 1997.
2.1 Development and Implementation of the Plan
The NSBRI was initiated with a Definition Phase lasting from April 1 to May 31, 1997. During
this period, meetings were held between representatives of NASA and the NSBRI to discuss the
approach to be taken for further interactions, to develop a mutual understanding of the strengths
of and resources of each side, and to develop the appropriate management interfaces. These
meetings resulted in the development of the Cooperative Agreement Management Plan for the
Establishment of the National Space Biomedical Research Institute (CAMP), a controlled
document that provides details through which NASA and the NSBRI will manage and conduct
their joint activities. The CAMP and the Cooperative Agreement itself were signed at Johnson
Space Center by senior representatives of NASA and the NSBRI on May 29, 1997.
A ground-breakingactivity during the Definition Phasewas a series of working scientist
meetings held at JSC to orient both NSBRI and NASA investigators to the function of the
NSBRI within the NASA program, and to enable the scientists themselves to interact and
develop collegial relationships. The full NSBRI management team and JSC senior management
facilitated interactions between the two sides at each of the meetings. Table 1 presents the
definition-period schedule of these working meetings.
Table 1. Schedule of NSBRI/NASA team meetings held at Johnson Space Center.
DATE TEAM NSBRI NASA
Q997_ COORDINATOR COORDINATOR
April 16-17 Human Performance Factors, C. Czeisler L. Putcha
Sleep, and Chronobiology
April 29-30 Neurovestibular Adaptation C. Oman M. Reschke
May 5-6 Muscle Alterations and R. Schwartz D. Feeback
Atrophy
May 7-8 Hematology, Immunology, F. Rudolph D. Pierson
and Infection
May 8-9 Bone Demineralization & J. Shapiro L. Schakelford
Calcium Metabolism
May 12-13 Radiation Effects J. Dicello T. Yang
May 13-14 Technology Development V. Pisacane D. Feeback
May 15 Data Archive V. Pisacane J. Cox
May 27-28 Cardiovascular Alterations R. Cohen J. Yelle
May 28 Education & Outreach W. Thomson D. Sickorez
May 30 Telemedicine V. Pisacane R. Billica
These meetings discussed the latest space research activity by NASA investigators and the
research strategies proposed by NSBRI teams; they enabled the NSBRI research teams to
develop even stronger sets of research projects for possible funding as part of the NSBRI core
research program. During the months of April and May, significant effort was devoted to
proposal preparation by all of the teams. Finally, during the Definition Period, the NSBRI
implemented its proposed and accepted peer review plan by developing a contract with
Information Dynamics, Inc. (IDI) to select and manage eight panels to review the detailed
research proposals of the NSBRI Research Teams during July and August.
Table 2 presents the schedule of activities related to the peer review of the initial set of NSBRI
research proposals. The members of the eight panels carrying out the reviews are provided in
Appendix A of this report.
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Table 2. Schedule of activities concerned with peer review and selection of initial set of
NSBRI research proposals.
DATE
_1997)
June 20
ACTIVITY
Integrated Research Team Proposals Due at Peer Review Contractor
(IDI) Offices in Washington, DC
July 20-22 Cardiovascular Alterations Site Visit. MIT
July 22-24 Neurovestibular Adaptation Site Visit. MIT
July 24-26 Hematology, Immunology, and Infection Site Visit. Rice
July 29-31 Technology Development Site Visit. Johns Hopkins/APL
July 30 - August 1 Bone DemineralizationlCalcium Metabolism Site Visit. Johns Hopkins
August 3-5 Muscle Alterations and Atrophy Site Visit. Baylor College of Medicine
August 5-7 Human Performance Factors, Sleep, and Chronobiology Site Visit.
Harvard Medical School
August 10-12 Radiation Effects Site Visit. Johns Hopkins
August 15 Latest Date for IDI to Provide Peer Review Scores and Critiques to
NSBRI
September 2-3 Team Leaders Present Funding Recommendations to NSBRI
Management (Baltimore)
September 5 Recommended Selection/Funding Plan Developed by NSBRI
Management and Sent to NSBRI Council
September 15-16 NSBRI Council Meeting to Review FY 1998 Operational Plan;
Recommendation Forwarded to NSBRI Board (Houston)
September 22-23 NSBRI Board of Directors Meeting to Determine FY 1998 Operational
Plan (Houston)
September 30 NSBRI Start-Up Phase Ends
October 1 First Operational Year (FY 1998) of NSBRI Begins
Research Team Funding Initiated for Approved Program
Fitly-eight project proposals were submitted for possible inclusion in NSBRI's initial research
program. Five were in Bone Loss: Mechanical Load Effects on Bone Formation and
Remodeling," Novel Receptor-Based Countermeasures to Microgravity-Indueed Bone Loss; Bone
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Blood Flow and Hindlimb Suspension; The Effects of Partial Mechanical Loading and
Ibandronate on Skeletal Tissues in the Adult Rat Hindquarter Suspension Model of
Microgravity; and Skeletal Structural Consequences of Reduced Gravity Environments. Eleven
were in Cardiovascular Alterations: Human Studies Core; Alterations in Cardiovascular
Regulation and Function During Simulated Microgravity; Microgravity-Induced Changes in
Vascular Reactivity and Cardiac Mass; Renal and Cardio-Endocrine Responses in Humans to
Simulated Microgravity; Non-Invasive Assessment of Susceptibility in Ventrieular Arrhythmias
During Simulated Microgravity; Rodent Studies of Cardiovascular Deconditioning;
Cardiovascular Responses to Gravitational Stress Following Prolonged Exposure to Simulated
Microgravity; Effect of Microgravity on Cardiovascular Hemodynamic and Neuroendocrine
Responses; Role of Nitric Oxide and ACE in Cardiovascular Deconditioning in Microgravity;
Computational Models of the Cardiovascular System and Its Responses to Microgravity," and
Cardiac Atrophy.
Six projects were in Human Performance: Circadian Entrainment Sleep-Wake Regulation and
Neurobehavioral Performance During Extended Duration Space Flight; Countermeasures to
Neurobehavioral Deficits from Cumulative Partial Sleep Deprivation During Space Flight;
Topographical EEG Monitoring of Vigilance: Effects of Sleep Deprivation and Posture; On-
Line Analysis of Physiologic and Neurobehavioral Variables During Long-Duration Space
Missions; Human Interaction with Trusted Automation; P.I.-in-a-Box. Four were in
Immunology, Infection, and Hematology: Cellular and Molecular Mechanisms of Immune
Dysfunction in Space Flight; Immune Function and Reactivation of Latent Virus; Molecular
Pathogenesis of Infection Caused by Opportunistic Gram-Positive Bacteria; and Neocytolysis:
Mechanisms and Limitations.
Nine projects were in Muscle Alterations and Atrophy: GH/IGF-1 Transgene Expression on
Muscle Homeostasis; fl-Adrenergic Receptor Agonist Countermeasures; Pharmacological
Inhibitors of the Proteosome in Atrophying Muscles; Proprioceptive Regulation Release of
Growth Factors; Molecular Signaling in Muscle Plasticity; Activity Dependent Signal
Transduction in Skeletal Muscle; Molecular Mechanisms Regulating Muscle Fiber Composition
Under Microgravity; Motoneuron Influences on Muscle Atrophy in Simulated Microgravity
Induced Muscle Atrophy; Aging as a Model for Microgravity-Induced Functional Deficit:
Pulsive Exercise as a Countermeasure. Five projects were in Neurovestibular Adaptation:
Context-Specific Adaptation of Gravity-Dependent Vestibular Reflex Responses; Visual
Orientation in Unfamiliar Gravito-Inertial Environments; Advanced Techniques for Assessment
of Postural and Locomotor Ataxia, Spatial Orientation, and Gaze Stability; Validated Post-
Flight Neurovestibular Countermeasures for Patients and Astronauts; and Predictive Models
and Assessment of Astronaut Movement Control Dynamics.
Eleven projects dealt with Radiation Effects: Radiation Effects: Core Project;
Chemoprevention of Radiation Induced Rat Mammary Neoplasms; Radiation-Induced
Cytogenetic Damage as a Predictor of Cancer Risk for Protons and Fe Ions; Cytogenetic Studies
of Mammary Epithelial Cells Exposed to Gamma Rays and Charged Particles; Validating
Rodent Chemopreventive Studies for Humans: Repair of Space Radiation DNA Damage; Effects
of Whole-Body Proton and 6OCobalt Irradiation on Tumor Promotion in an Intact Animal Model,"
Modulation of Ionizing Radiation Effects in C. Elegans by Genes Regulating Apoptosis and
Oxidative Stress; Quantitation of Radiation Induced Deletion and Recombination Events
Associated with Repeated DNA Sequences; Ocular Effects of High Atomic Number High Energy
(HZE) Particles; Dose-Response Model for Radiation Induced Cataract," Loss of Cell Cycle
Control in Radiation Induced Cataracts: A Role for p57 (KIP2). Finally, seven projects
focussedon TechnologyDevelopment: Miniature X-ray Bone Densitometer," Instrumentation
for Non-Invasive Assessment of Cardiovascular Regulation; Advanced Ingestible Telemetry Pill
Development," Miniature Time-of-Flight Mass Spectrometer," In-Situ Spectrometry of Neutrons;
Multi-Beam Echocardiography; Development of Rapid, Noninvasive Chemical Sensing and
TransdermaI Drug Delivery For Space Flight.
Proposals were scored from 0 to 100 points. Each project was placed in one of the following
categories.
Excellent Scoring Range: 85 - 100 Points
Proposals in this category represent superior proposals and are
definite candidates for funding as part of the research program.
• Good Scoring Range: 65 - 84 Points
Proposals in this category represent sound proposals that are
worthy of support, but with a lower priority than those in the
Excellent category.
• Weak Scoring Range: 0 - 64 Points
Proposals in this category represent proposals that have significant
weaknesses in any area. They are not worthy of support in their
present form.
Figure 1 shows the distribution of scores for all 58 proposals received. Thirty-six proposals were
candidates for selection, having scores of 65 or better. From these candidates, 34 projects were
selected for funding, although budgetary constraints frequently required that awards were less
than the requested level. Funding for these projects began in October 1997.
NSBRI PROJECT REVIEW' SCORES
(58 SUBMITTED PROJECTS)
16 • 15
Number ]
of 10 4
Projects 8 I
Excellent (85 - 100): 19 (33%)
Good (65 - 84): 17 (29%)
Weak (0 - 64): 22 (38%)
7 7 7
::,,!i,ill3 3 3I! ,' .'
-.., _ ÷ ÷--_ _ _ _ _ _ _ _-- _ -_ _- _--_--_ _---_
100 94- 89- B4- 79- 74- 69- 64- fd). f*4- 49- 44- 39- 34- lg- 24- 19- 14- 9 - 4 -
-95 90 S5 80 75 70 63 60 55 ._0 45 40 3J 30 ZS 20 lS 10 _ 0
SCOreS
Figure 1. Project review scores for the 58 initial NSBRI project candidates.
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Following the Octoberselection,it becameclearthat severalgapswerepresentin theNSBRI's
researchprogram, particularly in the areaof Immunology. Stepswere taken to close that
particulargapby recruitinga seniorscientistfrom Baylor Collegeof Medicineto developa key
projectto studyspaceimmunodeficiency.Proposalsfor this projectandseveralothersidentified
ashighly relevant to the researchprogrambut requiring revision and further review prior to
selection,werepreparedandsubmittedfor reviewin February1998. Theywerereviewedto the
samestandardsby the samepanelsthatwereusedin theSummer1997review. Threeadditional
projectswere selectedfor funding(beginningin April 1998)asa resultof this review. Finally,
theFebruarysubmissionincludedaspecialsetof "synergyproposals"for researchto be carried
out and completedin oneyearat a total cost not to exceed$50,000. Thesesynergyproposals
wereconcernedwith new researchactivitiesthat relatedto currentlyfundedprojectsin at least
two different researchareas. Review criteria for this new group of proposalsincluded the
scientificandtechnicalmeritof theproposal,theability of the investigatorandhis teamto carry
out the proposalto a successfulconclusionin thetime available,andthe contribution that the
proposedactivity would maketo integratingtheresearchactivitiesof two or more teams. Nine
synergyproposalsweresubmitted;fourwereselectedfor funding.
AppendixB providesabstractsandinvestigatorinformationfor all 41 currentlyfundedresearch
projects.TheNSBRI researchprograminvolves133investigatorsfrom 25 institutions.
2.2 Research Highlights
All 41 of the NSBRI funded research projects were initiated in FY 1998. Although not all of
these studies have had sufficient time to produce results, having completed only 6 months to one
year of work, a number of research results and findings are available. These highlights are only
some of the initial results from some of the projects and are, by no means, a complete summary
of the first year research. They are presented here for NASA internal use only. Results are
privileged and should not be published or quoted from directly until the investigators have had
the opportunity of publishing them in peer-reviewed joumals.
Peripheral quantitative computed tomography (pQCT) was applied to the study of femoral neck
bone from male Fischer rats aged 6 months (n=8) and 24 months (n=8). A single slice located at
the center of the femoral neck perpendicular to its long axis was assessed for volumetric BMD
and area of the entire bone as well as for cortical (CRT) and trabecular (TRB) components. Polar
cross-sectional moment of inertia (CSMIp) for total bone were calculated from area and density
values. Bones were then subjected to mechanical testing with an Instron 1125 device. Maximal
(MAX) load at fracture and stiffness were calculated from the load-displacement curve. When
comparing results from the senescent, 24-mo-old rats to those of 6-mo-old adult rats, density of
trabecular bone declined 21% (p = 0.002), whereas density of the cortical shell remained
constant. Total bone area and cross-sectional moment of inertia increased 11% and 23%,
respectively. Direct measurement of structural properties shows that MAX load is higher by
23% and stiffness by 52% in older rats. Multiple linear regression analysis of pooled data
suggests that variations in femoral neck morphometry (i.e., cross-sectional moment of inertia) are
largely responsible for the higher MAX load and stiffness of femoral necks in aged male rats, and
that alterations in trabecular bone mineral density of the femoral neck minimally affect its
strength. These same analyses are being applied to various bone sites, including the femoral
neck, in animals subjected to hindlimb unloading as a model ofmierogravity. (Bloomfield)
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Bioreactorshavebeenusedto grow three-dimensionalarraysof MG-63 cells and the responses
of these cells have been compared with those at unit gravity and with those exposed to
microgravity aboard the Foton 10 satellite by Carmeliet et aL (J. Bone Miner Res 1997:786-794).
Carmeliet et al. measured alkaline phosphatase activity, as well as the mRNA levels for a
number of marker genes. They found that in microgravity, induction of alkaline phosphatase by
TGF-13 and 10 .7 M calcitriol was only about 1.8 fold. In agreement with this, a similar increase
was found in the present bioreactor study. The flight studies showed that microgravity treatment
reduced the levels of osteocalcin mRNA to about 15-20% of control, but the investigators were
unable to measure osteocalcin secretion for technica[reasons. In the present studies, osteocalcin
was measured by immunoassay. While there are essentially identical extremely low levels of
osteocalcin in the uninduced conditions, osteocalcin increased 100 fold upon treatment in unit
gravity whereas no increase was detected in the bioreactor. Measurements of mRNA levels are
ongoing. These studies support the hypothesis that that the bioreactors are mimicking the
microgravity conditions. In order to begin to understand the reasons for the lack of response to
calcitriol, vitamin D receptor levels have been measured in cells grown in the bioreactor versus
control cells. Initial immunoblots suggest that the levels of the vitamin D receptor are
substantially reduced in the bioreactor. To determine whether the cells exposed to microgravity-
like conditions in the bioreactor alter their basal signaling responses, phosphorylation site-
specific antibodies have been used to measure the levels of mitogen-activated protein kinases
(MAPK) and stress-activated protein kinases (SAPK). Although there was little change in
activation of MAPK, the SAPK activity was greatly increased indicating that the MG-63 cells
respond to microgravity as a stress condition. If these findings are confirmed in the ongoing
experiment, then a major defect in microgravity may be downregulation of the vitamin D
receptor. Microgravity-induced bone loss is a consequence of bone resorption in excess of bone
formation. Although both decreased bone formation and increased resorption have been
documented in different animal models and in bed rest studies, the flight response appears
weighted towards increased bone resorption. Increased Calcium Receptor (CAR) activity
promotes bone formation and inhibits bone breakdown. CaR activity may modulate increased
osteoblastogenesis and reduced osteoclastogenesis. Thus, CAR activators could be beneficial for
the treatment of microgravity-induced osteoporosis. Results to date indicate that CaR agonists
stimulate chemotaxis and DNA synthesis in MC3T3-E1 osteoblastic cells. The treatment of
mixed mouse marrow cultures with 1,25-dihydroxyvitamin D promotes the formation of CAR
positive multinucleated osteoclast-like cells that also express tartrate-resistant alkaline
phosphatase characteristic of osteoclasts. This result suggests strongly that the osteoclast will be
responsive to the inhibitory action of CAR agonists. (O'Malley)
The project on Circadian Entrainment, Sleep-Wake Regulation and Neurobehavioral
Performance has carried out seven experiments in healthy adults in which circadian rhythms of
body temperature and hormones, as well as sleep, performance and mood were measured 24
hours a day for 55 consecutive days in the laboratory, to determine the light exposure (intensity,
duration, and timing) necessary for humans to maintain circadian entrainment to the Martian day
(24.61 hr) relative to the Earth day (24.0 hr). This research on light as a countermeasure for
extended duration flight was complemented by research these investigators completed on (i) the
implementation of pre-launch bright light exposure to help shuttle astronauts quickly adjust to
circadian inversions caused by dual-shift missions; and on (ii) flight-based studies of circadian
physiology, sleep, and performance aboard 1998 space shuttle missions STS-90 and STS-95, to
determine the effectiveness of melatonin to improve in-flight sleep of astronauts. These
investigators have also recently received an NIH grant to perform ground-based experiments on
the effectiveness ofmelatonin as a hypnotic. (Czeisler)
The project on Countermeasuresto NeurobehavioralDeficits from CumulativePartial Sleep
Deprivation has studied 30 healthy adults in which circadiancore body temperature,sleep
physiology, and a rangeof neurobehavioralfunctionswere measured24 hours a day for 14
consecutivedaysin the laboratory,to determinethe sleeptiming (episodes,duration,circadian
placement)necessaryto preventcumulativeperformancedeficits. Eventually,18different sleep
regimeswill be evaluatedand comparedquantitativelyusingresponsesurfacemodeling.This
NSBRI project is complementedby researchtheseinvestigatorshaveunderwayfor NIH on the
natureof cumulativecognitiveperformancedeficitswhensleeprestrictionoccurschronicallyat
different circadianphases.A secondmajor goalof this projectis to developnovel technologies
for the objectiveassessmentof humanfunctional capability relativeto chronic sleeploss and
circadiandisturbancein spaceflight. To this end,threeadvanceshavebeenmadein year 1: (i)
thedeploymentof highly sensitive,brief performancetests(e.g.,PVT) in otherteamprojectsand
for testing astronautsin STS-90and STS-95 shuttle missions; (ii) testing of a new non-
thrombogeniccatheterand miniatureblood pump systemfor the study of growth hormone
secretionduring alteredsleepandwaking; and (iii) througha complementaryproject with the
Department of Transportation, validation of a new, objective non-performance-based
biobehavioraltechniquefor detectingdrowsinessduringwork. (Dinges)
TheprojectonQuantitativeEEGMonitoringof VigilancehasanalyzedEEGandEOGcorrelates
of decrementsin neurobehavioralperformanceassociatedwith circadianmelatoninphaseand
sleeplossin tenhealthyadultsundertheunmaskingconditionsof aconstantroutine. Theresults
confirma closerelationshipbetweensleepiness,slow eyemovements,andmelatoninlevels,and
indicate that low frequencyEEG activity (1-7 Hz) recordedfrom frontal areasof the brain
changesin responseto thedurationof wakefulness.(Dijk)
Thephi-X174 bacteriophagehasbeengrownin cultureto testup to 60Antarctic studysubjects
for this project. Thebacteriophageandotherreagentswill be takento theAntarctic outpostsby
an ice-breakersupply ship in December1998. This sophisticatedneo-antigenwill yield
extremely valuable information on the ability of T-lymphocytesto signal B-lymphocytesto
switch from transient IgM antibody to long-lasting IgG antibody production, a previously
untestedcomponentof spaceresearch.(Shearer)
Theprojectinvolving Immune Function and Reactivation of Latent Viruses has made substantial
progress in completing the creation of viral nucleic acid probes which will enable investigators to
determine latent virus (e.g., EBV, HSV, CMV) activation in study subjects in the Antarctic and
in earth-bound space capsules. (Butel)
A real-time bacterial contamination system is nearing completion and can already detect many
bacteria found in drinking water. Plans are being made to develop an instantaneous readout
system that can send space capsule drinking water contamination information back to Mission
Control on Earth. (Fox)
Young red blood cells have been identified successfully by the binding of wheat germ lectin to
membrane sialic acid molecules with flow cytometry. This is important as a first step in
determining why young red blood cells are so susceptible to the effects of leaving and entering
Earth's gravity. (Alfrey)
Procedures have been established for this project to perform hindlimb unweighting and resistance
training in mice. The development of mice as an experimental model allows the addition of the
powerful tool of transgenic animals to NASA's toolbox. Mice with normal cage activity that
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weregeneticallyengineeredto over express IGF-I had muscle hypertrophy. However, the excess
amount of IGF-I in muscle did not prevent atrophy in the Earth-model of space flight either in
mice without a countermeasure or in mice with two daily bouts of treadmill walking. Currently a
new group of mice with excess IGF-I in their skeletal muscles are undergoing concentric and
eccentric resistance training while in the Earth model of space flight. In very exciting data being
collected now, growth hormone releasing factor administration to normal young pigs resulted in
doubling their growth rate. Next, this technology will be applied to hindlimb-unweighted mice
performing resistance training. (Schwartz)
Muscle is converted to an inefficient motor during space flight because skeletal muscle loses its
efficient myosin enzyme and burns extra ATP resulting in premature fatigue. NSBRI research
has shown that the loss of the efficient enzyme from the muscle is due to a reduced translational
formation of this protein. In addition, space flight induced muscle loss is produced in part by
increased breakdown of existing muscle proteins. It has been found that most of this breakdown
occurs in the "N-end" ubiquitination pathway in skeletal muscle myosin. (Goldberg)
In examining head/neck reflexes in response to whole body rotation in different orientations, it
has been found that yaw head rotation is the largest response component to on-axis yaw trunk
rotation, roll is the largest response component to eccentric rotation while facing (or back to) the
direction of motion (centripetal force along the inter-aural axis), and pitch is the largest response
component to eccentric rotation facing (or back to) the rotation axis. Seventeen subjects have
now been tested, with three-dimensional measurements made of head and trunk motion during
yaw rotation while centered or at the end of a short-radius centrifuge. This systematic
investigation using the combination of three-dimensional measures of both head and body has
never been done before. (Shelhamer)
In human experiments conducted in a tumbling room (n = 17) or in a similar virtual room created
using the NASA Virtual Environment Generator (n = 6), it was found that the majority of
subjects viewing a room with visual verticals aligned with the head to foot axis report feeling
subjectively nearly upright, even though they are actually supine. (When subjects raise their
hands, they feel curiously weightless). Tests in the rotatable room indicate visual vertical cues
can dominate for prone and inverted subjects as well. We have also found a new simple
technique for inducing a levitation illusion which may be useful in some training applications:
the subject lies supine, and observes the world through a mirror set at 45 ° so that it is sloping up
from below the nose to above the forehead. In addition, susceptibility to visual reorientation
illusions (VRIs) in 1- G can be assessed by measuring the subjective vertical in a virtual tilted
room. Among visually dependent subjects, results appear sensitive to head/body tilt. Subjects
can be successfully trained using an exocentric strategy to perform a three-dimensional spatial
memory task analogous to that required to traverse a space station node module. Once trained,
performance in this task appears insensitive to gravitational orientation of the head. This finding
suggests that the orientation of a trainee's head may not be as critical as had previously been
thought for effective astronaut preflight orientation training. (Oman)
In recent parabolic flight experiments while recording from several head direction (HD) cells in
the anterior thalamic nucleus of Sprague-Dawley rats, it was found that directional tuning was
often maintained during both the 0-G and 1.8 G (pullout) phases of parabolic flight. Animals
were tested in a rectangular chamber, gridded on the floor, ceiling, and one wall so the animals
could walk in 0-G. The plane of sensitivity generally remained aligned with the 1-G/1.8G
"floor" of the chamber, even when the animal climbed on a "wall" in 0-G. The latter finding
suggests that the plane of sensitivity is determined by the animal's cognitive reference frame, and
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not simply by theplaneof its locomotion.Further,whenanimalscrawledon the"ceiling" of the
chamberin 0-G, the directionof sensitivity sometimesreverseddirection,acrossthe principal
axis of symmetry of the container,as would be expectedif the animal, like an astronaut,
experienceda VRI. This is the first time ananimalmodelhasbeensuccessfullyusedto define
thelimbic basisof animportant0-Gspatialorientationillusion. (Oman)
Discriminant analysishasbeensuccessfullyappliedto distinguishunilateralvestibular lesions
from normalresponsesusing sinusoidalharmonicrotation,andto distinguishbetweenpatients
havingMrnirre's diseaseandmigraineassociatedizziness.To understandhow discreteangular
andlinear motionsof the visual surroundinfluencethebody segmentvariablesduring normal
gait initiation and straightand circular treadmill walking, a uniquecircular treadmill hasbeen
constructedand an ISCAN binocular eye movementmonitor has been integratedwith an
Optotraksystemsothat eyemovementsaswell asheadandbody partmotion canbe recorded
duringnatural linearandcircular locomotion. It h_sbeenfoundthatwalking overa largerange
of velocitieshasa tight frequencyboundaround2 Hz. Theimplication is that increasedwalking
velocity is achievedprimarily by increasingstride length rather than increasingstepping
frequency. An optimalwalking velocity rangesfrom 1.4-1.8m/sec. In this range,thereis the
highest coherencebetweenhead, trunk and stepping. Head pointing stays approximately
constantover the optimal rangeof walking velocities. Head and trunk rotationsin the pitch
plane during linear forward locomotion are govemedby two overlappingmechanisms:one
mechanismworksat low velocitieswhereheadrotationcompensatesfor trunk rotation,while at
higher walking velocitiesheadtranslationplays a role in controlling the headpitch. These
results are consistent with our hypothesis that at low walking velocities the head is
predominantly controlled by the angular vestibulo-collic reflex, while at higher walking
velocitiesit is mainlycontrolledby thelinearvestibulo-collicreflex. (Wall)
Experimentswere carriedout at BrookhavenNationalLaboratorywith Sprague-Dawleyrats of
approximately60 to 65 daysof agereceivingtotal-bodyirradiationsat threedoses,0.05,0.16,
and 0.5 Gy, of 1-GeViron ions at two depths. The first groupwas irradiatedwith minimum
absorberupstreamandthe secondwith a Lucite absorberproducinga meanenergyof 600 MeV
(typical Berkeleyenergy)at thebreastsof the animals. Eighteenrats werealso irradiatedat 2
Gy. Control experimentswereperformedwith cesiumbeforeand after the iron irradiationsat
dosesof .50, 1.60,and5.0Gy. Shamirradiationswereincludedin all cases.Both humanandrat
mammarycells were irradiatedin vitro. Human cells from individual donors and rat lympho-
cytes from pooled donors were irradiated at four doses, 0.1, 0.25, 0.5, and 1.0 Gy. In addition,
human lymphocytes and human colorectal cells were also irradiated at the same doses. Because
lymphocytes and colorectal cells are well studied in vitro, the results will provide insights into
the differences in mechanisms leading to carcinogenesis for different particle types. Correspond-
ing experiments with both rats and cells have been done at one depth with 250-MeV protons at
Loma Linda University. This was the first experiment done at this new NASA-supported
facility. Tumors began to appear in the iron study, including the unirradiated shams, at about
three months after irradiation. The proton group also began developing tumors at about the same
time after irradiation, but the proton studies were started several months later, so the numbers are
few at this point. The frequency of tumors appears to increase with increasing dose, although the
statistics are still poor; however, the frequencies with iron are about the same as those with
photons, indicating that the estimated RBEs used to design the experiments were approximately
correct. There is an enhanced response in a small set of animals at 2 Gy of iron. These animals
were irradiated intentionally at a higher dose, in case the RBE was overestimated significantly.
This group is developing tumors significantly more rapidly than the photon -irradiated animals,
again substantiating the original hypotheses used to design the original experiments. Despite the
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rapid tumor developmentat 2 Gy, there has been no clinical bone-marrowtoxicity, gut
complications,or CNSdamageto date. Pathologicalexaminationof theexcisedtumorsfrom all
irradiatedanimalsshowsthatthemajority arecarcinomas.Thecolonyremainshealthy,with no
animals lost at the highest iron dose. All of the cell datahave not been analyzed,but the
analyzeddatashow increasedefficacyof iron ions for the inductionof complexchromosome
aberrations.An interpretationof thedatamight be that biologicalprocessescontributemore to
carcinogenesisthantheinitial inductionof irreparablelesions.(Dicello)
3.0 KEY PERSONNEL
Senior Institute management personnel (Bobby R. Alford, M.D., Chairman of the Board and
Chief Executive Officer, Laurence R. Young,Sc.D., Director, and Ronald J. White, Ph.D.,
Associate Director) have developed a stable, fully functioning management unit. One Team
Leader change was instituted in April 1998, involving the Immunology, Infection and
Hematology Team. Dr. Fred Rudolph of Rice University asked to be relieved of his duties since
he is not personally involved in the NSBRI research program at the present time. He was
replaced by Dr. William T. Shearer, the principal investigator for the key immunology project
added at mid-year.
Dr. Shearer is the Director of the Allergy and Immunology Training Program at Baylor College
of Medicine and Professor of Pediatrics and Microbiology and Immunology. He graduated from
Washington University School of Medicine in St. Louis in 1970 and received his clinical training
in pediatrics and allergy and immunology at the Washington University's affiliated hospitals, St.
Louis Children's Hospital and Barnes Hospital. Dr. Shearer received a Research Scholar Award
of the Cystic Fibrosis Foundation and a Faculty Research Award from the American Cancer
Society for his early research work. He joined the faculty of Washington University in 1974 and
was promoted to professor in 1978 prior to moving to Baylor College of Medicine. In 1981 he
was elected to membership in the American Society for Clinical Investigation and received the
Distinguished Teacher Award in 1984 from Baylor College of Medicine. Dr. Shearer has been
active in professional clinical immunology organizations at the national level for many years,
serving as Director and Chair of the American Board of Allergy and Immunology, Chair of the
American Academy of Allergy, Asthma, and Immunology Training Program Directors
Committee, Chair of the Academy's National Issues Subcommittee, and Chair of the Academy's
Clinical and Laboratory Immunology Committee which published the Core Content Outline for
Clinical and Laboratory Immunology and the Practice Parameters for the Diagnosis and
Management of Immunodeficiency. Dr. Shearer has been an appointed (1994) and elected
(1997) Councilor of the Clinical Immunology Society and has also served as Chair of its
American Board of Allergy and Immunology Nominations Committee.
Dr. Shearer's basic research work deals with immunoglobulin gene activation in HIV infection
and his clinical research involves directing the Pediatric HIV/AIDS Research Center at Baylor
College of Medicine and Texas Children's Hospital, a center currently involving over 100
professionals and funded by 12 National Institutes of Health and private organization grants and
contracts. Dr. Shearer is Vice-Chair of the Pediatric AIDS Clinical Trials Group, 22-center
national research group devoted to the study of antiretroviral and immune-based therapies in
HIV-infected children. A brief biographical sketch for Dr. Shearer is provided as Appendix C.
Three principal investigators (PIs) were changed during the first year of operation of the Institute.
On the Bone Loss Team, L. W. Schultheis replaced J. R. Shapiro as PI for the project "The
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effectsof Partial MechanicalLoading and Ibandronateon SkeletalTissuesin the Adult Rat
HindquarterSuspensionModel of Microgravity." Dr. Shapiromovedfrom JohnHopkinsSchool
of Medicineto UniformedServicesUniversityof theHealthSciences(USUHS)andWalterReed
Army Medical Centerandwill continueto work on the project at JohnsHopkins,but as a co-
investigator. On the RadiationEffectsTeam,D. L. HusoreplacedS.P. HowardasPI for the
project "Chemopreventionof Radiation-InducedRat Mammary Neoplasms." Dr. Howard
moved to anotherinstitution. On the TechnologyDevelopmentTeam,R. S. Potemberof the
JohnsHopkins Applied PhysicsLaboratory(APL) replacedH. W. Ko as PI for the project
"Miniature Time-of-Flight MassSpectrometer."Dr. Ko askedto be replacedto allow him to
spendmoretimeworking onanotherlargeprojectatAPL.
4.0 MANAGEMENT PLAN
By the end of the Institute's first year of operation, the Management Plan described in the
original proposal to NASA had been fully and faithfully implemented. Figure 2 presents a
sketch of the relationships among the elements of the originally proposed plan. The optional part
of the program concerned with the management of the non-Institute NASA biomedical research
program has been removed, as this option was not exercised.
Current membership of the NSBRI Board of Directors is shown in Table 3. The Board of
Directors has met three times since the formation of the Institute, on September 22-23, 1997,
March 19-20, 1998, and September 24-25, 1998. All meetings were held in Houston. At each
meeting, they reviewed and approved the program plan for the Institute.
Current membership of the NSBRI External Advisory Council is shown in Table 4. The
External Advisory Council also met three times, on September 15-16, 1997 and March 16-17,
1998 in Houston, and on September 3-4, 1998 in Boston. Two members, Drs. Ann Kennedy and
M. Rhea Seddon, were added to the Council and attended the September 1998 meeting. At each
of the meetings, the status of the entire research program and the Institute outreach program was
presented and discussed. In-depth presentations and corresponding discussions were initiated in
March (Muscle Team) and continued in September 1998 (Human Performance Team). This
approach will be continued and the meeting location will rotate from Houston to Boston to
Baltimore in order to expose the Council to the investigators and vice versa.
Membership in the NSBRI Board of Scientific Counselors is shown in Table 5. This Board will
function as a standing peer panel or study section for the NSBRI's intramural core research
program, reviewing new proposals as required and providing an annual assessment of the quality
of the ongoing program. The initial meeting of the Board of Scientific Counselors was held on
June 7-11, 1998 at the NSBRI retreat location near Houston (Del Lago Conference Center). The
Board provided NSBRI management with a written critique of progress made during the
Institute's first year.
Finally, membership in the NSBRI User Panel is shown in Table 6. The User Panel met on June
9, 1998 at the Del Lago Conference Center during the NSBRI retreat. Short overview briefings
were provided by each of the Team Leaders in order to acquaint the panel with the general
approach taken by the Institute to develop countermeasures.
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Table 3. National Space Biomedical Research Institute BOARD OF DIRECTORS.
Bobby R. Alford, M.D. (Chairman and CEO)
Executive Vice President and Dean of Medicine
Baylor College of Medicine
Joseph V. Bonventre, M.D., Ph.D.
Co-Director, Harvard University-MIT
Division of Health Sciences & Technology
Harvard Medical School
Aaron Cohen
Zachry Professor
Department of Mechanical Engineering
Texas A&M University
E. Nigel Harris, M.D.
Dean and Senior Vice President
for Academic Affairs
Morehouse School of Medicine
Dennis Kasper, M.D.
Executive Dean of Academic Programs
Harvard Medical School
Joseph P. Kerwin, M.D.
Senior Vice President
Wyle Laboratories
J. David Litster, Ph.D.
Vice President for Research and
Dean of Graduate Education
Massachusetts Institute of Technology
Francis D. Moore, M.D.
Moseley Professor of Surgery, Emeritus
Harvard Medical School
Gary L. Smith, Ph.D.
Director
Johns Hopkins University
Applied Physics Laboratory
W. Dalton Tomlin (Secretary/Treasurer)
Senior Vice President and General Counsel
Baylor College of Medicine
Torsten N. Wiesel, M.D.
Former President
Rockefeller University
Laurence R. Young, Sc.D. (Ex Officio)
Director, NSBRI
Massachusetts Institute of Technology
William L. Allen
Editor
National Geographic Magazine
James F. Buchli
Manager, Mission Support
Boeing Defense & Systems Group
Michael DeBakey, M.D.
Chancellor Emeritus
Baylor College of Medicine
Richard J. Johns, M.D.
Distinguished Service Professor of Biomedical
Engineering and Professor of Medicine
Johns Hopkins Medical School
Robert A. Kennedy, Ph.D.
Vice President for Research and
Associate Provost for Graduate Studies
Texas A&M University
Jordan Konisky, Ph.D.
Vice Provost for Research and Graduate Studies
Rice University
Larry Mclntire, Ph.D.
Chairman, Institute of Biosciences and
Bioengineering & Department of Bioengineering
Rice University
James W. Patrick, Ph.D.
Vice President and Dean for Research
Professor of Neuroscience and
Chairman of the Division of Neuroscience
Baylor College of Medicine
Walter Sullivan, Ph.D.
Vice President of Operations and Planning
Morehouse School of Medicine
Arnold N. Weinberg, M.D.
Medical Director
Massachusetts Institute of Technology
Bernard Cohen, M.D. (Ex Officio)
Professor, Department of Neurology
Mount Sinai School of Medicine
16
Table4. National SpaceBiomedicalResearchInstituteEXTERNAL ADVISORY COUNCIL.
Bernard Cohen, M.D. (Chairman)
Professor, Department of Neurology
Mount Sinai School of Medicine
Antonio Gotto, M.D.
Provost for Medical Affairs
The Stephen and Suzanne Weiss Dean
Comell University Medical College
Michael F. Holick, M.D., Ph.D.
Professor of Medicine, Physiology
and Dermatology
Boston University Medical Center
Martin J. Kushmerick, M.D., Ph.D.
Professor of Radiology, Bioengineering and
Physiology and Biophysics
University of Washington School of Medicine
Robert Y. Moore, M.D., Ph.D.
Professor & Chairman
Department of Neurology
University of Pittsburgh
Richard M. Satava, M.D., F.A.C.S.
Professor of Surgery
Yale Laparoendoscopic Center
Warren K. Sinclair, Ph.D.
National Council on Radiation Protection &
Measurement
Thomas J. Wronsld, Ph.D.
Department of Physiological Sciences
The University of Florida
Ronald J. White, Ph.D. (Ex Officio)
Associate Director
National Space Biomedical Research Institute
Martin J. Fettman, D.V.M., Ph.D.
Mark L. Morris Chair in Clinical Nutrition
Department of Pathology
College of Veterinary Medicine & Biomedical
Sciences
Colorado State University
Michael N. Gould, Ph.D.
Professor of Human Oncology
University of Wisconsin
Ann R. Kennedy, D.Sc.
Richard Chamberlain Professor of Research Oncolog_r
Department of Radiation Oncology
University of Pennsylvania School of Medicine
Donald J. Marsh, M.D.
Dean of Medicine and Biological Sciences
Brown University School of Medicine
Danny A. Riley, Ph.D.
Department of Cellular Biology & Anatomy
Medical College of Wisconsin
M. Rhea Seddon, M.D.
Assistant Chief Medical Officer
Vanderbilt University Medical Center
Victor J. Wilson, Ph.D.
Professor of Neurophysiology
Rockefeller University
Bill J. Yates, Ph.D.
Assistant Professor of Otolaryngology
and Neuroscience
Eye and Ear Institute
University of Pittsburgh
Laurence R. Young, Sc.D. (Ex Officio)
Director, NSBRI
Massachusetts Institute of Technology
During the first year of operation of the Institute, we began a special activity in partnership with
the biomedical personnel at the Johnson Space Center called the Critical Path Roadmap Project.
This activity began for the NSBRI with a special workshop held in Houston from January 6 to
January 9, 1998. The purpose of the roadmap is to relate the biomedical risks and questions
critical to the human exploration of Mars to the sequence of risk mitigation activities. It is
designed to build a pathway that is dynamic and evolving as new knowledge and mission
planning develops. The Critical Path Workshop had three objectives. First, to define the risks to
crew health and performance resulting from a human expedition to Mars and to categorize those
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risksaccordingto their risk typeandlevel. Risksweredefinedby DISCIPLINE usingthe seven
scientific researchareasof theNSBRI asthe startinglist of disciplines. PrimaryRisks involve
knownrisks with severeimpactson eithermissioncompletionor crewhealthduringor afterthe
expedition. Potential Risks involve potential risks with severeimpactson either mission
completionor crewhealthduringor aftertheexpedition. SecondaryRisksincludeall otherrisks.
The secondobjectivewasto definethecritical questionsthatshouldbeaddressedfor eachRISK
definedaboveandto categorizethosequestionsasto their questiontype. Risk Definition or
Clarification Questionsare thosewhich involve questionsaimed at definingandclarifying a
Table5. NationalSpaceBiomedicalResearchInstituteBOARD OF SCIENTIFIC
COUNSELORS.
Hal E. Broxmeyer, Ph.D. (Chairman)
Indiana University School of Medicine
Cancer Research Institute Building
David J. Anderson, Ph.D.
Department of Electrical Engineering
and Computer Science
University of Michigan
James B. Bassingthwaighte, Ph.D.
Center for Bioengineering
University of Washington
Arthur A. Ciarkowski
Food and Drug Administration
Paul M. DeLuea, Jr., Ph.D.
Department of Medical Physics
University of Wisconsin-Madison
R. J. Michael Fry, M.D.
Oak Ridge National Laboratory
Peter E. Lipsky, M.D.
Department of Internal Medicine
University of Texas Southwestern Medical Center
Connie Weaver, Ph.D.
Department of Foods and Nutrition
Purdue University
H. Elliott Albers, Ph.D.
Laboratory ofNeuroendocrinology & Behavior
Departments of Biology & Psychology
Georgia State University
David M. Bader, Ph.D.
Vanderbilt School of Medicine
Division of Cardiology
Mary A. Carskadon, Ph.D.
Emma P. Bradley Hospital
Sleep Research Laboratory
Priscilla M. Clarkson, Ph.D.
Department of Exercise Science
School of Public Health and Health Sciences
Amherst
Paul A. DiZio, Ph.D.
Ashton Graybiel Spatial Orientation Laboratory
Brandeis University
Benjamin D. Levine, M.D.
Institute for Exercise & Environmental Medicine
Presbyterian Hospital of Dallas
Robert Marcus, M.D.
Geriatrics Research, Education & Clinical Center
Veterans Affairs Medical Center, Palo Alto
certain risk. Risk Mitigation Questions involve questions aimed at reducing or otherwise
mitigating a certain risk. The third objective was to initiate the development of a critical path
diagram by relating the questions defined above to each other by development of a critical path
flow diagram that includes the necessary research progression required to answer the questions
and mitigate the risk. This activity continued at the NSBRI retreat in June and is ongoing.
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As a result of extensive discussions during the first few months of the Institute's existence, the
NSBRI signed a five-year Affiliation Agreement with the Institute of Aerospace Medicine of the
German Aerospace Center in Krln, Germany on January 21, 1998. This agreement will enable
German scientists to join NSBRI Teams and will augment the NASA-funded projects with
complementary German-funded activities. The research projects to be undertaken by the German
scientists will consist entirely of new projects that have been peer reviewed in the standard
NSBRI manner, selected jointly by the NSBRI and the German Aerospace Center, and funded by
the German Aerospace Center. A copy of this agreement is included in Appendix D.
In the original NSBRI proposal, it was stated that "Every other year, beginning in 1999, the
Institute will hold a one-week retreat for all its investigators, Industry Forum and User Forum
members, and selected NASA scientists, medical personnel, and administrators. The purposes of
these retreats are to enable and encourage dialogue and synergy across the teams, to foster critical
examination of research pathways, and to enable technology transfer to and from the private
sector. This process should lead to a dynamic, synergistic research program appropriate to the
NSBRI."
Table 6. National Space Biomedical Research Institute USER PANEL.
David Hilmers, M.D. (Chairman)
Baylor College of Medicine
Ellen S. Baker, M.D., M.P.H.
Lyndon B. Johnson Space Center
William R. Carpentier, M.D.
Division Director of Nuclear Medicine
Scott & White
Temple, TX
John M. Fabian, Ph.D.
President & CEO
ANSER
Robert L. Gibson
Murfreesboro, TN
Byron K. Lichtenberg, Ph.D.
Gunbarrel, TX
Joseph P. Allen, Ph.D.
Chairman
Veridian
Roger D. Billiea, M.D.
Chief, Medical Operations Branch
Lyndon B. Johnson Space Center
Laurel B. Clark, M.D.
Lyndon B. Johnson Space Center
Owen K. Garriott, Ph.D.
Huntsville, AL
Joseph P. Kerwin, M.D.
Senior Vice President
Wyle Laboratories
Sam L. Pool, M.D.
Chief, Medical Sciences Division
Lyndon B. Johnson Space Center
It was decided to initiate the biennial retreats in 1998 instead of 1999 in order to foster a strong
sense of NSBRI identity as early as possible in the life of the Institute. The first retreat was held
from June 8 through June 11, 1998 at the Del Lago Conference Center just north of Houston.
The agenda for this retreat is included as Appendix E. The retreat was highly successful. Atten-
dance was over 200, including significant NASA participation. The first User Panel meeting and
the first Board of Scientific Counselors meeting were held in conjunction with the retreat. The
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NSBRI's Industry Forum played an important role in the retreat activities. Further steps in the
Critical Path Roadmap Project were taken at the retreat.
5.0 COMMERCIALIZATION, EDUCATION AND PUBLIC OUTREACH
Even before NASA selected the present consortium to form NSBRI, the consortium recognized
the critical importance to the future of human space exploration of close collaboration between
the NSBRI and the industrial community. For industry to build the operational systems to
support exploration, the Institute will have to find solutions to the deleterious effects of space
flight on humans. Conversely, the Institute will be strengthened by industry's efforts to identify
operational problems, contribute to cost-sharing, and assist in leveraging Federal support to the
Institute through cooperative activities. Thus, an Industry Forum (see Table 7) composed of
Table 7. Membership in the National Space Biomedical Research Institute INDUSTRY FORUM.
Patrick Bellamy
Director of Business Sales/Technical Support
Southwestern Bell
Jair Bobys
Silicon Graphics, Inc.
C. Thomas Caskey, M.D., F.A.C.P.
Senior Vice President
Merck Research Laboratories
James von Arx Harrison
Director, New Ventures
Draper Laboratories
Joseph P. Kerwin, M.D.
Senior Vice President
Wyle Laboratories
Cathy Lutz
Silicon Graphics, Inc.
Rick Reyes
Area Manager, Systems Engineering
Southwestern Bell
David R. Strome, Ph.D.
Director, Life Sciences Technical Operations
Veridian
David A. Watson, Ph.D. (Executive Secretary)
Information Dynamics, Inc.
Julianne Zimmerman
Payload Systems, Inc.
C. Donald Bishop
Executive Vice President and
Chief Operating Officer
Information Dynamics, Inc.
James F. Buchli
Manager, Mission Support
Boeing Defense & Systems Group
James Fountain
The Boeing Company
John Huffman
Corporate Research and Development
Medical Market Manager
Silicon Graphics, Inc.
Javier de Luis, Ph.D.
President
Payload Systems, Inc.
Homer Pien, Ph.D.
Manager, Biomedical Technologies
Draper Laboratories
Gerald Stafford
Program Development Director
Lockheed Martin
Saul A. Volansky, Ph.D.
Raytheon Company
Mark E. Wilson
The Boeing Company
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representatives from the aerospace industry, pharmaceutical companies, biotechnology finns, and
other relevant organizations was formed to: advise the Director and the Board of Directors,
provide technological advice and support to the Institute and its investigators, and assist in
technology transfer.
The Industry Forum has held two meetings (including one at the Institute retreat) and numerous
telecons to organize and discuss technology issues related to the NSBRI research program. The
members have developed a charter, guidelines for membership in the Forum and a proposal for
partnering, all of which are included in Appendix F.
The NSBRI education andpublic outreach activities directly support the mission of the Institute
that involves ensuring open involvement in the Institute's activities by the scientific community,
industry, and the public at large, and a robust exchange with NASA. By targeting multiple and
diverse populations, Institute outreach programs aim to inform a large community about NSBRI
activities; attract young people to related fields in science, engineering and medicine; provide
opportunities for promoting excellence and innovation in America's science education system;
promote scientific literacy among teachers, students and their families, and the general
population; and engender public awareness and appreciation of the opportunities and benefits of
space life sciences research. This is being accomplished through an integrated array of programs
that focuses on students and teachers at all levels, K-undergraduate, as well as the general public.
The educational programs created for the NSBRI respond to the needs of the full educational
spectrum and focus on three primary areas: creation of supplementary educational materials for
use by teachers and students in elementary and secondary schools; development of educational
opportunities and courses for undergraduate students and teachers; and production of educational
resources for school audiences and the general public using a variety of electronic media, such as
computer-based multimedia (including the World Wide Web), radio and television.
Activities in these three areas are supported by the creation of a compendium of existing
educational resources from NASA and NSBRI consortium institutions, and through the
identification of relevant content areas described within the National Science Education
Standards that can be taught by using space life sciences as unifying themes.
Within the overall vision of the Institute, NSBRI educational outreach activities have the
following objectives: promote scientific literacy among teachers, students and their families, and
the general population; foster excellence in America's science education systems; and engender
public awareness and appreciation of the opportunities and benefits of space life sciences
research. The educational programs created for the NSBRI respond to the needs of the full
educational spectrum and focus on the following three primary areas:
1. Creation of supplementary educational materials for use by teachers and students in
elementary and secondary schools.
2. Development of educational opportunities and courses for undergraduate students and
teachers.
3. Production of educational resources for school audiences and the general public using a
variety of electronic media, including computer-based multimedia, radio and television.
Activities in these three areas are supported by the creation of a compendium of existing
educational resources from NASA and NSBRI consortium institutions and through the
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identification of relevant content areas described within the National Science Education
Standards (National Research Council, 1996) that can be taught by using space life sciences as
unifying themes.
Current outreach activities are being led by teams at three consortium institutions: Morehouse
School of Medicine, Texas A&M University and Baylor College of Medicine. Project activities
being conducted by each partner are described below.
Morehouse School of Medicine (MSM). The goals of the MSM-NSBRI Education and Outreach
Program are to establish partnerships to produce multimedia educational materials that bring
NSBRI's science activities to America's teachers and students and that extend the benefits of
space life sciences technology to the general public. To accomplish these goals, the MSM-
NSBRI Education and Outreach Program is carrying out activities within the following areas.
1. Elementary and Secondary Education. MSM is developing the following products to
support elementary and secondary school education programs: (a) two secondary case-
based lessons (focusing on circadian rhythms and neurovestibular research), to be
prepared in consultation with the Harvard Medical School Teacher Institute; and (b) a
color version of the NASA-approved Neurolab curriculum, The Brain in Space, for
inclusion on the NSBRI educational Web site and dissemination to secondary school
audiences.
2. Undergraduate Education. MSM aims to attract young people to science careers through
the following two training and educational opportunities that introduce students to space
biomedical research: (a) design and implementation of a Human Body in Space Course
for undergraduate students, taught for the first time in spring, 1998; and (b) sponsorship
of internships for undergraduate students in the MSM Neuroscience Institute and the
MSM-NASA Space Medicine Life Sciences Research Center each summer. Both of
these programs were created to encourage women and minority-group students to pursue
careers in science and to provide pathways for students to access other NSBRI
opportunities.
3. Public Outreach. In collaboration with the Atlanta Educational Telecommunications
Collaborative (AETC), which encompasses Atlanta's Public Broadcasting Services (PBS)
television and radio activities, MSM is (a) creating a series of twelve short-format radio
programs (Life in Space) on NSBRI science and activities; (b) carrying out archival
filming to document the development of the NSBRI; and (c) establishing partnerships to
produce at least two PBS documentaries on NSBRI research and human exploration of
space.
4. Space Life Sciences Archives. MSM is establishing a multimedia archive containing
educational materials on human exploration of space and on NSBRI scientific and
technological developments. This archive will serve as a resource for all related education
and outreach activities. The film archives contain all footage and multimedia resources
associated with the Neurolab Education Program, a five-day teacher training workshop on
the brain, summer intern presentations, and selected NASA films and print materials.
Texas A&M University (TAMU). Education and outreach activities conducted by TAMU
provide innovative space life sciences learning experiences and resources for teachers. To this
end, current work is focusing on the following two primary project activities.
1. Teacher Academy Program. This activity is preparing a national group of teachers to lead
their peers in implementing learning activities in K-12 science classrooms. Young people
will thereby gain an understanding of the medical and policy issues associated with sus-
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,tained space flight to Mars. The Teacher Academy Program, initiated in summer 1997, is
designed to: (a) enhance the background of fellows of the Academy in medical science
concepts, and in the educational and research implications of sustained manned space
flight; (b) prepare a small national cadre of science teachers who will lead in the identifi-
cation, development and implementation of NSBRI-related learning activities in their
classrooms; (c) develop peer training protocols and develop leadership skills of the
Academy fellows to enable them to lead NSBRI staff development activities with out-
reach activities for other K-12 science teachers; and (d) collect instructional resources for
science teachers to use in teaching future citizens the medical concepts and issues
associated with sustained manned space flight.
Electronic Textbook--Website Development. Through applications of multimedia
technologies, TAMU is preparing electronic curricular materials for K-12 science
classrooms to promote students' understanding of the medical and policy issues
associated with sustained space flight to Mars. TAMU also is creating and managing the
primary educational Web site for NSBRI. These activities are focusing on (a) completing
the development of a prototype electronic on-line secondary school human physiology
course based on the text Human Physiology in Space (Lujan and White, 1997) and (b)
refining the Website homepage of the NSBRI education and outreach component, so that
educational resources provided by all partners and supporting resources will be available
through a centralized location.
Baylor College of Medicine (BCM). Education and outreach activities conducted by BCM aim
to (a) facilitate the acquisition of inquiry skills and science content knowledge--particularly in
the areas of physical, earth/space and life science related to the research areas of the NSBRI--by
elementary and secondary school teachers and students, and (b) generate public awareness and
enthusiasm for space biomedical research. These objectives are being met through the following
activities.
1. Resources for Educational Activities. To guide curriculum development and other
outreach activities, content areas described within the National Science Education
Standards (National Research Council, 1996) that can be taught by using space life topics
as unifying themes have been aligned to NSBRI research areas. The resulting matrices,
which identify grade level appropriate science concepts for grades K-4 and 5-8, guided
selection of the topics for supplementary curriculum materials. TAMU's outreach team
compiled a similar grid of concepts for grades 9-12.
2. Collaboration of scientists and educators for curriculum development. Unique topical
areas related to NSBRI research are being presented in an inquiry-based format for ele-
mentary and secondary school teachers, students and families. Ten age-appropriate,
supplemental K-12 curriculum modules based on space biomedical themes (two modules
per year) are being produced.
3. Public Education and Awareness. Bimonthly news format radio stories on NSBRI
research areas and related topics are being produced and distributed free-of-charge
through BCM's Radio HealthLine series to more than 2,800 radio stations nationally in
English and/or Spanish.
4. Support for Public Outreach. Public awareness of NSBRI research also is being engen-
dered through the following products designed to reach additional national audiences: (a)
an eight-by-eight foot traveling NSBRI exhibit for use at conventions; (b) a series of
informational brochures about the NSBRI and individual research team activities; (c)
activity-based educational posters for K-8 students, teachers and parents, to be distrib-
uted free-of-charge to approximately 8,400 elementary and middle schools (representing
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4,900,000students)in homestatesof consortiuminstitutions;and(d) anNSBRI Home
Web site for researchersandthegeneralpublic.
Thus, NSBRI educationand outreachactivities are designedto reach a wide spectrumof
audiences,includingundergraduatestudentsandK-12 schoolteachers,studentsandfamilies. In
addition to targetededucationalactivities, considerableeffortsarebeingdevotedto promoting
public understandingof the relevanceof NSBRI researchto solvingdiverseailmentson Earth.
To accomplishprogramgoalsefficiently, eachcollaboratinginstitution is focusingona different
subsetof activities,basedon individual areasof expertiseand experience. Outreachpartner
institutionsandareasof concentrationarepresentedin Table8.
Table 8. Outreach and Public Education Partners and Areas of Concentration
Educational Activities
MSM BCM TAM
INITIAl. ACTIVITIES
• Compendium of resources • [] []
• Outline of science concept_ [] • []
lIAR JHU MIT RIC NAS
K-12 CURRICULUM MODULES
• Create [] • []
• Field test [] • [] [] [] [] [] []
•Dis_mlnate [] • [] [] [] [] [] []
POSTSECONDARY EDUCATION
• Teacher Academy / internships [] [] •
• Curricula & student enhancement • [] •
[] [] [] [] []
[] [] [] [] []
ELECTRONIC MEDIA
• Educational wcbsite / CD-ROM • [] • • Indicates
• Educational Television • [] [] Lead
• Radin • • [] Institution
The major accomplishments in the education and public outreach area are summarized in Table
9.
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Table 9. First year accomplishments of the NSBRI education and public outreach team.
INSTITUTION YEAR ONE ACCOMPLISHMENTS
Morehouse School of
Medicine (MSM)
Texas A&M University
(TAMU)
Baylor College of Medicine
fBCM)
Neurolab curriculum completed--ready for Web conversion.
Undergraduate pilot course, The Human Body in Space, taught at
Spelman College in Spring 1998 (seven participants).
Students selected for 1998 12-week intensive MSM Neuroscience
Institute Summer Program (program also will sponsor two school-wide
lectures by Dr. Shin Yamazki and Dr. Clarence Sams).
Participated in 1997 NSBRI summer research program by two
Morehouse undergraduate students.
First stage approval, pre-production and staffing arrangements made
for June initiation of video filming production of documentaries by
AETC.
State-of-the-art technology suite, including AVID editing system,
established to create comprehensive space life sciences archives;
multimedia technology director hired.
Pilot Teacher Academy conducted during July 1997 (six participants).
Follow-up activities held for Teacher Academy Fellows in October and
November 1997, and in January, February and March 1998.
Two "Field Trip to Mars" workshops given to students and teachers
attending the Science, Technology and YOUth Symposium at TAMU
in March 1998.
Academy Fellows documented and refined classroom implementation
strategies and created web pages to present information and classroom
applications.
Second wave of 13 middle school Teacher Fellows (representing 11
states) recruited to participate in Teacher Academy, June 20-26.
NSBRI educational web site (nsbri.tamu.edu/-nsbri/) created and
under continued development; currently includes complete electronic
version of textbook, Human Physiology in Space and audio and video
media clips from NASA Spacelab Life Sciences Missions.
NSBRI research areas aligned to science standards for grades 9-12.
NSBRI research areas aligned to science standards for grades K-4 and
5-8.
Topics for development of ten supplementary curriculum modules
identified.
Field test version of K-4 educational module, Sleep and Daily
Rhythms, produced; currently being field tested in 20 classrooms with
ca. 400 students.
Background research and activities development underway for
educational module, Bones and Calcium, aimed at grades 5-8.
Three bimonthly Radio HealthLine stories produced and distributed for
broadcast; will be made available on NSBRI Web site.
Traveling NSBRI exhibit and nine informational brochures designed
and produced.
NSBRI home Web site (www.nsbri.org) deployed and under continued
development; recent features include video greetings by Directors and
Team Leaders, descriptions of research areas and projects, internal
information for NSBRI collaborators, and new user interface with pull-
down menus.
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6.0 INSTITUTE DIVERSITY AND SCIENTIFIC COMMUNITY OUTREACH
The initial NSBRI research program consists of 41 research projects focussed on eight research
areas and on synergistic activities relating two or more areas. The total number of different
principal and co-investigators involved in NSBRI research is 133 (see Appendix G for a list of
investigators). These investigators are from 25 different institutions: Andersen Consulting,
Australian Antarctic Division, Baylor College of Medicine, Brookhaven National Laboratory,
Brooklyn College, Dartmouth College, Harvard Medical School, Loma Linda University
Medical Center, Massachusetts Institute of Technology, Mayo Clinic, Morehouse School of
Medicine, NASA Johnson Space Center, SmithKline Beecham Pharmaceuticals, Texas A&M
University, The Johns Hopkins University, Uniformed Services University of the Health
Sciences, University of California, Irvine, University of Florida, University of Houston,
University of Pennsylvania, University of Texas Health Science Center at Houston, University of
Texas M. D. Anderson Cancer Center, University of Washington, University of Wisconsin, and
York University. Rice University, a member of the NSBRI consortium, does not participate
presently in the research program, but it does participate in the data archiving project of the
Institute.
Thus, the Institute activities include a diverse research base from the seven consortium member
schools and nineteen research institutions outside of the consortium. In order to broaden that
extramural base even more, the Institute developed an agreement with the National Institute on
Deafness and Other Communication Disorders to jointly fund research projects of mutual
interest. The NSBRI pledged to raise private money ($400,000/year) for its share of the monies
to support this joint program. This led to the publication of a Program Announcement in the
NIH Guide in June 1998. A copy of that announcement is included in Attachment H. Fourteen
investigators responded to that Program announcement. Selection is expected in the summer of
1999.
7.0 SPECIAL PROJECTS
In the Cooperative Agreement Management Plan (CAMP) signed by NASA and Institute
representatives on May 29, 1997, provision was made to undertake special projects outside of the
core funding envelope of the NSBRI. Section 5.6, dealing with Addition of Work Elements,
states that: "It is expected that additional specific work elements may be jointly agreed to be
within the original intent and within the overall scope of the NASA CAN and the resulting
CA/CAMP scope of this effort. An initial work element (project) identified in the CAN was the
Life Science Data Archive (LSDA) effort, which is not within the core funding envelope. NASA
and NSBRI agree that either entity can propose specific work element/projects that are within the
overall scope of the NASA CAN, but by their nature would not normally be research activities
included within the NSBRI core research plan. When both NASA and NSBRI agree to the
implementation of a new work element/project, a project plan will be prepared and included as a
supplement to the CA."
During the first year of Institute operation, four special projects were initiated. Three of them
were related to transitioning senior scientific personnel from a support contractor or visiting
scientist base to an academic research base more appropriate to their future role in the life
sciences program at both the Institute and JSC. The fourth had to do with the data archive
activity mentioned above.
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Project97-1,a Transition Plan for Senior Scientific Personnel Currently Employed by KRUG
Life Sciences Inc. (currently Wyle Laboratories), described a strategy to continue the
uninterrupted involvement of six identified employees of Wyle Laboratories (T. Brown, C.
Layne, V. McDonald, W. Waters, J. Wood, and S. Wood) as they transition from research (co-
investigator) involvement simultaneous with their Wyle employment. The strategy consisted of
three phases of activity, of six months duration each:
• Phase I (July 1, 1997 through December 31, 1997). During this period, an individual
transition plan was developed for each of the affected scientists. This was done by
interviewing each person and discussing their personal career plans, reviewing their
resumes, and arranging for visits with appropriate senior NSBRI scientists. The
transition plan took into account their own and NASA's research program and the
research strengths of the NSBRI.
• Phase II (January 1, 1998 through June 30, 1998). During this period, the individual
transition plans were implemented. Most persons transitioned from KRUG during this
period, so long as there was sufficient research funding to support them beyond the start
of FY 1999 (October 1998).
• Phase III (July 1, 1998 through December 31, 1998). During this period, all transitions
are to be completed. In fact, the goal of the plan was to complete transitions by the
beginning of FY 1999. The last three months (October - December 1998) were available
as a contingency period in case NASA funding decisions for new grant awards were not
made on schedule.
Project 97-2, Transition Plan." Universities Space Research Association (USRA) Visiting
Scientist Personnel, described a similar plan for five identified USRA employees (M. Clarke, J.
Conkin, P. Foster, R. Nammagudda, and J. Penkala), but with a time frame of only 15 months.
Finally, Project 97-3, National Space Biomedical Research Institute Visiting Scientist Research
Associate Program, established an appropriate host program for senior scientific personnel
within the Institute using Baylor College of Medicine infrastructure. Table 10 presents the final
results of implementing these three projects. Note that all transitions were completed no later
than October 1998, one of the goals set early in the development of these projects. Note also
that, at the request of NASA, two additional researchers were included in Project 97-3, one from
the Aerospace Medicine Residency Program and one from the National Research Council
Resident Research Associates Program. Projects 97-1 and 97-2 are complete and will end
officially by December 31, 1998. Project 97-3 is ongoing.
Project 98-I, the NSBRI Data Archive System, was initiated in April 1998, mid-way through the
first year of the research program. This project was identified in NASA's Cooperative
Agreement Notice (CAN) defining the basic structure of the NSBRI: "One of the initial projects
that may be supported by this Cooperative Agreement (outside of the core and grant funding)
will be the Life Sciences Data Archive Project (LSDA). This project, as it applies to the NSBRI,
is to ensure that all data collected as part of the NASA biomedical research program are properly
acquired, catalogued, archived, and disseminated to the general scientific community. Initially,
$400K/year will be provided to the Institute for collaborative work on this project. These funds
will be in addition to Institute core funding."
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Table 10. Life Sciences Scientific Personnel Transitions.
Name
Troy Brown, Ph.D.
Mark Clarke, Ph.D.
Johnny Conkin, Ph.D.
Dominick D'Aunno, M.D.
Philip Foster, M.D.
Initial Status
Wyle Employee
USRA Employee
USRA Employee
Aerospace
Medicine
Residency, UTMB
Galveston
USRA Employee
Final Status
Wyle Employee
(Support Staff Only) and
Adjunct Assistant
Professor, Baylor
College of Medicine
USRA Employee (Non-
Research Duties)
Assistant Professor,
Baylor College of
Medicine
Assistant Professor,
Baylor College of
Medicine
Assistant Professor,
Baylor College of
Medicine
Transition
Date
9/30/98
6/30/98
6/1/98
11/1/97
10/19/98
Brian Hashemi, Ph.D. NRC Resident Research Associate, 10/6/97
Research Associate Baylor College of
Medicine
Charles S. Layne, Ph.D. Wyle Employee Resigned 8/5/97
Vernon McDonald, Ph.D. Wyle Employee 9/30/98Wyle Employee
(Support Staff Only) and
Adjunct Assistant
Professor, Baylor
College of Medicine
Ram Nimmagudda, Ph.D. USRA Employee Resigned 3/31/98
Joseph Penkala, Ph.D. USRA Employee Resigned 1/11/98
Wendy Waters, Ph.D. Wyle Employee Assistant Professor, 11/24/97
Baylor College of
Medicine
JoAnna Wood, Ph.D. Wyle Employee Assistant Professor, 10/1/98
Baylor College of
Medicine
Scott Wood Wyle Employee Research Associate, 9/14/98
Baylor College of
Medicine
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Thus,Project98-1definestheplanto collect, catalogue,archive,andprovideretrievalaccessto
the scientific communityfor datacollectedundertheauspicesof theNSBRI. A team has been
formed from NSBRI Consortium members to establish an Institute Data Archiving System
(IDAS). The Team Leader is Lora L. Suther of the Johns Hopkins University Applied Physics
Laboratory (APL). Team members include Anthony Elam and Ross Reedstrom of Rice
University, and Joan Fetter and Bruce Hamill of APL. This team is responsible for identifying
the Institute data archiving needs and requirements, carrying out a functional analysis of those
requirements, and, finally, determining an architecture and design compatible with the Life
Sciences Data Archive (LSDA) at the Johnson Space Center. In addition, they are responsible
for establishing and maintaining the Institute data archive, identifying the operating procedures,
identifying data rights and release procedures, and specifying the management and development
process for Institute data archives.
The Institute Data Archive team has had several meetings with the NASA data archive group
based at JSC, presented the issues in data archiving to NSBRI researchers at the June retreat, and
selected a small number of model projects as examples to initiate archiving activities. The team
will receive its guidance and priorities from an Institute Special Interest Group focusing on data
archiving with representatives from each integrated research team and from the NASA data
archive group. This Special Interest Group will be chaired by Vincent Pisacane (Johns Hopkins
University Applied Physics Laboratory) and will have Ronald White, the Associate Director of
NSBRI as an ex-officio member. The planned architecture for the Institute archive is shown in
Figure 3.
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Figure 3. Architecture planned for the Institute Data Archiving System (IDAS).
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_SEAR_ A_A: Bone Lossl ......
PRINCIPAL INVESTIGATOR: Bert W, O'Malley, M.D.
ORGANIZATION: Baylor College of Medicine
PROJECT TITLE: Novel Receptor-Based Countermeasures to Microgravity-Induced
Bone Loss
FUNDING: $281,000 (FY1998)
PROJECT SUMMARY
The biological actions mediated by the estrogen receptor (ER), vitamin D receptor (VDR) and
Ca 2+ sensing receptor (CAR) play key roles in the normal control of bone growth and skeletal
turnover that is necessary for skeletal health. These receptors act by controlling the
differentiation and/or function of osteoblasts and osteoclasts, and other cell types within the bone
and bone marrow microenvironment. The appropriate use of selective ER modulators (SERMs)
which target bone, vitamin D analogs that favor bone formation relative to resorption, and CaR
agonists that modulate osteoclastogenesis, should make it possible to prevent the reduction in
bone formation and increase in bone resorption that normally contribute to the bone loss induced
by weightlessness. Indeed, there may be synergistic interactions among these receptors that
enhance the actions of any one used alone. Therefore, we propose to: 1) assess the in vitro
ability of novel ER, VDR and CaR agonists, alone or in combination, to modulate
osteoblastogenesis and mature osteoblast function under conditions of lg and simulated
microgravity; 2) assess the in vitro ability of novel ER, VDR and CaR agonists, alone or in
combination, to modulate osteoclastogenesis and bone resorption under conditions of lg and in
normal rat bone as well as the in vivo actions of our novel ER-and VDR-based therapeutics in
the rat in preparation for their use, alone or in combination, in well-established ground-based
models ofmicrogravity and eventually in space flight.
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PRINCIPAL INVESTIGATOR: Sus_aln A. Bloomfield, Ph.D.
ORGANIZATION: Texas A&M_Un!ye!'sity
PROJECT TITLE: Bone B!oodlF_ow During Simulated Mierogravity: Physiological
and Molecular Mechanisms
FUNDING: iii$212,000 (FY1998)
PROJECT SUMMARY
There is a demonstrable relationship between bone blood flow and indices of bone mass in
human and animal models. Large increases or decreases in bone blood flow appear to stimulate
resorption and/or suppress bone formation, resulting in decreases in bone mass. Preliminary data
indicate that blood flow to the rat femur decreases after 14 days of hindlimb suspension.
Administration of dobutamine, a f32-agonist, prevents the loss of cortical bone area observed after
28 days hindlimb suspension in adult rats. An increase in peripheral blood flow to the unloaded
hindlimb as stimulated by the g2-agonist may provide the mechanism for this protective effect.
Further, potential molecular mechanisms exist to link changes in bone blood flow to changes in
bone cell activity, particularly for vasoactive agents like endothelium-derived nitric oxide
(EDNO). The decreases in fluid shear stress associated with the shifts of plasma volume during
microgravity may result in alterations in expression of vasoactive agents such as EDNO having
important functional effects on bone cells. The primary aim of this project is to characterize
changes in 1) bone blood flow, 2) indices of bone mass, geometry, and strength, and 3) changes
in gene expression for modulators of nitric oxide activity (e.g., nitric oxide synthase) and other
candidate genes involved in mechanotransduction after 7, 14, 21, and 28 days of hindlimb
suspension in the adult rat. Utilizing the results of these studies, we will then define the
mechanistic contribution of altered blood flow to changes in bone with simulated microgravity
by administering a vasodilatory agent during hindlimb suspension. In all studies, responses in
the unloaded hindlimb bones (tibial shaft, femoral neck) will be compared with those in the
weightbearing humeral shaft and the non-weightbearing calvarium from the same animal. Bone
mineral density, mineral content, and geometry will be quantified by high-resolution
radiography; structural and material properties of the long bones will be determined by 3-point
bending (tibia humerus) or compression (femoral neck) testing to failure. A unique aspect of
these studies will be defining the time course of changes in gene expression in bone cell
populations with unloading, accomplished with Northern blots, in situ hybridization and
immunohistochemistry. These studies have high relevance for concurrent protocols being
proposed by investigators on NSBRI Cardiovascular and Muscle teams with blood flow data
available on a number of tissues other than a bone. Further, dobutamine and other g2-agonists
have been tested as countermeasures for altered muscle and cardiovascular function. Results of
the intervention tested in our studies have potential relevance for a number of systemic changes
seen with prolonged exposure to microgravity.
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RESEARCH AREA: Bone Loss iiiiiiiiiii"i iiii_ii_ii"i/i........................
PRINCIPAL INVESTIGATOR; .......Lester.W, Schultheis, M.D.
ORGANIZATION: Johns Hopkins School of Medicine
PROJECT TITLE: .....Th.e. Effec_ts._of.p.art.i.a!..Mfchanical Loading and Ibandronate on
Skeletal Tissues in the Adult Rat Hindquarter Suspension Model
for Mierogravity
FUNDING: $279,000 (FY1998)
PROJECT SUMMARY
Exposure to microgravity as occurs in extended space flight is associated with bone loss that
ranges from 0.5%-2.0% per month. Nutritional and physical countermeasures employed to
diminish bone loss have not thus far proven effective. We hypothesize that the maximal
protection against microgravity induced bone loss will be provided by a combination of partial
weight bearing and episodic full weight bearing, combined with ibandronate. Ibandronate, a
powerful, third generation bisphosphonate, can be administered parentally at infrequent intervals
with minimal toxicity. Specific aims: 1) The hindquarter suspended adult rat model of weight-
lessness will be studied using a novel force plate system for the application of graded amounts of
mechanical loading on the fore limbs. Animals will be suspended for 35 days after appropriate
acclimation, 2) the additional effect of episodic full weightbearing will be determined in the
suspended rat model, 3) The skeletal actions of ibandronate will be studied as a countermeasure
to bone loss, 4) Combination therapy of partial weightbearing on the forelimbs, episodic full
weightbearing and ibandronate will be evaluated. Ibandronate will be administered in a dose of
10 ug/kg, and 30 ug/kg on day 0. Specific cellular, histomorphometric, biochemical and
biomechanical properties of bone will be assayed and compared in control, suspended and
ibandronate treated animals.
Study Groups Year 1 (15 animals per group) • 1) control-free roaming, 2) hindlimb suspension-
force monitored, 3) hindlimb suspension-ibandronate 10 ug/kg, 4) hindlimb suspension-
ibandronate 30 ug/kg, 5) suspension-50% chronic weight bearing, 6) suspension-50% chronic
weightbearing and episodic full weightbearing. Study Groups Year 2: 1) control-free roaming,
2) hindlimb suspension-front full weightbearing, force plate monitored, 7) hindlimb suspension-
50% front weightbearing, ibandronate 10 ug/kg, 8) hindlimb suspension-50% front weight-
bearing, ibandronate 30 ug/kg, 9) suspension-50% front weightbearing + episodic full weight-
bearing + ibandronate, 10 ug/kg; 10) suspension-50% front weightbearing + episodic full weight-
bearing + ibandronate 30 ug/kg. Expected outcomes are that compared to the same bones under
non- weightbearing suspension: 1) 50% chronic weightbearing will reduce bone loss, 2) 50%
chronic weightbearing + episodic full weightbearing will further reduce bone loss, 3) ibandronate
will independently reduce bone loss, 4) ibandronate + 50% weight bearing + episodic full
weightbearing will further reduce bone loss. Thus, we will compare: 1) full weight bearing on
fore- and hindlimbs to unloaded hindlimbs and 50% weightbearing forelimbs, 2) episodic full
weightbearing to chronic full weightbearing and 50% only weightbearing models and, 3) the
effects of ibandronate in each model. This project will provide a comprehensive evaluation of
tissue and cellular effects of graded mechanical loads and antiresorptive therapy on bone. The
50% weightbearing model is relevant to the 0.4g environment on Mars and permits an evaluation
of potential limited artificial gravity on spacecraft.
B-4
Appendix B
RESEARCH AREA: Bone Loss ......
PRINCIPAL INVESTIGATOR: Christopher B. Ruff, Ph.D.
ORGANIZATION: Johns Hopkins University
PROJECT TITLE: Skeletal Structural Consequences of Reduced Gravity
Environments
FUNDING: $168,000 (FY1998)
PROJECT SUMMARY
The main goal of this project is to provide a better assessment of bone strength and fracture risk
following extended exposure to a microgravitational environment. Another goal is to evaluate the
effectiveness of countermeasures (intermittent or partial weight-bearing, resistive exercise, treatment
with bisphosphonates) in maintaining bone structure under conditions of microgravity. Using semi-
automated programs developed by us, bone structural parameters will be determined from DEXA
scans of the hip and thigh of astronauts/cosmonauts who flew aboard the Mir Space (data provided
by A. Leblanc and L. Schackelford). In addition, bone structural parameters of the femur and
humerus will be derived from pQCT scanning of rats subjected to partial weight-bearing, again with
and without treatment with periodic exercise and ibandronate. Bone stresses before and after
experimental periods will be calculated under simulated applied loadings. 3-D finite element
analyses will be used to verify and extend loading configurations, including loadings encountered
during space flight. Results will also be compared to those obtained from direct mechanical testing
of rat femurs and humeri.
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[_SEARCH A_A: C a r di0_cu_riilARe_ti_onsi- .............................
PRINCIPAL INVESTIGATOR: Go!:dQ_WiJ|!_.ms, M.D.
ORGANIZATION: Brigham and Women's hospital
PRO_CT TITLE: Cardiova.sc.u.|a._...Def.Qnd.itiloning in Humans: Human Studies Core
FUNDING: $420,000 (FY1998)
PROJECT SUMMARY
Major cardiovascular problems, secondary to cardiovascular deconditioning, may occur on
extended space missions. While it is generally assumed that the microgravity state is the primary
cause of cardiovascular deconditioning, sleep deprivation and disruption of diurnal rhythms may
also play an important role. Factors that could be modified by either or both of these per-
turbations include: autonomic function and short-term cardiovascular reflexes, nitric oxide
mediated vasoreactivity, circadian rhythm of cardiovascular hormones (specifically the renin-
angiotensin system) and renal sodium handling and hormonal influences on that process, venous
compliance, cardiac mass, and cardiac conduction processes. The purpose of the Human Studies
Core is to provide the infrastructure to conduct human experiments that will allow for the
assessment of the likely role of such factors in the space travel associated cardiovascular
deconditioning process and to develop appropriate countermeasures. The Core will take ad-
vantage of a newly created Intensive Physiologic Monitoring (IPM) Unit at the Brigham and
Women's Hospital, Boston, MA, to perform these studies.
The Core includes two general experimental protocols. The first protocol involves a supine bed-
rest study to simulate microgravity. The second protocol includes the addition of a disruption of
circadian rhythms to the simulated microgravity environment. Before and after each of these
environmental manipulations, the subjects will undergo acute intensive stressors simulating
changes in volume and/or stress, which could occur in space and on return to Earth. The subjects
will be maintained in a rigidly controlled environment with fixed light/dark cycles, activity
pattern, and dietary intake of nutrients, fluids, ions and calories.
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RESEARCH AREA: Cardiovascular Alterations
PRINCIPAL INVESTIGATOR: Richard Cohen, M.D., Ph.D.
ORGANIZATION: Massachusetts Institute of Technology
PROJECT TITLE: Cardiovascular Deconditioning in Humans: Alteration in
Cardiovascular Regulation and Function during Simulated
Microgravity
FUNDING: $140,000 (FY1998)
PROJECT SUMMARY
Alterations in cardiovascular regulation and function that occur during and after space flight have
been reported. These alterations are manifested, for example, by reduced orthostatic tolerance
upon reentry to the Earth's gravity from space. However, the precise physiologic mechanisms
responsible for these alterations remain to be fully elucidated. Perhaps, as a result, effective
countermeasures have yet to be developed. We propose to apply a powerful, new method -
cardiovascular system identification (CSI) - for the study of the effects of space flight on the
cardiovascular system so that effective countermeasures can be developed.
CSI involves the mathematical analysis of second-to-second fluctuations in non-invasively meas-
ured heart rate, arterial blood pressure (ABP), and instantaneous lung volume 0LV - respiratory
activity) in order to characterize quantitatively the physiologic mechanisms responsible for the
couplings between these signals. Through the characterization of all the physiologic mechanisms
coupling these signals, CSI provides a model of the closed-loop cardiovascular regulatory state in
an individual subject. The model includes quantitative descriptions of the heart rate baroreflex as
well as other important physiologic mechanisms. With an additional non-invasive measurement
of stroke volume (SV - ultrasound Doppler method), the model may be extended to also include
the characterization of the peripheral resistance baroreflex - which may play a central role in the
development of orthostatic intolerance - and measures of systolic and diastolic function.
We will apply CSI in conjunction with the two general protocols of the human studies core. The
first protocol involves ground-based, human bed-rest to simulate microgravity and acute stressors
- standing and lower body negative pressure (LBNP) - to provide orthostatic challenges. The
second protocol is the same as the first but with the addition of circadian rhythm disruption to
determine whether such disruption contributes to cardiovascular alterations. In these studies, we
will focus on the basic physiologic mechanisms responsible for the alterations in cardiovascular
regulation and function during the simulated microgravity in order to formulate hypotheses re-
garding what countermeasures are likely to be most effective.
In future studies, we plan to apply CSI to test the potential countermeasures in conjunction with
the same bed-rest and acute stressor models. We also anticipate applying CSI for studying astro-
nauts before and after space flight and ultimately, during space flight. The application of CSI,
along with the other specialized measurement techniques proposed for the human core studies,
promise to provide information relevant to the development and evaluation of effective counter-
measures allowing humans to adapt appropriately upon reentry to the Earth's gravity and to live
and work for longer periods of time in microgravity.
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RESEARCH AREA: Cardiovascular Alterations
PRINCIPAL INVESTIGATOR: Gordon H. Williams, M.D.
ORGANIZATION: Brigham and Women's Hospital
PROJECT TITLE: Renal and Cardio-Endocrine Responses in Humans to Simulated
Microgravity
FUNDING: Included in Human Studies Core Funding
PROJECT SUMMARY
The volume regulating systems are integrated to produce an appropriate response to both acute
and chronic volume changes. Their responses include changing the levels of the hormones and
neural inputs of the involved systems and/or changing the responsiveness of their target tissues.
Weightlessness during space travel produces a volume challenge which is unfamiliar to the or-
ganism. Thus, it is likely that these volume regulatory mechanisms may respond inappropriately,
e.g., a decrease in total body volume in space and abnormal responses to upright posture and
stress on return to Earth. A similar "inappropriateness" also can occur in disease states, e.g., con-
gestive heart failure. While it is clear that weightlessness produces profound changes in sodium
and volume homeostasis, the mechanisms responsible for these changes are incompletely under-
stood. Confounding this analysis is sleep deprivation, common in space travel, which can also
modify volume homeostatic mechanisms.
The purpose of this project is to provide the required understanding and then to design appropri-
ate countermeasures to reduce or eliminate the adverse effects of microgravity. To accomplish
this we will address five Specific Aims: 1) To test the hypothesis that microgravity modifies the
acute responsiveness of the renin-angiotensin-aldosterone system AAS) and renal blood flow;
2) Does simulated microgravity change the circadian rhythm of the volume-regulating hor-
mones?, 3) Does a simulated microgravity change the target tissue responsiveness to angiotensin
II (AnglI)?; 4) Does chronic sleep deprivation modify the circadian rhythm of the RAAS and
change the acute responsiveness of this system to posture beyond what a microgravity environ-
ment alone does? and 5) What effect does salt restriction have on the volume homeostatic and
neurohumoral responses to a microgravity environment? Because the renin-angiotensin system
(RAS) plays a pivotal role in blood pressure control and volume homeostasis, it likely is a major
mediator of the adaptive cardio-renal responses observed during space missions and will be a
special focus of this project. Thus, the overall goal of this proposal is to assess the impact of
microgravity and sleep deprivation in humans on volume-regulating systems. To achieve this
overall objective, we will evaluate renal blood flow and the status and responsiveness of the
volume-regulating systems (RAAS, atrial natriuretic peptide and vasopressin), and the adrenergic
system (plasma and urine catecholamines) in both simulated microgravity and normal gravity
with and without sleep deprivation. Furthermore, the responses of the volume homeostatic
mechanisms to acute stimulation by upright posture and exercise will be evaluated before and
after achieving equilibrium with these interventions.
This work has implications for the treatment and prevention of maladaptive hemodynamic responses
experienced by astronauts in flight and on return to Earth. It will increase our understanding of the
mechanisms by which weightlessness and sleep deprivation change plasma volume and sodium
homeostasis, thereby providing entrre to develop appropriate counter-measures.
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RESEARCH AREA: Cardiovascular Alterations
PRINCIPAL INVESTIGATOR: Artin A, Shoukas, Ph. D.
ORGANIZATION: Johns Hopkins University School of Medicine
PROJECT TITLE: Rodent Studies of Cardiovascular Deconditioning
FUNDING: $175,000 (FY1998)
PROJECT SUMMARY
Changes in cardiac output can occur for two reasons: the altered contractility of the heart or
through changes in venous filling pressure of the heart via the Frank Starling mechanism. The
observed changes in cardiac output after long term long term space flight cannot be entirely ex-
plained through changes in contractility or heart rate alone. Therefore, changes in filling
pressure mediated through changes in systemic venous capacitance function may be an important
determinant of cardiac after long-term space flight. Our laboratory has previously shown the im-
portance of veno-constriction by the carotid sinus baroreceptor reflex system on overall circula-
tory homeostasis and in particular the regulation of cardiac output.
Our proposed experiments will test our overall hypothesis, that alterations in venous capacitance
function by the carotid sinus baroreceptor reflex system is an important determinant of the
cardiac output response seen in astronauts after returning to Earth from long term exposure to
micro gravity. This hypothesis is important to our overall understanding of circulatory
adjustments made during long-term space flight as well as to provide for counter measures to
reduce the incidence of orthostatic hypotension caused by an attenuation of cardiac output. We
will use the tail suspended rat model to simulate the pathophysiological effects as they related to
cardiovascular deconditioning in microgravity. We will study the baroreceptor reflex control
from the organism level to the level of venous micro vessels and the adrenergic receptors
responsible for veno constriction. This proposal advances a novel hypothesis: orthostatic intol-
erance following microgravity exposure is due in part to changes in function of intestinal
(splanchnic) capacitance vessel alpha-1 adrenoreceptors (ARs). This hypothesis is based on: 1)
our preliminary animal and human data which demonstrate that inhibition of a single alpha-1 AR
subtype results in both blockade of sympathetically mediated splanchnic capacitance vessel
constriction and orthostatic intolerance, and 2) published studies which document intact efferent
sympathetic responses to postural stress (norepinephrine (N-E) release) in returning astronauts,
possibly pointing to a vascular smooth muscle insensitivity as contributing to orthostatic intoler-
ance. This proposal will test the hypothesis that simulated microgravity produces alterations in
alpha 1 A_R-mediated control of splanchnic capacitance vessel tone. A chronic rat model and in
vitro microvessel bioassay will be sued to investigate effects of simulated microgravity on
splanchnic vessel responses to adrenergic stimulation. These studies will provide important new
data concerning normal capacitance vessel function in compensating for postural blood volume
redistribution, test our novel hypothesis regarding the pathogenesis of orthostatic intolerance
following microgravity exposure and provide insights into potential countermeasures and thera-
pies to prevent problematic postural hypotension on reentry.
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RESEARCH AREA: Cardiovascular Alterations ..................................................
PRINCIPAL INVESTIGATOR: Roger D. Kamm, Ph. D.
ORGANIZATION: Massachusetts Institute of Technology
PROJECT TITLE: Computational Models of the Cardiovascular System and its
Response to Microgravity
FUNDING: $75,000 (FY1998)
PROJECT SUMMARY
Experimental studies of the cardiovascular system in humans, and even in laboratory animals, are
necessarily limited in scope because of restrictions on the types of measurements that can be
made. Often, the true parameter of interest cannot be measured directly so .it must be inferred
from other measures. Even when appropriate measurements can be made, the cause of the
observed variations may not be evident because of the complexity of the interactions between the
numerous components of the system. These and other issues can often be addressed more
effectively with the aid of a computational model that simulates the critical components and
behaviors of the cardiovascular system. Models depend upon experiments for refinement and
specification of their parameters, but also illuminate and enhance the interpretation of
experimental results. We view the experiments and computational models as highly synergistic
in that the value of one is greatly enhanced by the existence of the other. It could be argued that
these are not merely advantages, but essential aspects of a study of orthostatic intolerance.
The primary objectives of this project are to develop a general, modular model of cardiovascular
function that contains the essential features associated with the effects of gravity, and to use this
model to examine the short term effects of (1) transitions between normal gravity and micro-
gravity, (2) interventions to minimize or eliminate the adverse effects of re-entry, (3) counter-
measures that might be used by astronauts while in the micro-gravity environment and in
preparation for re-entry, and (4) screening measures that might be used to identify high risk
individuals who may require special interventions or countermeasures to avoid orthostatic
hypotension. The model will also be used in conjunction with land-based experiments on human
subjects to enhance the interpretation of the experimental data. We also propose to develop a
finite element model of the electrical activity of the heart to support research study of cardiac
electrical instability and arrhythmogenesis.
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RESEARCH AREA: Cardiovascular Alterations
PRINCIPAL INVESTIGATOR: Michael D. Schneider, M.D.
ORGANIZATION: Baylor College of Medicine
PROJECT TITLE: Cardiac Atrophy
FUNDING: $140,000 (FY1998)
PROJECT SUMMARY
The objective of this project is to determine the cellular and molecular mechanisms of cardiac
atrophy caused by microgravity (already demonstrated in space-flown rats), determine the func-
tional consequences on basal cardiac function and contractile reserve, and identify specific
countermeasures. We will study a well-established rodent model of cardiac unloading that re-
sults in atrophy, heterotopic transplantation of the heart to the abdomen, as a test-bed for genes
and gene products to protect against atrophy. The project will utilize measurements of cardiac
genes which modulate growth, contractility, and calcium homeostasis. Cardiac muscle cell con-
tractility and intracellular calcium will be assessed using fluorescence microscopy, and activity
of key endogenous growth regulators will be monitored. We propose to address three Specific
Aims: (1) Are ventricular myocyte intrinsic contractile function and intracellular calcium
regulation impaired in cardiac atrophy, and are endogenous growth-regulators affected, such as
the angiotensin converting enzyme (ACE)-angiotensin pathway, which augments growth and
contractility, and nitric oxide formation, which inhibits growth and contractility? (2) Do hor-
monal countermeasures with direct trophic effects on cardiac cell growth (growth hormone)
effectively blunt atrophy of the unloaded heart in vivo, or block the functional impairments? (3)
Do genetic countermeasures that augment cardiac protein synthesis protect myocardium from
cardiac atrophy?
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RESEARCH AREA: Cardiovascular Alterations
PRINCIPAL INVESTIGATOR: Richard J. Cohen, M,D,, Ph.D.
ORGANIZATION: Massachusetts Institute of Technology
PROJECT TITLE: Non'Invasive Assessment of Susceptibility To Ventrieular
Arrhythmias During Simulated Mierogravity
FUNDING: $10,800 (FY1998)
PROJECT SUMMARY
The Cardiovascular Alterations Team is currently conducting studies to determine what alterations in
hemodynamic regulation result from ten days of simulated microgravity exposure in normal human
subjects. We propose here to make additional measurements on these same study subjects in order
to determine whether there is an increase in susceptibility to ventricular arrhythmias resulting from
simulated microgravity exposure. We wish to emphasize the fact that all measurements described in
this proposal can be made with instruments already being used in our ongoing studies at no
additional expense and very little additional effort by the investigators and study subjects. The only
budget item is for fifty percent support for a graduate research assistant who will analyze the data
that will be generated by this effort.
Numerous anecdotal and documented reports from the past 30 years suggest that the incidence of
ventricular arrhythmias among astronauts is increased during space flight. For example,
documented runs of ventricular tachycardia have been recorded from crew members of Skylab
and Mir [Charles JB, Bungo MW, and Fortner GW, 1994, Yelle, in press], there was much at-
tention given by the lay press to Mir Commander Vasily Tsibliyev's complaints of heart rhythm
irregularities in July of 1997, and cardiovascular mechanisms are suspected to be causal in the
recent deaths of two experimental primates shortly after return from space [Richard Grindeland,
Bion 11 Project Scientist, personal communication]. In 1986, a Mir cosmonaut, Alexander
Laveikin, was brought home and replaced with an alternate cosmonaut as a result of cardiac dys-
rhythmias that began during extravehicular activity [Charles, 1998]. Furthermore, at a joint
NASA/NSBRI workshop held in January 1998, cardiac arrhythmias were identified as the
highest priority cardiovascular risk to a human Mars mission [Workshop to Develop Critical Path
Roadmap, 1998]. Despite the evidence for the risk of a potentially lethal arrhythmia resulting
from microgravity exposure, the effects of space flight and the associated physiologic stresses on
cardiac conduction processes are not known, and an increase in cardiac susceptibility to
arrhythmias has never been quantified.
In this project, we will determine whether simulated space flight increases the risk of developing
life-threatening heart rhythm disturbances such as sustained ventricular tachycardia (defined as
ventricular tachycardia lasting at least 30 seconds or resulting in hemodynamic collapse) and
ventricular fibrillation. We will obtain measures of cardiac susceptibility to ventricular arrhyth-
mias in subjects exposed to simulated space flight in the Human Studies Core protocol being
conducted by the Cardiovascular Alterations Team, which involves ten days of bed rest. In par-
ticular, we will apply a powerful new non-invasive technology, developed in Professor Cohen's
laboratory at MIT, for the quantitative assessment of the risk of life-threatening ventricular ar-
rhythmias. This technology involves the measurement of microvolt levels of T wave alternans
during exercise stress. In addition, we will obtain other non-invasive markers of susceptibility to
ventricular arrhythmias based on signal-averaged electrocardiography (SAECG), QT dispersion,
and 24 hour Holter monitoring (to detect non-sustained ventricular tachycardia and to assess
heart rate variability). We have also developed protocols to obtain these same measures on a
monthly basis for up to four months in subjects in the Bone Demineralization/Calcium Metabo-
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lism Team's long term bed-rest study. These protocols were submitted as an NSBRI Synergy
Proposal in February 1998.
The information obtained in this study will enable us to determine for the first time whether
simulated space flight has a systematic and measurable effect on susceptibility to life threatening
ventricular arrhythmias. The methodologies employed, such as T wave alternans analysis, are
very sensitive, and do not require the presence of visually apparent arrhythmias to quantify an
increased susceptibility to ventricular arrhythmias. Merely the presence of subtle alterations in T
wave morphology on the electrocardiogram indicates an increased susceptibility to such
arrhythmias. Therefore, we believe it will be possible to quantify an increase in susceptibility to
arrhythmias if it is present, even in a small population of healthy volunteers. In the event that
simulated space flight increases such susceptibility, we will be better able to hypothesize poten-
tial countermeasures, such as specific anti-arrhythmic agents and electrolyte therapy. In the
future, we may employ the same non-invasive measurement techniques to evaluate the
effectiveness of these countermeasures.
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RESEARCH AREA: Human PerformanceiFactors,:Sleep and Chronobiology ...........
PRINCIPAL INVESTIGATOR: ChadesA, Czeis|er, Ph.D., M.D.
ORGANIZATION: Harvard Medica[Schoo! and Brigham and Women's Hospital
PROJECT TITLE: Circadian Entrainment, Sleep-Wake Regulation and
Neurobehavioral Performance during Extended Duration Space
Flight
FUNDING: $390,600 (FY1998)
PROJECT SUMMARY
Sustaining high levels of performance throughout extended duration space missions requires: 1)
circadian entrainment of the intrinsic longer-than-24-hour period of the human circadian
pacemaker to the 24-hour day; 2) maintenance of an appropriate phase relation of the human
circadian pacemaker to the 24-h sleep-wake schedule. In space, astronauts are often exposed to
light-dark cycles that are characterized by either an abnormal period, i.e., 1.5 hours during Earth
orbit, or by a reduced intensity, i.e., between 20-50 lux in the angle of gaze, when the space craft
is illuminated artificially and under power constraints. Preliminary data suggest that such light-
dark cycles are inadequate to maintain the appropriate phase-relation between the 24-h sleep-
wake cycle and the circadian system and will typically result in misaiignment of circadian phase.
Such circadian phase misalignment can result in sleep disturbances, reduced attention,
gastrointestinal disorders and impaired daytime alertness. Our preliminary data suggest that
exposures to bright light episodes of very short duration are effective in resetting the human
circadian pacemaker.
Based on these preliminary results, we propose four testable hypotheses, the evaluation of which
will be critical for the development of effective countermeasures to prevent circadian misalign-
ment: 1) that synchronization of the human circadian pacemaker will be disturbed in men and
women by the reduction in LD cycle strength during space flight; 2) that this disturbed circadian
synchronization will result in the secretion of the sleep-promoting hormone melatonin during the
waking day, disturbed sleep, reduced growth hormone secretion, and impaired performance and
daytime alertness; 3) that four brief (12 minute) daily exposures to mid-day bright light (10,000
lux) will reestablish normal entrained circadian phase, resulting in improved sleep consolidation,
normalized sleep structure and endogenous growth hormone secretion and enhanced daytime per-
formance; and 4) that the same intermittent bright light exposures in the late evening will on
average worsen circadian phase misalignment, causing an exacerbation of the sleep disruption,
further reduction in growth hormone secretion and greater impairment of daytime performance.
To test hypotheses 1 and 2, a long-term (48-day) clinical trial is proposed for Year 1 utilizing
methodologies that allow direct measurement of endogenous circadian phase and amplitude
before, during and after extended duration exposure to an environment with a reduction in the
strength of external synchronizing cues [i.e., low (50 lux) daytime light intensities]. Hypotheses
3 and 4 will then be tested during Years 2 and 3 by evaluating the efficacy of properly timed
exposure to intermittent bright light as a countermeasure in a randomized, long-term clinical
trial. Subjects will be randomly assigned to receive four brief (12-minute) daily exposures to
bright light at either mid-day (treatment condition) or in the late evening (active "placebo"
condition) to evaluate intermittent mid'day bright light exposure as a countermeasure to maintain
appropriate circadian phase during entrainment.
This work has important implications for the treatment of circadian rhythm sleep disorders, such
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as delayed sleep phase syndrome and shift-work dyssomnia, which are anticipated to have a high
incidence and prevalence during extended duration space flight. Careful analysis of the efficacy
of brief, intermittent bright light episodes in the treatment of these conditions has important
ramifications for the practical application of bright light treatment during space flight, since
repetitive uninterrupted exposure to bright light for many hours each day would not be feasible
due to the operational demands of space missions. The results of the proposed research could
have a profound effect on the health, productivity and safety of astronauts during extended
missions, such as those planned for the International Space Station.
B-17
Appendix B
RESEARCH AREA: Human Performance F_c_ors, sleep and Chr0n0bioi0gy .......
PRINCIPAL INVESTIGATOR: David F, Dinges, Ph.D.
ORGANIZATION: University of Pennsylvania
PROJECT TITLE: Countermeasures to Neur0behavioral Deficits from Cumulative
Partial Sleep Deprivation During Space Flight
FUNDING: $297,700 (FY1998)
PROJECT SUMMARY
The performance capability of astronauts during extended duration space missions depends
heavily on achieving recovery through adequate sleep. Even with appropriate circadian
alignment, sleep loss will erode fundamental elements of human neurobehavioral performance
capability including vigilance, cognitive speed and accuracy, working memory, reaction time,
and physiological alertness, leading to diminished executive functions and loss of situational
awareness. Chronic sleep restriction has been a common experience during manned space flight,
occurring in response to endogenous disturbances of sleep by microgravity and related factors
(motion sickness, stress, circadian rhythms), environmental disruptions of sleep (noise,
temperature, light), and curtailment of sleep due to the extended work demands that accompany
space flight sustained operations. However, reductions in total sleep per 24 hr can lead to
elevated homeostatic pressure for sleep and compromise astronaut performance. Preliminary data
indicate that a "sleep debt" can lead to cumulative waking neurobehavioral deficits in the form of
vigilance errors, slowed thought processes, and fatigue. These experiments also reveal that such
deficits occur reliably when sleep is limited to 4-6 hr per day, which is a range commonly
experienced by astronauts. To counter cumulative waking deficits from sleep restriction, research
suggests that either the sleep drive must be met through increased duration of the major (anchor)
sleep period, and/or through the strategic use of a single pre-planned (preemptive) nap, which
also segments one long waking period into two shorter durations. However, there is a critical
deficiency in knowledge of the effects of varying combinations of anchor sleep and nap durations
that will yield the most efficient return of performance per unit time invested in sleep. The
primary aim of this project is to meet this critical deficiency through utilization of a response
surface experimental paradigm, testing in a dose-response manner varying combinations of
anchor sleep and nap sleep durations for the purpose of establishing how to most effectively limit
the cumulative effects of chronic sleep restriction in space flight. An algorithm involving a two-
stage regression analysis will be used to test the hypothesis that the addition of a relatively brief
preemptive nap to restricted sleep each day will markedly attenuate the slope (growth) of the
cumulative performance deficits developing across days. This approach will also be used to test
the hypothesis that the addition of a nap to anchor sleeps will yield the optimal sleep-related
secretion of growth hormone, which may be a natural countermeasure for limiting the effects of
microgravity on muscle, bone, and cardiovascular systems. To apply this approach, healthy men
and women will undergo a 14-day ground-based laboratory protocol involving random
assignment to one of 17 cells, each involving the same sleep ration for 10 consecutive days. The
sleep-ration assignments will involve 4 anchor sleep durations (4.2, 5.2, 6.2, 8.2 hr) and 6 nap
sleep durations (0.4, 0.8, 1.2, 1.6, 2.0, 2.4 hr) crossed to yield a total of 4 anchor-sleep-only
conditions, and 14 anchor + nap sleep conditions, and spanning a dynamic range of cumulative
sleep debts (i.e., up to 40 hr in a 10-day period). The results of this experiment will be used in
development of a mathematical model of the effects of cumulative sleep loss (across days)
relative to circadian dynamics (within days), in collaboration with investigators in Project 1. In
addition, the data will be used to prospectively test the hypothesis that a probed performance
algorithm, to be derived retrospectively from a database of previously sleep-deprived subjects,
can be used to prospectively predict individual vulnerability to sleep loss, thereby permitting
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more precise utilization of countermeasures for prevention of performance-impairing sleep loss
during extended manned space flight. The project affords a high return of information regarding
the duration and timing of sleep that most effectively promotes optimal waking performance and
healthy functioning during space flight.
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RESEARCH A_A: Human Performance Factors, Sleep and chr0n0bi010_ [
PRINCIPAL INVESTIGATOR: Derk-Jan Dijk, Ph.D.
I
ORGANIZATION: Harvard Medical School and Brigham and Women's Hospital
PROJECT TITLE: Quantitative EEG Monitoring of Vigilance: Effects of Sleep
Deprivation, Circadian Phase and Sympathetic Activation
FUNDING: $137,700 (FY1998)
PROJECT SUMMARY
Shuttle astronauts typically lose 2 hours of sleep per day while in orbit. This sleep loss is related
to recurrent sleep cycle shifting due to mission-dependent orbital mechanics and mission dura-
tion requirements, the operational demands of space flight, noise and space motion sickness.
Such cumulative sleep loss is known to produce predictable changes in sleep structure and the
spectral composition of the EEG during sleep, daytime sleepiness, reduced attention, negative
mood, slower reaction times, gastrointestinal disorders and impaired daytime alertness. The need
to develop effective but safe countermeasures to allow crew members to obtain an adequate
amount of sleep has been recognized and such countermeasures are being investigated. However,
it is necessary to develop methods which allow effective and attainable in-flight monitoring of
vigilance to evaluate the effectiveness of these countermeasures and to detect and predict online
critical decrements in alertness/performance. During the past decade we and others have demon-
strated that the spectral composition of the EEG during nonREM sleep accurately reflects the
status of the sleep homeostat, i.e. there is a quantitative relationship between EEG power density
and sleep loss even within the physiologic range of 1 to 2 hours of sleep loss. There is growing
evidence to indicate that the status of the sleep homeostat and the effects of sleep loss and
decrements in neurobehavioral function are also reflected in the spectral composition of the EEG.
Furthermore, our preliminary data indicate that these changes in the EEG during wakefulness are
more pronounced when subjects are in a supine posture. Since a supine posture mimics some of
the physiologic effects of microgravity, such as changes in sympathetic activation, these
preliminary data suggest that in microgravity EEG changes similar to those observed during
sleep deprivation while in a supine posture may occur. Therefore, we propose to evaluate the
following hypotheses: (1) that during a 40 h period of wakefulness (i.e., one night of total sleep
deprivation) neurobehavioral function deteriorates and EEG power density in the theta
frequencies increases especially in frontal areas of the brain; (2) that the sleep deprivation
induced deterioration of neurobehavioral function and changes in the spectral composition of the
EEG are more pronounced when subjects are in a supine position; and (3) that based on
quantitative on-line topographical analyses of EEG during wakefulness an EEG parameter can be
derived/constructed which accurately predicts changes in neurobehavioral function.
If shown to be accurate this EEG based online monitoring of alertness/performance would serve
as a practical and attainable tool to predict and prevent critical decrements in performance and
alertness. It would complement investigations of the effectiveness of countermeasures based on
neurobehavioral function. Understanding the relationship between EEG and neurobehavioral
function could thus have a profound effect on the health, productivity and safety of astronauts
during space missions. The proposed research is relevant for the round-the-clock work schedules
(day, evening and night work) on the International Space Station, the altered sleep/wake schedule
on a Mars surface station, or any other situation where the work-rest schedule is shifted and sleep
loss is incurred. It also has relevance for ground personnel monitoring orbiting crewmembers
who must do so working round-the-clock schedules.
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RESEAR_ AREA: Human Performance Fact0rs, sleep and Chr0n0biol0gy
PRINCIPAL INVESTIGATOR: Emery N. Brown, M,D., Ph.D.
ORGANIZATION: Harvard Medical School andMaSsachusetts General Hospital
PROJECT TITLE: On:Line Analysis of Physiologic and Neurobehavioral Variables
During Long-Duration Space Missions
FUNDING: $104,000 (FY1998)
PROJECT SUMMARY
The goal of this project is to develop reliable statistical algorithms for on-line analysis of
physiologic and neurobehavioral variables monitored during long-duration space missions.
Maintenance of physiologic and neurobehavioral homeostasis during long-duration space
missions is crucial for ensuring optimal crew performance. If countermeasures are not applied,
alterations in homeostasis will occur in nearly all physiologic systems. During such missions
data from most of the systems will be either continually and/or continuously monitored.
Therefore, if these data can be analyzed as they are acquired and the status of these systems can
be continually assessed, then once alterations are detected, appropriate countermeasures can be
applied to correct them.
One of the most important physiologic systems in which to maintain homeostasis during long-
duration missions is the circadian system. Alterations in the circadian system will occur due to loss
of contact with the normal geophysical light-dark cycles. Assessing the status of the circadian system
is an especially challenging task because this normally requires special protocols such as the constant
routine, free-run and forced desynchrony. Under these protocols the status of the circadian oscillator
is assessed by statistical analyses of phase, amplitude and period of circadian marker rhythms such
as core-temperature, cortisol, melatonin, mental alertness and actographic data. The use of these
protocols on long-duration space missions is not possible since they would disrupt crew work
schedules.
To detect and treat alterations in circadian physiology during long-duration space missions
requires development of: 1) a ground-based protocol to assess the status of the circadian system
under the light-dark environment in which crews in space will typically work; and 2) appropriate
statistical methods to make this assessment. The protocol in Project 1, Circadian Entrainment,
Sleep-Wake Regulation and Neurobehavioral will study human volunteers under the simulated
light-dark environment of long-duration space missions. Therefore, we propose to develop
statistical models to characterize in near real time circadian and neurobehavioral physiology
under these conditions.
The specific aims of this project are to test the hypotheses that: 1) Dynamic statistical methods
based on the Kronauer model of the human circadian system can be developed to estimate
circadian phase, period, amplitude from core-temperature data collected under simulated light-
dark conditions of long-duration space missions. 2) Analytic formulae and numerical algorithms
can be developed to compute the error in the estimates of circadian phase, period and amplitude
determined from the data in Specific Aim 1. 3) Statistical models can detect reliably in near real-
time (daily) significant alternations in the circadian physiology of individual subjects by
analyzing the circadian and neurobehavioral data collected in Project 1. 4) Criteria can be
developed using the Kronauer model and the recently developed Jewett model of cognitive
performance and subjective alertness to define altered circadian and neurobehavioral physiology
and to set conditions for immediate administration of countermeasures.
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Our framework will help ensure circadian and neurobehavioral homeostasis during long-duration
missions and will define paradigm for monitoring and maintaining homeostasis of other
physiologic systems under the same conditions.
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RESEARCH AREA: Human Performanc_ Factors, Sleep and Chronobm|ogy
PRINCIPAL INVESTIGATOR: .... Laur_enfe_ R. Young, Sc.D.
ORGANIZATION: Massachusetts Institute.0.f Technology
PROJECT TITLE: Principal Investigator-in-a-Box
FUNDING: $60,000 First Year ($30,000 FY1998)
PROJECT SUMMARY
This project will investigate the ability of a real-time expert system to improve performance and
reduce the time needed to diagnose errors and troubleshoot a realistic space life science
experiment that monitors sleep. The experiment will test the efficacy of "Principal Investigator
in a Box", or [PI], as a human factors tool for assisting relatively untrained "astronaut
surrogates" to detect and correct realistic experiment artifacts. It will be the first evaluation of
such a decision aid under controlled conditions, and should help to determine the applicability of
expert systems in future space flight research. Matched groups of subjects, receiving identical
training on sleep monitoring will be tested. Their time to detect and identify randomly
introduced artifacts and to complete a normal sleep monitoring calibration will be measured with
and without [PI]. Half of the subjects will receive [PI] assistance in their first, and half in their
second exposure to the tests. The expert system rules build on the existing [PI] strategies for
troubleshooting and error detection developed for the Neurolab Sleep experiment.
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NSBRI RESEARCH PROGRAM
IMMUNOLOGY, INFECTION AND HEMATOLOGY
Team Leader: Shearer, W. Baylor
Shearer, W.T. PI
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RESEARCH AREA: Immunology, Infection and Hematology
PRINCIPAL INVESTIGATOR: William T. Shearer, M.D., Ph.D.
ORGANIZATION: Baylor College of Medicine
PROJECT TITLE: Space Flight Immunodeficiency
FUNDING: $330,000 First Year ($165,000 FY1998)
PROJECT SUMMARY
The potential threat of immunosuppression and abnormal inflammatory responses in long-term
space travel, leading to unusual predilection for opportunistic infections, malignancy, and death,
is of major concern to the National Aeronautics and Space Administration (NASA) Program.
This application has been devised to seek answers to questions of altered immunity in space
travel raised by previous investigations spanning 30-plus years. We propose to do this with the
help of knowledge gained by the discovery of the molecular basis of many primary and
secondary immunodeficiency diseases and by application of molecular and genetic technology
not previously available. Two areas of immunity that previously received little attention in space
travel research will be emphasized: specific antibody responses and non-specific inflammation
and adhesion. Both of these areas of research Will not only add to the growing body of
information on the potential effects of space travel on the immune system, but be able to
delineate any functional alterations in systems important for antigen presentation, specific
immune memory, and cell:cell and cell:endothelium interactions. By more precisely defining
molecular dysfunction of components of the immune system, it is hoped that targeted methods of
prevention of immune damage in space could be devised.
We plan to use ground-based human and animal models of space travel existence in making
measurements of immune function. Human studies will include neo-antigen ((I)X 174
bacteriophage) challenge of research subjects before and after subjection to eight-month Antartic
isolation with the Australian National Antarctic R__search Expedition (ANARE) with Dr.
Desmond Lugg, Head of Polar Medicine, and six-month closed chamber isolation at the
NASA/Johnson Space Center in Houston, in collaboration with Dr. Duane L. Pierson, Director of
Microbiology and Dr. Clarence F. Sams, Director of Immunology. Assessments of specific
antibody production (IgM or primary and IgG or secondary), IgM to IgG class switching, and
antigen clearance will be useful in assessing antibody responses, antigen clearance, and T-cell
helper effects. In addition, using 3-color flow cytometry with new monoclonal reagents, we will
be able to detect differences in memory and naive T-cells and in activated and cytotoxic T-cells.
These new measurements will more carefully define the subpopulations of T-cells that carry out
specific effector function. Also, by studying lymphocyte responsiveness to recall antigens, we
will be able to detect harmful effects upon cellular-initiated immunity. By assessment of T-
lymphocyte helper type 1 (TH1) and TH2 cytokine secretion, we will be able to discern a loss of
cytotoxic T-lymphocyte control and a shift to inflammatory cytokine control. By determination
of the chemokine secretion patterns of human peripheral blood mononuclear cells, we will be
able to discern the likelihood of viral infection in subjects, since several viruses compete with
chemokines for chemokine receptor occupancy and cell entry. We will determine nonspecific
natural killer (NK) cell activity in subjects under space flight conditions to assess potential
damage to this primal protective cellular immune system. Lymphocyte apoptosis studies will
enable us to recognize whether space flight conditions accelerate the natural process of planned
cell death. Finally, with determination of proto-oncogene, oncogene, and transcription factors in
subjects under space flight conditions, we will be able to assess the possibility of abnormal gene
regulation. Since Dr. Janet Butel will be studying reactivation of latent viruses in these same
B-25
Appendix B
subjects in a research project of the Immunology, Infection, and Hematology Research Team,
currently funded by the National Space Biomedical Research Institute (NSBRI), we will be able
to correlate immune suppression with reactivation of latent virus infections.
Animal model studies by Dr. Wayne Smith will concem the stress and shear forces experienced by
cellular membrane adhesion molecules. Specifically, the model (anti-orthostatic suspension) system
is already being utilized by Dr. Janet Butel and Dr. Margaret Connor in the funded study on latent
viruses and immune function. This is an established model that induces many physiological changes
consistent with those observed in humans and animals returning from actual space flight. In an
effort to establish whether basic inflammatory mechanisms are influenced by simulated space flight,
we will elicit both non-specific, acute inflammation (ischemia/reperfusion), and relatively delayed,
antigen-induced specific inflammation (late phase allergic and delayed type hypersensitivity
responses) in anti-orthostatically suspended and control mice. Specifically, we will directly
determine if anti-orthostatic suspension affects various stages of leukocyte recruitment, which is a
key feature of inflammation. We anticipate that any changes in leukocyte recruitment induced by the
experimental conditions will significantly contribute to the development and/or resolution of
inflammation. In addition, since leukocyte recruitment is almost entirely dependent upon the
expression of and interactions between adhesion molecules, we will systematically measure adhesion
molecule expression on the surface of both endothelial cells and leukocytes. These assays will be
conducted in anti-orthostatically suspended and control mice, under non-inflamed and inflamed
conditions. It is likely that any observed changes in adhesion molecule expression will contribute
significantly to leukocyte recruitment and the overall inflammatory process. Finally, we will
systematically examine whether anti-orthostatic suspension affects the ability of inflammatory
leukocytes (neutrophils and macrophages) to perform basic functions, including oxidative burst,
phagocytic, bactericidal and candidacidal activity. Insight into these mechanisms in animals models
of anti-orthostatic suspension will enhance our understanding of the potentially increased infectious
susceptibility associated with long term space travel. The knowledge gained on the importance of
phagocytic and endothelial cellular adhesion recognition pathways will be shared with the other
NSBRI-funded research project on "Neocytolysis", headed by Dr. Clarence Alfrey, which concerns
cellular adhesion pathways on erythrocytes as part of its goals.
By exploring perturbations of specific and non-specific immunity in space models in humans and
animals, we expect to be able to make definitive statements concerning the types of cellular and
molecular dysfunction likely to be experienced by space travelers on long journeys. With better
definition of space-induced defects in immunity, it might be possible to avoid these changes with
specific immune intervention. Since immune reconstitution has now become the primary goal of
several human diseases, e.g. HIV-infected patients given highly active antiretroviral therapy, it may
be possible to prescribe specific immune prophylaxis or early treatment of space flight
immunodeficiency. Examples of such prophylaxis and treatment regimens would include potential
drugs, such as pentoxiphylline, which inhibits the inflammatory cytokine profile and boosts the
cytotoxic cytokine profile, and intravenous immunoglobulin, which contains a panoply of specific
antibodies to infectious agents.
B-26
Appendix B
_SE ARCH A_Ai i iiImmu_i_|ogy,-Jn]'ecfion-a-nd Hein af6iog3_ ..................................................................................
PRINCIPAL INVESTIGATOR: Janet S, Butel, Ph.D.
ORG ANI ZATI oN! i iBa ylo r College of Medicine
PROJECT TITLE. Immune Function and Reactivation of Latent Viruses
FUNDING: .........$277_006 (_i998i '_ .............................................................................
PROJECT SUMMARY
A major issue associated with long-duration space flight is whether infectious diseases will pose
an unacceptable medical risk for crewmembers. This project is designed to address several
questions raised in the Immunology/Infectious Disease Critical Path. We propose to assess the
possibility that long-duration space flight conditions may have adverse effects on the immune
system, that latent or persistent viruses may be reactivated and shed, and that reactivated viruses
may be transmitted among crew members within a confined environment. We will address these
questions by focusing on important viruses that establish latent or persistent infections in many
people (herpesviruses, polyomaviruses) and are capable of causing disease, either in the initial
host after reactivation or following transmission after reactivation to a susceptible person; on
functions of the mucosal immune system, the first line of defense against infection by many
viruses; and on gastroenteritis viruses (rotaviruses), both as mucosal immunogens and as agents
able to cause significant disease.
Specifically, we will determine the frequency and magnitude of reactivation and shedding of
latent herpesviruses and polyomaviruses under ground-based models of space flight conditions.
First, we will develop and standardize sensitive, quantitative PCR-based assays and establish
baseline patterns of reactivation and shedding using those assays in normal volunteers over time.
We will then proceed to testing ground-based analogs in collaboration with Dr. D. Pierson,
Lyndon B. Johnson Space Center. We believe this approach is necessary to be able to critically
evaluate the significance of any virus reactivations detected under space-flight conditions. We
will develop molecular genetic virus marker assays to track the transmission of reactivated
viruses in ground-based analog tests. We will determine whether immune clearance and
protection from mucosal virus infection (rotavirus) are altered in a ground-based mouse model
(the anti-orthostatic suspension of mice). Finally, we will determine whether subunit mucosal
vaccine countermeasures will induce immune response and protective efficacy in the ground-
based mouse model.
We expect that reactivation of latent viruses will be observed and that measurable changes in the
mucosal immune system will occur, but the extent of those virus reactivations and immune changes
cannot be predicted with confidence. This project is designed to evaluate whether adverse events
that occur are of such a nature and magnitude as to pose serious risks to the success of long-term
flight missions. Results from these studies will reveal if countermeasures are indicated; we plan to
test the use of a subunit mucosal vaccine as one potential countermeasure.
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RESEARCH AREA: Immunology, Infection and Hematology ............
PRINCIPAL INVESTIGATOR: George E. Fox, Ph.D.
ORGANIZATION: University of Houston
PROJECT TITLE: DNA Probe Design for Preflight and Inflight Microbial
Monitoring
FUNDING: $48,000 (FY1998)
PROJECT SUMMARY
Crew health is a dominant issue in manned space flight. Microbiological concerns, in particular,
have repeatedly emerged as determinants of flight readiness. For example, in at least one case,
suspected contamination of the potable water supply nearly forced a launch delay. In another
instance, a crewmember's urinary tract infection nearly led to early termination of the mission, in
part due to the difficulty of accurately diagnosing the nature of the infection inflight. Microbial
problems are an increasing concern with the trend towards longer-duration missions. It is
essential to the success of such missions that systems that deliver acceptable quality of air and
water during the anticipated lifetime of the spacecraft be available. As mission duration and
resupply intervals increase, it will be necessary to rely on advanced life support systems which
incorporate both biological and physical-chemical recycling methods for air and water as well as
provide food for the crew. It therefore is necessary to develop real-time, robust, inflight
monitoring procedures that are sensitive enough to detect less than 100 CFU (colony forming
units) of bacteria per 100 milliliters of water. It would be desirable if the monitoring system
could be readily "reprogrammed" to identify specific pathogens if an inflight incident were to
occur.
The long-term objective of the proposed work is to develop an automated hybridization system
that can be used to monitor microbial populations and, when necessary, to identify pathogens in
air and water samples during long-duration space missions. We will initially focus on the water
system with the intention of developing a prototype general purpose water analysis system as
soon as possible. Our specific aims in the current year are (1) to design a set of probes that can
in principle be used to simultaneously monitor the levels of total bacteria, fecal coliforms,
Escherichia coli, Pseudomonas aeruginosa, Enterococcus and Burkholderia; (2) to synthesize
and test the probes needed to implement the prototype system using a microtiter-format
fluorescence assay. The utility of each probe will be established individually and then verified
when all the probes are used together and to test a ground-based implementation of the probe
design using a prototype hybridization array, "DNA chip" system.
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_SEARCH AREA: Immun0iogy, In feet|on and'Hematoiogy ...............................................
PRINCIPAL INVESTIGATOR.; ............C !arenceP, A!frey, M.D., Ph.D.
ORGANIZATION: Baylor College of Medicine
PROJECT TITLE: Neocytolysis: Mechanisms and Limitations
FUNDING: $230,000 (FY1998)
PROJECT SUMMARY
For decades, it has been reproducibly demonstrated that astronauts journeying in space for even a
few days return to Earth with a significant, symptomatic anemia. A previously unsuspected
physiologic process that selectively hemolyzes the youngest circulating red blood cells under
conditions of red cell excess, termed "neocytolysis" is responsible for this change. This process
is operative not only in space flight, but it is generalizable to other physiologic adaptive and
pathophysiologic maladaptive situations. For example, neocytolysis occurs when polycythemic
individuals acclimated to high altitude are transported to sea level and can be prevented by
crythropoietin (Epo) injections. Renal failure represents a pathophysiologic situation in which
Epo is depressed, and neocytolysis may be related to the anemia of renal failure. The recognition
of neocytolysis is leading to a fresh look at the basis underlying a number of hematologic
disorders.
Changes in surface adhesion molecules may lead to an altered red cell-RE cell interaction that
culminates in neocytolysis. The proposed study herein begins to address whether the changes in
adhesion molecule expression are mainly in non-nucleated red cells or in the RE cell (both cells
are not known to have Epo receptors) or somehow through endothelial cell changes. Analysis
will include which adhesion molecules are affected and how, what levels of Epo deficiency are
required for initiation, and how can these factors be manipulated. A more basic understanding of
the process could be directly referable to a space travel countermeasure program. It would also
be directly applicable to hematologic disorders, including the anemia of renal disease. This
could be a sterling example of how insights gained from the space program can find unforeseen
applications in bettering the management of human disease. Finally, more fundamental
understanding of neocytolysis seems likely to have broad physiologic and pathophysiologic
implications. In addition, a viral gene transfer system will be developed that may have broad
application in many of the Institute studies.
Specific studies on the basic mechanisms underlying neocytolysis and the limitations of the
process will include:
1. Establish (for the first time) a panel of assays to define normal red cell adhesion
molecule expression
2. Quantitate differences between adhesion molecule expression in young red cells
(neocytes) and older cells
3. Establish an in vivo model of neocytolysis in normal volunteers given Epo injections.
Begin to define the minimum levels of polycythemia and of endogenous Epo
suppression necessary to initiate the process. Establish whether there are degrees of
neocytolysis, or whether it is an "all or none" phenomenon.
4. Analyze pre- and post- neocytolysis blood specimens in these Epo-treated volunteers
employing the previously established adhesion molecule assays. (How does adhesion
molecule expression differ after neocytolysis? Are these differences entirely
explained by a loss of young cells?)
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5. Investigate these same issues (adhesion molecules, limits of initiation and prevention)
through development of an animal model of neocytolysis, the exhypoxic polycythemic
mouse.
6. Investigate the borders of neocytolysis in this mouse model by inducing different
levels of constitutive Epo secretion through the use of viral vectors.
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RESEARCH AREA: MusCle Alterations and Atrophy .... :........
PRINCIPAL INVESTIGATOR: Robert J. Schwartz, Ph.D.
ORGANIZATION: Baylor College of Medicine
PROJECT TITLE: GH/IGF-I Transgene Expression on Muscle Homeostasis
FUNDING: $225,920 (FYI998)
PROJECT SUMMARY
We propose to test the hypothesis that the GH/IGF-I axis through autocrine/paracrine
mechanisms may provide long term muscle homeostasis under conditions of prolonged
weightlessness. As a key alternative to hormone replacement therapy, ectopic production of
hGH, growth hormone releasing hormone (GHRH), and IGF-I will be studied for its potential on
muscle mass impact in transgenic mice under simulated microgravity. Expression of either hGH
or IGF-I would provide a chronic source of a growth-promoting protein whose biosynthesis or
secretion is shut down in space. Muscle expression of the IGF-I transgene has demonstrated a
20-30% increase in hindlimb muscle mass over control nontransgenic litter mates. These recent
experiments, also establish the utility of hind-limb suspension in mice as a workable model to
study atrophy in weight bearing muscles. Thus, transgenic mice will be used in hind-limb
suspension models to determine the role of GH/IGF-I on maintenance of muscle mass and
whether concentric exercises might act in synergy with hormone treatment. As a means to
engineer and ensure long-term protein production that would be workable in humans, gene
therapy technology will be used by to monitor muscle mass preservation during hind-limb
suspension, after direct intramuscular injection of a genetically engineered muscle-specific vector
expressing GHRH. Effects of this gene-based therapy will be assessed in both fast twitch
(medial gastrocnemius) and slow twitch muscle (soleus). End-points include muscle size,
ultrastructure, fiber type, and contractile function, in normal animals, hindlimb suspension, and
reambulation.
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RESEARCH AREA: Muscle Alterations and Atrophy ................
PRINCIPAL INVESTIGATOR: Alfred Goldberg, M.D.
ORGANIZATION: ..... Ha_ar f!..Medical. Sc_hQo!..........
PROJECT TITLE: Effect of Unloading on Protein Content in Skeletal Muscle:
Regulation of the Ubiquitin-Proteasome System
FUNDING: $291,980 (FY1998)
PROJECT SUMMARY
Previous studies clearly show that the slow (Type I) myosin heavy chain (MHC) and other
contractile protein isoforms are down regulated in the antigravity muscles of mammals (rodents)
in response to space flight and/or hindlimb unloading. However, relatively little is known
concerning the regulation of this process at the subcellular/molecular level. The primary
objective of this proposal is to use the rodent hindlimb suspension model, in both the presence
and absence of a) resistance loading paradigms; and b)interventions altering the actions of
hormones known to regulate muscle protein turnover such as glucocorticoids in order to examine
the regulation of type I MHC expression at three distinct, but interrelated levels of investigation.
These include: 1) determining protein synthesis rates for fast and slow MHC isoforms relative to
that of total protein as well as determining if there are altered levels of known regulatory factors
involved in protein translation; 2) ascertaining the intrinsic level of activity of the ubiquitin-
proteasome system (changes in conjugating enzyme activity including El, E2, and E3; ubiquitin
and ubiquitin-protein conjugate levels, and proteolytic activity of the proteasome complex),
which has been demonstrated recently to be a primary pathway for degradation of proteins such
as myosin and other myofibrillar proteins in cell free extracts of skeletal muscle; and 3)
determining the transcriptional control of the type I MHC gene by measuring nuclear run-on
capacity (as well as activity of a transfected type I promoter construct) coupled with assessing the
relative expression of a battery of transcriptional factors (_e.g., transcriptional enhancing factor- 1,
myogenin, myo-D, thyroid receptors, and other putative factors) that interact with cis-regulatory
elements in the type I MHC promoter.
To achieve these objectives and to test the six working hypotheses proposed in the text of the
proposal, a series of experiments will be performed using adult female rats with initially stable
body and muscle mass, i.e., non growing muscles. In the first series of experiments (phase #1),
groups of animals will be studied after one, two, and four weeks of suspension in order to deter-
mine the rates of protein synthesis for MHC isoforms as well as the altered functional activity of
the ubiquitin-proteasome system including its specificity for degrading the slow type I and fast
type Iib native myosins in the context of the atrophy response. The experiments at the four-week
time point will be performed in order to identify markers for altered transcriptional activity of the
type I MHC gene. In the second series (phase #2), experiments will be performed to block the
interactive effects of glucocorticoids with its receptor complex in the cascade of events causing
muscle atrophy. Whereas, subsequent experiments (phase #3) will utilize a rodent heavy resis-
tance training paradigm as a countermeasure for the atrophic response. Collectively, these
experiments will more clearly define the role of several interactive processes in the control of
muscle protein turnover along with associated transcriptional factors specifically involved in the
control of slow MHC expression, which will be used as a marker system for regulation of muscle
atrophy. Also, these experiments will further delineate the role of specific hormonal activity
factors in either the induction of atrophy/and or the prevention of atrophy during states of
unloading.
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RESEARCH AREA: Muscle Alterations and Atrophy
PRINCIPAL INVESTIGATOR: Henry F. Epstein, M.D.
ORGAMZATION: Baylor College of Medicine
PROJECT TITLE: Molecular Signaling in Muscle Plasticity
FUNDING: $109,500 (FY1998)
PROJECT SUMMARY
Extended space flight under microgravity conditions leads to significant atrophy of weight-
bearing muscles. Atrophy and hypertrophy are the extreme outcomes of the high degree of
plasticity exhibited by skeletal muscle. Stimuli which control muscle plasticity include neuronal,
hormonal, nutritional, and mechanical inputs. The mechanical stimulus for muscle is directly
related to the work or exercise against a load performed. Little or no work is performed by
weight-bearing muscles under microgravity conditions. A major hypothesis is that focal
adhesion kinase (FAK) which is associated with integrin at the adherens junctions and
costameres of all skeletal muscles is an integral part of the major mechanism for molecular
signaling upon mechanical stimulation in all muscle fibers. Additionally, we propose that
myotonic protein kinase (DMPK) and dystrophin (DYSTR) also participate in distinct
mechanically-stimulated molecular signaling pathways that are most critical in type I and type II
muscle fibers, respectively. To test these hypotheses, we will use the paradigms of hindlimb
unloading and overloading in mice as models for microgravity conditions and a potential
exercise countermeasure, respectively, in mice. We expect that FAK loss-of-function will impair
hypertrophy and enhance atrophy in all skeletal muscle fibers whereas DYSTR and DMPK loss-
of-function will have similar but more selective effects on Type II and Type I fibers,
respectively. Gene expression will be monitored by muscle-specific creatine kinase M promoter-
reporter construct activity and specific mRNA and protein accumulation in the soleus (type I
primarily) and plantaris (type II primarily) muscles. With these paradigms and assays, the
following Specific Project Aims will be tested in genetically altered mice: 1) identify the roles of
DYSTR and its pathway; 2) evaluate the roles of the DMPK and its pathway; 3) characterize the
roles of FAK and its pathway and 4) genetically analyze the mechanisms and interactions
between the FAK, DYSTR, and DMPK-associated pathways in single and specific combinations
of mutants. The identification of potential signaling mechanisms may permit future development
of pharmacological countermeasures for amelioration and prevention of the microgravity-
induced atrophy in extended space flight, and the analysis of both overloading and unloading
paradigms may provide further support for development of exercise-based countermeasures.
Understanding the basic mechanisms of molecular signaling in muscle plasticity may aid our
understanding and treatment of skeletal muscle atrophy not only in space flight but in similar
problems of the aging population, in prolonged bedrest, and in cachexia associated with chronic
disease.
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RESEARCH ...................................................................
PRINCIPAL INVESTIGATOR; Susan L, Hami!ton, Ph,D.
ORGANIZATION:Ill iilBaYlor College of Medicine
PROJECT TITLE: Activity Dependent Signal Transduction in Skeletal Muscle
FUNDING: $94,900 (FY1998)
PROJECT SUMMARY
Significant loss of skeletal muscle mass, especially in slow twitch muscle, occurs in astronauts
exposed to microgravity for even relatively short periods of time. Additional damage to muscle
occurs upon return to Earth's gravitational field. To develop effective countermeasures the
molecular mechanisms that produce these changes need to be identified. We propose to identify
the early signal transduction events by which removal of load from the weightbearing muscles
alters signal transduction in the muscle ultimately leading to deconditioning and atrophy.
Our working hypothesis is that the transcription factor nuclear factor-vJ3 (NF-KB) acts as an
index of muscle activity and regulates the compiex adaptive response of skeletal muscle to
chronic loading. We propose to evaluate the early signal transduction mechanisms involved in
maintaining muscle phenotype. Preliminary data have shown that hind limb suspension, used as
a model of microgravity, alters both Ca 2+ levels and NF-KB signaling.. We postulate that
exposure to microgravity decreases the NF-KB signaling via a pathway that involves: 1) changes
in intracellular Ca 2÷, 2) a multi-step process involving enzymes such as calpain, protein kinase C
(PKC), and calcineurin, and 3) changes in phosphorylation, ubiquitin conjugation, degradation
by 26S proteasomes of I-KB and movement of NF-KB to the nucleus. NF-_:B in the nucleus
controls several different transcriptional events. We postulate that exposure to microgravity
decreases signaling via this pathway, leading to muscle atrophy. We will evaluate the effects of
hindlimb suspension on excitation-contraction coupling, the activity of several Ca z+enzymes and
NF-KB signaling pathways.
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RESEARCH A_A: MUscle Aiterati0ns and Atrophy ....................
PRINCIPAL INVESTIGATOR: Nadia A. Rosenthal, Ph.D.
ORGANIZATION: Harvard Medical School
PROJECT TITLE: MoleCUlar Mechanisms Regulating Muscle Fiber Composition
Under Microgravity
FUNDING: $135,900 (FY1998)
PROJECT SUMMARY
Molecular mechanisms regulating muscle fiber composition under microgravity. Drs. Rosenthal
(Harvard), and Baldwin(UC, Irvine) specifically proposed the hypothesis that impairment of load
bearing effect the distribution of E protein belonging to the basic helix-loop-helix (bHLH) family
of transcription factors and that these transfactors control muscle fiber type transitions.
Molecular mechanisms underlying the dramatic changes in muscle fiber composition produced
by weightlessness will be determined (Rosenthal). Several of the E proteins, belonging to the
bHLH family of transcription factors are differentially distributed among mammalian fiber types.
Moreover, mice carrying homozygous null mutations in several of the E proteins exhibit severe
postnatal muscle atrophy in each case due to a decrement in a different subset of fiber types.
These preliminary data underscore the potential importance of E proteins in regulating fiber-
specific patterns of muscle gene expression, and suggest that they may comprise upstream targets
for the effects of weightlessness. E protein composition and distribution will be characterized in
normal versus unweighted mouse muscles. Fiber specific expression of a potential E protein tar-
get, and the Skeletal a-actin promoter driven transgene, will be evaluated during hind-limb
unweighting. The SkA b-galactosidase gene in transgenic mice is severely reduced under
conditions of weightlessness. The effects of overexpression in vivo of E2-2 and HEB, E proteins
in transgenic mice will be used to evaluate their biological role in controlling fast type IIb and IIx
fibers respectively, on the fast fiber atrophy observed in unweighted and space flown mice.
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RESEARCH AREA: Muscle Alterations & Atrophy
PRINCIPAL INVESTIGATOR: Dennis R. Mosier, M.D., Ph.D.
ORGANIZATION: Baylor College of Medicine
PROJECT TITLE: Motoneuron Influences on Muscle Atrophy in Simulated
Microgravity Induced Muscle Atrophy
FUNDING: $116,800 (FY1998)
PROJECT SUMMARY
Numerous alterations in motor unit structure and function occur with exposure to microgravity
during space flight, many of which could result in impairment of motor performance. While
much work is ongoing to ascertain the nature of biochemical, structural, and physiological
changes originating in muscle fibers, comparatively little attention has been paid to the striking
changes occurring in motoneuron terminals at the skeletal neuromuscular junction during
exposure to microgravity. It is highly unlikely that these changes, whether primary or secondary
to changes in the muscle fibers innervated, are without consequences for the regulation of motor
unit function. Accordingly, the central hypothesis of this study is that alterations in motoneuron
structure and function occur during the process of microgravity-induced muscle atrophy, and that
these alterations may significantly influence muscle dysfunction, adaptation, and recovery from
atrophy induced by microgravity. These changes may be manifested as early structural and
functional alterations in the distal motoneuron terminal, in addition to alterations in motoneuron
activity produced by changes in supraspinal drive and in stretch reflexes during microgravity.
Initiation of these alterations in motoneuron terminals may be influenced by retrograde signals
from muscle which induce, as an early event, alterations in intracellular calcium and transmitter
release. A combination of electrophysiologic assays of presynaptic transmitter release, coupled
with light and electron microscopic assays of nerve terminal sprouting and junctional remodeling
and with electron microscopic assays of synaptic vesicles and intraterminal calcium, is proposed
to define quantitatively the nature, extent, and possible significance of changes in motoneuron
terminals occurring in a mouse model of unloading-induced muscle atrophy recently developed
to simulate aspects of muscle dysfunction in microgravity. This laboratory, in collaboration with
the laboratory of Dr. Stanley Appel and other members of the Department of Neurology at
Baylor College of Medicine, offers the ability to comprehensively test electrophysiological,
anatomical, and biochemical parameters of motoneuron function, particularly with respect to the
neuromuscular junction, which will be critical to further our understanding of motoneuron
influences on muscle atrophy. This approach will be further extended to determine
motoneuronaI responses to treatments designed to ameliorate muscle atrophy induced by
unloading, and to test the hypothesis that an activity-dependent growth factor released locally by
skeletal muscle may produce alterations in presynaptic terminals of innervating motoneurons.
The data produced by this study, in addition to increasing our knowledge of mechanisms
influencing motor unit dysfunction occurring during space travel, will result in a model with
which to test neural influences on other aspects of muscle dysfunction, and are expected to be of
interest to a number of different scientific and clinical areas of investigation.
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NEUROVESTIBULAR ADAPTATION
Team Leader: Oman, C.M. MIT
Shelhamer, M.J. PI
Goldberg, J. CO-I
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RESEARCH A_A: Neuro_e_tib_[_i_ i_dap_tation ............................................
PRINCIPAL INVESTIGATOR: Mark J. Shelhamer, Sc.D.
ORGANIZATION: Johns Hopkins School of Medicine
PROJECT TITLE: Context-Specific Adaptation of Gravity-Dependent Vestibular
Reflex Responses
FUNDING: $304,500 (FY1998)
PROJECT SUMMARY
Eye movements are important for keeping the images of objects stationary on our retinas, since
visual acuity can be significantly degraded with retinal slip of only a few degrees per second. Im-
pairment of this ability can lead to disorientation and reduced performance in sensorimotor tasks
such as piloting of spacecraft. Transitions between different gravitoinertial force environments -
as during different phases of space flight - provide an extreme test of the adaptive mechanisms. It
is vitally important to determine the adaptive capabilities of crewmembers in such a
circumstance, so that we can know to what extent the sensorimotor skills acquired in one gravity
environment will transfer to others. Our work will begin to lay the foundation for understanding
these capabilities, and for determining how we can aid the processes of adaptation and
readaptation.
An integrated set of experiments is planned to address this issue. We use the general approach of
adapting the vestibulo-ocular reflex (VOR) or the vestibulo-colic reflex (VCR) to a particular
change in gain or phase in one condition of gravitoinertial force, and adapting to a different gain
or phase (or asking for no change) in a second gravitoinertial force condition, and then seeing if
the gravitoinertial force itself- the context cue - can recall the previously learned adapted
responses. Previous evidence indicates that unless there is specific training to induce context-
specificity, reflex adaptation is sequential rather than simultaneous.
We will begin to investigate the behavioral properties, neurophysiological basis, and anatomical
substrate of context-specific learning mechanisms using otolith (gravity) signals as the contextual
cue for elaborating both the angular and the linear vestibulo-ocular reflex (AVOR and LVOR)
and the VCR. (By linear VOR we mean the oculomotor response - horizontal, vertical, and tor-
sional - to linear translation of the head and body; it is sometimes referred to as the translational-
LVOR.) We will study the effect of context on adaptation of the phase and gain of both the
AVOR and LVOR, on ocular counterrolling (OCR) in response to static head tilt, and on
head/neck reflexes (VCR) in response to centered and off-axis (eccentric) rotation. Such research
is particularly germane to potential problems of postural and oculomotor control upon exposure
to different gravitational environments.
The knowledge gained from these studies will help us to design potential pre-adaptation
strategies to assist flight crews in making transitions between different gravitoinertial force
situations, and can provide design data for spacecraft facilities (artificial gravity, exercise
centrifuge) by delineating the limits of human adaptive capabilities.
B-39
Appendix B
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PRINCIPAL INVESTIGATOR: Charles M. Oman Ph.D.
ORGANIZATION: Massachusetts !nstitute Of TeCl_n0i0gy .....
PROJECT TITLE: Visual Orientation in Unfamiliar Gravito-Inertial Environments
FUNDING: $324,700 (FY1998)
PROJECT SUMMARY
The goal of this project is to better understand the process of spatial orientation and navigation in
unfamiliar gravito-inertial environments. How do we estimate the location, direction, and tilt of
our body fixed ("egocentric") reference frame with respect to the external ("exocentric") frame
established by the environment? What cues do we use to keep track of this exocentric frame? Our
intrinsic sense of location ("place") and direction is ultimately visually determined. On Earth, the
gravitational stimulus to our otolith organs, and proprioceptors in skin, muscles and joints
strongly influence our sense of "down". In space, the gravitational "down" reference is absent, so
our sense of self-orientation becomes much more labile. Crewmembers "visually upright" in a
familiar area of the spacecraft are rarely disoriented. However, when working in an unfamiliar
"agravic" orientation, they sometimes misinterpret visual cues from surrounding objects, and
experience striking "visual reorientation illusions" (VRIs), and misperceive their own orientation
with respect to the environment, often because the walls, ceiling, and floors of the spacecraft
have exchanged subjective identities. VRIs trigger attacks of space motion sickness. VRIs occur
because of scene symmetries, and the subconscious assumption that the floor is beneath their
feet. Fluid shift and gravireceptor bias probably also contribute, and make certain astronauts feel
continuously inverted. Reports from MIR astronauts indicate that several weeks of
weightlessness are required before orientation and navigation become natural, particularly when
going between modules. Navigation in 0-G has not yet been studied. It appears crewmembers
learn routes, but that even after several months, they do not develop 3D "survey" knowledge of
the station. It is thought that there are large individual differences in the ability to remain
oriented using visual cues, and that experience in mockups, parabolic flight, neutral buoyancy
and virtual reality (VR) simulators helps. However, no techniques have been developed to
quantify individual differences in orientation and navigation abilities, or the effectiveness of
spacecraft-specific or generic preflight visual orientation training. Our understanding of the
underlying physiology - for example how orientation and navigation information is neurally
coded - is incomplete. We propose a set of collaborative experiments grouped under five specific
aims, each the responsibility of a lead investigator:
. To define how the strength of visually induced tilt and reorientation illusions in humans
depends on head orientation with respect to gravity, and the axis of scene polarity. How do
these illusions depend on the type of polarity of objects in the visual scene, and their
foreground vs. background location? Do they remain while the subject moves over an air
beating surface, or change with foot pressure cues? (Dr. Howard).
. To see whether the strength of tilt illusions and VRIs correlates with measures of visual field
dependence and gravireceptor bias when subjects using a head mounted display view a
compelling virtual visual environment. Do results correlate with the same subjects' p0stural
reactions to visual scene motion in Project 3? (Dr. Oman)
. To understand how human orientation and navigation depend on visual experience. Can
virtual reality techniques be used to improve orientation and navigation in simulated agravic
environments? Can and should subjects be trained to alternate between "exocentric" and
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°
"egocentric" visual orientation strategies? Does training influence response to measures of
visual field dependence? Postural responses to scene movement in Project 3? (Dr. Oman)
To understand how cognitive and motor abilities as well as visual polarity information
influence visually guided search and spatial memory in agravic environments. What
cognitive or motor abilities are critical in virtual reality training of visual search and memory
for spatial locations? Can added visual polarity cues and/or training within a space station
node improve visual search and spatial memory? Do search and memory improvements
within a node improve navigation between nodes? (Dr. Shebilske)
To develop an animal model for human visual orientation, to better understand some of the
neural correlates of visual reorientation illusions, and to define how the plane of head
direction cell response in the rat limbic system depends on visual, vestibular, gravireceptive,
proprioceptive and motoric cues both in 1-G and in parabolic flight. (Dr. Taube)
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RESEARCH AREA: Neu rovesiibuia rAdai_-tat|on .........................................................................
PRINCIPAL INVESTIGATOR: Conrad Wall, III, Ph.D.
ORGANIZATION: Hazard MedicalSchool
PROJECT TITLE: Advance.d,T.echp.!ques for Assessment of eostural and Locomotor
Ataxia, Spatial Orientation, and Gaze Stability
FUNDING: $350,800 (FY1998)
PROJECT SUMMARY
Major problems of space flight, in addition to adapting to microgravity, include postflight
difficulties with standing, walking, turning comers, and other activities that require stable upright
posture and gaze stability. These difficulties inhibit astronauts' ability to stand up, bail out or
escape from their vehicle during emergencies. The overall goal of this project is to develop
quantitative, parametric approaches for assessing gaze stability, and spatial orientation during
normal gait and when gait is perturbed. Compared to assessments of the vestibuo-ocular reflex,
analysis of vestibular effects on locomotor function is relatively less well developed and
quantified. We plan to improve this situation by applying the methodology of nonlinear orbital
stability to quantify responses in a single variable and by using multivariate statistical approaches
to link together the responses across separate tests, Inthis way we will exploit the information
available and increase the "resolving power" to discriminate between normal and pathological
responses. Responses will be studied with, and without, interactive visual environments.
Measures of stability and orientation will be compared and assessed with measures of dynamic
visual acuity and with other vestibular function tests. The responses of normal human subjects
and of subjects having well documented pathophysiologies will be characterized. When these
studies are completed, we should have a clearer idea about normal and abnormal patterns of eye,
head, and body movements during locomotion and their stability in a wide range of
environments. We will then use this information to characterize and validate neurovestibular
rehabitative approaches being developed in other projects.
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RESEARCH A_A: Radiation Effects: DNA Damage and Repair ........................................................................
PRINCIPAL INVESTIGATOR: John F. Dicello, Ph.D.
ORGANIZATION: Johns Hopkins Oncology Center
PROJECT TITLE: Radiation Effects: Core Project
FUNDING: $560,100 (FY1998)
PROJECT SUMMARY
The primary objective of this project is to determine the relative effectiveness of photons,
protons, and HZEs for tumorigenesis in female Sprague-Dawley rats at low doses. In addition,
as the lead project, this project will establish the protocols and supply appropriately irradiated
animals and controls for the other projects in Radiation Effects requiring them. The experimental
results from all projects within Radiation Effects will be combined and modeled in this project to
establish the relative efficiency of the different types of radiations to induce tumors and other late
effects. In a companion project, the novel use of a potentially mild pharmaceutical, tamoxifen
(TAM) will be studied in vivo as a countermeasure. Our group will model the results of this
known chemopreventor, which heretofore has been demonstrated to be an effective radiation
countermeasure only for photons. Molecular and genetic changes measured in other projects will
be modeled as well to establish correlations with carcinogenesis for eventually quantifying
individual levels of risk. Finally, these in vivo and other results will be used to derive a response
function and to normalize that response function for humans in order to improve risk assessment
accuracy.
This project will 1) perform all in vivo and in vitro irradiations with protons and HZE particles at
the accelerator facilities in collaboration with the investigators from the various projects; 2)
perform the biostatistics and dosimetry preparations for the biological irradiations; 3) coordinate
and correlate the biological data from this project and all others within the Radiation Effects
program and then model the results; 5) determine response functions as a function of particle
type and energy; 6) extrapolate and normalize these response functions to human response; and
7) improve estimations of risk based on new data from this program and other sources.
By combining the animal irradiations into a single core, we have been able to reduce the number
of animal irradiations in the Radiation Effects program to a minimum, with a corresponding
reduction in the number of shams and controls. Simultaneously, in collaboration with other
projects, we will effectively examine the novel use of relatively mild pharmaceuticals to
countermeasure observed effects of radiation exposures. Finally, two other studies originating
from this work and the interaction_s_of t_he investigators of this program with two other groups are
related to the goals of the overall program: Dr. Dicello is a co-investigator on studies proposed in
the Technology Program (R. Mauer) to develop a new approach for characterizing the doses in
space from secondary neutrons; and Dr. Dicello and colleagues with Dr. Jay Shapiro, the Lead
from the Bone Loss Program, are considering experimental methods to document changes in
bone marrow cell radiation sensitivity in astronauts.
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PRINCIPAL INVESTIGATOR: John F. Dicello, Ph.D.
ORGANIZATION: Johns Hopkins Oneology Center
PROJECT TITLE: Chemoprevention of Radiation Induced Rat Mammary Neoplasms
FUNDING: $139,900 (FY1998)
PROJECT SUMMARY
The carcinogenic effects of low-LET radiations such as x-rays, ),-rays, or electrons are relatively well
established environmental Earth exposures in experiments using the Sprague-Dawley rat mammary
tumor model, the antiestrogen tamoxifen has been shown to inhibit initiation and progression of
radiation-induced mammary tumors. Tamoxifen has also been shown to reduce the incidence of
contralateral secondary breast cancers in woman undergoing therapy for primary breast cancer.
Tamoxifen has thus been shown to be an effective chemopreventive agent in both animal models and
in humans, suggesting that, at least in the case of breast cancer, effective counter measures can
reduce the incidence of overt tumors.
This project seeks to evaluate the potential chemopreventive effects of tamoxifen for radiations to
which travelers may be exposed in space. As carcinogenic low-level radiation effects for space
travel remain unknown, we propose to mimic space radiations using energetic protons and iron
nuclei. We will determine whether the chemopreventive effects in mammary tumor formation
observed for tamoxifen in the Sprague-Dawley rat model following photon exposure can be
duplicated for these radiations.
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RESEARCH AREA: Radiation Effects: DNA Damage and Repair
PRINCIPAL INVESTIGATOR: ......Jerry R. Williams, Sc,D.
ORGANIZATION: Johns Hopkins Oncology Center
PROJECT TITLE: Radiation:Induced Cytogenetic Damage as a Predictor of Cancer
Risk for Protons and Fe Ions
FUNDING: $200,000 (FY1998)
PROJECT SUMMARY
This project will define the RBE for the induction of cytogenetic damage in relevant human and
rat cells as they respond to Fe ions and energetic protons compared to photons. Specifically, we
seek to determine whether cytogenetic response is a predictor of cancer induction in a rat model,
and if so, to use similar endpoints in human cells as a parameter to set exposure limits to these
radiations. In an analytic structure focusing on low dose and low dose-rate irradiation, we will
measure multiple cytogenetic endpoints induced in vitro in three important human cell types: the
peripheral lymphocyte, the hematopoietic stem cell and the mammary epithelial cell. We will
determine in each of these human cell types an RBE for in vitro induction of selected cytogenetic
endpoints by Fe ions and by energetic protons. We will perform parallel radiation studies in the
same cell types in Sprague-Dawley rats, the selected animal model, for both in vivo and in vitro
irradiation. Thus, this project will derive RBE values for three same cell types for both Fe ions
and energetic protons for both humans and for the Sprague-Dawley rat. These data will
demonstrate whether there is comparable response between cell types (lymphocyte versus bone
marrow versus mammary epithelium), between species (human versus rat) and between in vitro
and in vivo irradiation. We will compare the RBE for the induction of different cytogenetic
endpoints with the RBE for induction of cancer in the animal model. If the RBE in rat cells
correlates with the RBE for cancer induction, it will increase confidence that RBEs in human
cells can be used to predict astronaut cancer risk when exposed to radiation represented by Fe
nuclei and energetic protons.
Finally, we will address an important question relating to mechanisms in radiation- induced
breast cancer. We have demonstrated that lymphocytes and mammary epithelial cells from some
women at high risk for breast cancer are hypersusceptible to photon-induced damage, and
hypothesize that this radiosensitivity is a marker for increased cancer risk. Since the animal
model that the research team has chosen, the Sprague-Dawley rat is known to be
hypersusceptible to radiation carcinogenesis, it will be important to ask whether human cells that
are hypersusceptible to photon induced chromosomal damage are also more sensitive to the
representative space radiations. Therefore, we will determine RBEs for Fe ions and energetic
protons for induction of chromosomal damage in cells from women with elevated cancer risk that
are sensitive to photon radiation.
In summary, this project will determine RBE values for the induction of chromosomal damage in
a series of relevant human and rat cells from humans and from the Sprague-Dawley rat. The
intercomparison of these values should lead to answers of several important questions:
(1) What is the RBE for the induction of different forms of chromosomal damage induced in
relevant cells by Fe ions and by energetic protons?
(2) In comparing carcinogenesis to induction of chromosomal damage, is the RBE for response
of the target cells (mammary epithelial cells) closer to the value for breast cancer induction
than the RBE measured in other somatic cells (lymphocytes or hematopoietic stem cells)
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(3) Do cells that reside close to bony matrix (hematopoietic stem cells) experience more
chromosomal damage for space radiations when irradiated in situ than when irradiated in
vitro?
(4) Is there a systematic difference in RBE values between human cells and the same cells from
the selected animal model?
(5) Are photon-sensitive cells from women who are at elevated risk of breast cancer equally
sensitive to Fe ions and energetic protons?
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RESEARCH AREA: Radiation Effects: DNA Damage and Repair
PRINCIPAL INVESTIGATOR: Richard R. Sinden, Ph.D.
ORGANIZATION: Texas A&M University
PROJECT TITLE: Quantitation of Radiation Induced Deletion and Recombination
Events Associated with Repeated DNA Sequences
FUNDING: $50,000 (FY1998)
PROJECT SUMMARY
The goal of this proposal is to develop data on the relationship between gene mutations,
including deletions and recombination associated with direct repeats, and the quantity and quality
of the radiation that interacts with the biological system so that countermeasures designed to
minimize the health risks of radiation exposure in space can be devised. We will accomplish this
by quantifying the rate of deletions between direct repeats, which may involve primer-template
misalignment, recombination, or gene conversion in human cells following exposure to
radiations which reproduce the energy deposition patterns produced in individual cells by the
radiation environment in space. Using cell lines developed in the Sinden Lab that provide
sensitive reporters of mutations involving deletions between direct repeats and recombination
events, we will quantitate the rate of mutations in irradiated cells and in progeny of irradiated
cells following exposure. In addition, we will develop additional reporter constructs to increase
the sensitivity of measuring recombination events mediated by long direct repeats. The
hypothesis driving this proposal is that DNA damage introduced by high-energy (HZE) particles
induces aberrant DNA repair events, involving repeated DNA sequences that lead to
recombination, gene conversion, or other mutation, that initiate the sequence of cytogenetic and
functional changes which manifest themselves as the long term health effects of radiation
exposure in space, including cancer. Knowing the types of mutational events induced by
different radiations will contribute to sound decisions for optimizing shielding and reducing
biological consequences through use of radioprotective drugs. The cell lines and procedures
utilized in this proposal will be directly applicable to studies of the effect of radioprotective
drugs.
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RESEARCH AREA: Technology Development
PRINCIPAL INVESTIGATOR: Harry K. Charles, Jr., Ph.D.
ORGANIZATION: Johns Hopkins University Applied Physics Laboratory
PROJECT TITLE: Compact, High Precision, Multiple Projection DEXA Scanner
FUNDING: $310,000 (FY1998)
PROJECT SUMMARY
The atrophy of bone and muscle in microgravity is well known, and the mitigation of this
problem is an inevitable issue for long-term manned space flight. In order to gauge the
magnitude of the problem, and the efficacy of countermeasures, suitable means for assessing
status of the musculoskeletal system must be available to the astronauts during space flight.
Such means of assessment must provide measurements of both muscle and bone with a high
degree of precision. We propose to build and test a scanning system based on the principles of
dual energy x-ray absorptiometry. The device will be a logical extension of commercial bone
mineral scanning systems but it will differ in several ways. First, the scanner will be designed
not only to measure conventional bone mass and to decompose sol tissue into measurements of
fat and lean mass, but to use those measurements to derive structural properties permitting an
assessment of the biomechanical consequences of a microgravity on bone or muscle mass.
Multiple projection fan beam technology together with axial translation will be employed to
provide geometric properties in three dimensions, suitable for a three dimensional structural
analysis of the scanned region. Second, advanced fabrication techniques will be employed to
optimize the volume and mass of the scanner as appropriate for the space environment, while
maintaining required mechanical rigidity. Advanced electronic fabrication technologies such as
chip-on-board and multichip modules will be utilized to minimize size and weight while
maintaining overall system reliability. Commercial (off the shelf) parts will be incorporated
whenever possible to minimize system cost. Power, heat dissipation, and mechanical properties
will be optimized for the space environment.
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RESEARCH AREA: Technology Development
PRINCIPAL INVESTIGATOR: Richard J. Cohen, M.D., Ph.D.
ORGANIZATION: Massachusetts Institute of Technology
PROJECT TITLE: Instrumentation for Non-Invasive Assessment of Cardiovascular
Regulation
FUNDING: $110,000 (FY1998)
PROJECT SUMMARY
It is critically important to be able to assess alterations in cardiovascular regulation during and
after space flight. We propose to develop an instrument for the non-invasive assessment of such
alterations that can be used on the ground and potentially during space flight. This
instrumentation would be used by the Cardiovascular Alterations Team at multiple sites for the
study of the effects of space flight on the cardiovascular system and the evaluation of
countermeasures. In particular, the Cardiovascular Alterations Team will use this
instrumentation in conjunction with ground-based human bed-rest studies and during application
of acute stressors (e.g., tilt, lower body negative pressure, exercise) as well as in animal studies.
In future studies, the Cardiovascular Alterations Team anticipates using this instrumentation to
study astronauts before and after space flight and ultimately, during space flight. The
instrumentation may also be used by the Neurovestibular Team and the Human Performance
Factors, Sleep and Chronobiology Team to measure changes in autonomic nervous function.
The instrumentation will be based on a powerful new technology -- cardiovascular system
identification (CSI) -- which has been developed in our laboratory. CSI provides a non-invasive
approach for the study of alterations in cardiovascular regulation. This approach involves the
analysis of second-to-second fluctuations in physiologic signals such as heart rate and non-
invasively measured arterial blood pressure in order to characterize quantitatively the physiologic
mechanisms responsible for the couplings between these signals. Through the characterization
of multiple physiologic mechanisms, CSI provides a closed-loop model of the cardiovascular
regulatory state in an individual subject.
The application of CSI currently requires off-line computerized analysis of recorded physiologic
signals by an expert user. The user interacts iteratively with the computer to preproeess the data,
select data segments for analysis, run the CSI analyses, and evaluate and interpret the results. In
this project, we will develop integrated instrumentation capable of acquiring the physiologic
signals, performing the CSI analysis in a fully automated fashion, and displaying the results on-
line. The design of this instrumentation will be such that users with minimal training (including
astronauts and other NSBRI investigators) can perform CSI conveniently and effectively.
The availability of this instrumentation is essential for effectively studying the cardiovascular
effects of space flight and for the subsequent development and evaluation of appropriate
countermeasures. The development of such instrumentation may also have significant clinical
impact on the diagnosis and treatment of patients with a variety of cardiovascular and neurologic
disorders.
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RESEARCH AREA: T ech n QI9gy_De-veY-opment ..................................................................................................................................
PRINCIPAL INVESTIGATOR: ,_char_d S,,ppt_mber, Ph.D.
ORGANIZATION:J0hns Hopkins University Applied Physics Laboratory
PROJECT TITLE: Miniature T_.me-o.J':Fiight Mass Spectrometer
F_ING: $250,000 (FY1998)
PROJECT SUMMARY
A small, high resolution, time-of-flight mass spectrometer (TOFMS) will be designed, fabricated
and tested for long duration space flight. This instrument can be used to identify solids, liquids
and gases of both chemical and biological origins to quantify the habitat environment and
support biomedical research and medical care. Several miniature TOF mass spectrometers for
military use are presently under development at The Johns Hopkins University Applied Physics
Laboratory (JHU/APL) using unique multi-electrode TOF analyzers to characterize biological
and chemical compounds. The use of TOFMS in space varies from the analysis of chemicals and
microorganisms in the spacecraft environment to the analysis of microorganisms in body fluids,
breath, and space bioreactors. The virtue of the YHU/APL TOFMS technologies resides in the
promise for a small (less than one cubic ft), lightweight (less than 5 kg), low power (less than 50
watts), device that can be used continuously with advanced signal processing diagnostics.
Further, the quantitative and electronic nature of the TOFMS output makes it ideal for telemetry
to Earth.
The TOFMS system could use either laser desorption and ionization methods, or electron impact
methods to ionize compounds for analysis in near-real time with sensitivities down to the
attomole (10 "ts mole). The JHU/APL approach is to design the instrument for both wide mass
range and fine mass resolution by the use of electronic control in a tandem mass spectrometer
instrument. The tandem approach will provide both mass separation and exquisite mass
resolution for the precise characterization of many compounds. To date, the JHU/APL approach
for military application has demonstrated mass capability beyond 10,000 atomic mass units
(amu) in a very small, low power prototype for biological analysis.
This space instrument should be of value to the Hematology, Immunology, and Infection and
Muscle Alterations and Atrophy Research Teams, as well as being useful for gathering data on
other NASA experiments, such as in the Space Bio-reactor Systems. In addition to its low size,
weight, and power, the TOFMS offers tremendous savings in requirements for the transport and
stowage of materials. Therefore, this three-year project will work closely with collaborators in
the other NSBRI research teams and NASA Johnson Space Center investigations to develop
TOFMS system sampling, ionization, and analysis tools for high priority compounds and
microorganisms. The identification of analysis requirements and sample collection procedures
will lead to the focused development of a prototype TOFMS system for long duration space
flight.
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IRESEARCH AREA: Technoiogy Devdopment ....................................... .......
PRINCIPAL INVESTIGATOR; Richard H, Maurer, Ph.D.
ORGANIZATION: J0hns Hopkins University Applied Physics Laboratory
PROJECT TITLE: !n-Situ Spectrometry of Neutrons
FUNDING: $280,000 (FY1998)
PROJECT SUMMARY
This project proposes to build an in situ portable neutron spectrometer to monitor the neutron
environment produced by collisions of high energy charged primary cosmic rays with space
structures, with planetary atmospheres and surfaces. The instrument will combine two detection
systems--a proportional counter to detect low energy neutrons between 100 eV and 500 keV, as
well as counting neutrons with energies less than 100 eV, and a silicon solid state detector array
to detect neutrons between several hundred keV and 500 MeV.
Standard pulse height analysis techniques and instrument data handling electronics will be
employed to produce energy spectra from charge deposited by the secondaries created in the
neutron-silicon collision. Data processing will produce consequent neutron energy spectra and
will also calculate equivalent dose by converting energy deposited in silicon to that deposited in
tissue using the appropriate quality factors for damage. The instrument will be less than 10 kg to
insure portability. No animal or human testing is involved in this project.
This proposal responds to the need for such an instrument as indicated by both Johnson Space
Center experts and the chairman of the NSBRI Radiation Effects Team who is a co-investigator
on this project. It utilizes the substantial experience of the Applied Physics Laboratory in the
development of space instrumentation, will address the concerns and requirements established by
our colleague from the Johns Hopkins School of Medicine and builds upon the expertise of the
Clemson University group gained in radiation effects experiments and modeling during their
study of single event effects in electronics over the past fifteen years.
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Note:
NSBRI RESEARCH PROGRAM
SYNERGY PROJECTS
These projects, selected in April 1998, are limited to one year of funding at $50,000
(Total Cost). They are designed to integrate the research activities of two or more teams
and stimulate the development of multi-team research activities.
Cohen, R. J.
LeBlanc, A.
Mullen, T. J.
Ramsdell, C. R.
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Yelle, J. M.
PI MIT Alterations in Cardiovascular B-55
Regulation and Function During
Long-Term Simulated Microgravity
(Cardiovascular Alterations - Bone Loss)
CO-I Baylor
CO-I Harvard
CO-I Harvard
CO-I NASA JSC
CO-I NASA JSC
Dijk, D.
Cajochen, C.
Williams, G. H.
PI Harvard
CO-I Harvard
CO-I Harvard
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Sleep Deprivation: Effects on Neuro-
behavioral Function, Waking EEG and the
Renin-Angiotensin System
(Cardiovascular Alterations - Human
Performance)
Mullen, T. J.
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Oman, C. M.
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Yelle, J. M.
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CO-I MIT
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SYNERGY A_A: Cardi0VaScuiarAlterations - Bone Loss ......
PRINCIPAL INVESTIGATOR: RiChard J, Cohen, M,D,, Ph.D.
ORGANIZATION: Harvard Medical School/MIT
PROJECT TITLE: Alterations in cardiovascular Regulation and Function During Long-
Term Simulated Microgravity
FUNDING: $50.000 ($25,000 FY1998)
PROJECT SUMMARY
The Cardiovascular Alterations Team is already conducting studies of hemodynamic regulation and
susceptibility to arrhythmias resulting from ten days of simulated microgravity exposure. In these
studies very intensive measurements are made during a short duration of bed rest. In the
collaborative effort described in this proposal we will make many of the same measurements,
however much less frequently, on subjects who are exposed to a much longer duration of simulated
microgravity. It is anticipated that this will provide valuable additional data on the time course of
cardiovascular deeonditioning, especially with respect to susceptibility to cardiac arrhythmias as is
detailed below.
Alterations in cardiovascular regulation and function that occur during and after space flight have
been reported. These alterations are manifested, for example, by reduced orthostatic tolerance
upon reentry to the Earth's gravity from space [Charles et al., 1994, Buckey et al., 1996].
However, the precise physiologic mechanisms responsible for these alterations remain to be fully
elucidated. Perhaps, as a result, effective countermeasures have yet to be developed. In addition,
numerous reports from the past 30 years suggest that the incidence of ventricular arrythmias
among astronauts is increased during space flight [Charles et al., 1994, Yelle, in press].
However, the effects of space flight and the associated physiologic stresses on cardiac
conduction processes are not known, and an increase in cardiac susceptibility to arrythmias has
never been quantified.
The objective of this proposal is to apply the most powerful technologies available to determine,
in a ground-based study of long duration space flight, the mechanisms by which space flight
affects cardiovascular function, and then on the basis of an understanding of these mechanisms to
develop rational and specific countermeasures. To this end we propose a collaborative project
with the Bone Demineralization/Calcium Metabolism Team of the National Space Biomedical
Research Institute (NSBRI). The Bone Team plans to conduct bed-rest studies in human subjects
lasting 17 weeks, which will provide a unique opportunity to study the effects of long duration
microgravity exposure on the human cardiovascular system. We will apply a number of
powerful new methods to these long term bed-rest subjects, including cardiovascular system
identification (CSI), microvolt level T wave altemans analysis, and cardiac magnetic resonance
imaging to assess non-invasively the effects of simulated long duration space flight on the
cardiovascular system.
CSI involves the mathematical analysis of second-to-second fluctuations in non-invasively
measured heart rate, arterial blood pressure (ABP), and instantaneous lung volume (ILV -
respiratory activity) in order to characterize quantitatively the physiologic mechanisms
responsible for the couplings between these signals. Through the characterization of all the
physiologic mechanisms coupling these signals, CSI provides a model of the closed-loop
cardiovascular regulatory state in an individual subject. The model includes quantitative
descriptions of the heart rate baroreflex as well as other important physiologic mechanisms.
With an additional non-invasive measurement of stroke volume (SV - ultrasound Doppler
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method), the model may be extended to also include the characterization of the peripheral
resistance baroreflex - which may play a central role in the development of orthostatic
intolerance - and measures of systolic and diastolic function.
To determine whether simulated long term space flight increases the risk of developing life-
threatening heart rhythm disturbances such as sustained ventricular tachycardia (defined as
ventricular tachycardia lasting at least 30 seconds or resulting in hemodynamic collapse) and
ventricular fibrillation, we will apply a powerful new non-invasive technology, developed in
Professor Cohen's laboratory at MIT, for the quantitative assessment of the risk of life-
threatening ventricular arrhythmias. This technology involves the measurement of microvolt
levels of T wave altemans during exercise stress. In addition, we will obtain other non-invasive
markers of susceptibility to ventricular arrhythmias based on signal averaged electrocardiography
(SAECG), QT dispersion, and 24 hour Holter monitoring (to detect non-sustained ventricular
tachycardia and to assess heart rate variability). Finally, in order to investigate the effect of long
duration microgravity on cardiac mass, cardiac magnetic resonance images will be obtained
before and after the bed-rest period.
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SYNERGY A_A: Human Perf0rman_e2_C_rd]0vascular AIterati0ns i iiiiiii..............................................
PRINCIPAL INVESTIGATOR; De r!_=JanDijk, Ph.D.
ORGANIZATION: Harvard Medical School .....................
PROJECT TITLE: Acute Tot.a.!.ant!....Chro_M_cPart=_ia_[_Sl_ep Deprivation: Effects on
Neurobehavioral Function, Waking EEG and Renin-Angiotensin
System
FUNDING: $50,000 ($25,000 FY1998)
PROJECT SUMMARY
Exposure to the microgravity environment leads to changes in sleep and associated deterioration of
waking neurobehavioral function as well as changes in sodium and volume homeostasis and
associated renal and cardio-endocrine responses. We propose integration of research tools and
research projects to enhance the fidelity of the simulated conditions of space flight which are
characterized by complexity and mutual interactions. The effectiveness of countermeasures and
physiologic mechanisms underlying neurobehavioral changes and renal-cardio endocrine changes are
investigated in Project 3 of the Human Performance Team and Project 3 of the Cardiovascular
Alterations Team respectively. Although the specific aims of these two projects are very different,
they employ very similar research protocols. Thus, both projects investigate the effects of
posture/bedrest (2 days and 10 days) and sleep deprivation (total or partial) on outcome measures
relevant to their specific aims. The main aim of this enhancement grant is to exploit the similarities
in research protocols by including the assessment of outcome variables relevant to the Renal-Cardio
project in the research protocol of Project 3 of the Human Performance Team and by including the
assessment of outcome variables relevant to the Quantitative EEG and Sleep Deprivation Project in
the research protocols of Project 3 of the Cardiovascular Alterations team. In particular we will
assess Neurobehavioral Function and Waking EEG in the research protocols of the renal-cardio
endocrine project and renin-angiotensin and cardiac function in the research protocol of the
Quantitative EEG and Waking Neurobehavioral Function project.
This will allow us to investigate two additional specific aims:
1) Test the hypothesis that chronic partial sleep deprivation during a 10 day bedrest experiment
results in deterioration of neurobehavioral function during waking and increases in EEG
power density in the theta frequencies, especially in frontal areas of the brain, as well as the
nonREM-REM cycle dependent modulation of heart-rate variability.
2) Test the hypothesis that acute total sleep deprivation modifies the circadian rhythm of the
renin-angiotensin system, changes the acute responsiveness of this system to posture
beyond what a microgravity environment alone does and affects the nonREM-REM cycle
dependent modulation of heart-rate variability.
The data obtained on the waking EEG and neurobehavioral function in the chronic partial sleep
deprivation experiment will complement the data obtained on the effects of total sleep deprivation
which will be collected in project 3 of the Human Performance Team. The data obtained on the
renin-angiotensin levels in the acute total sleep deprivation experiment will complement data
obtained on the effects of chronic partial sleep deprivation which will be collected in project 3 of the
Cardiovascular Alterations team. The application of identical research tools and outcome measures
in research protocols across the Cardiovascular and Human Performance team will greatly enhance
the overall science return of these projects and emphasizes the synergistic nature of this application.
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SYNERGY A_A: cardiovascular Alterations - NeurovestibUlar Adaptation
PRINCIPAL INVESTIGATOR: Thomas J. Mullen, Ph.D, ....
ORGANIZATION: Harvard Medical School
PROJECT TITLE: Visual:and vestibular'Autonomic Influence on Short-term
Cardiovascular Regulatory Mechanisms
FUNDING: $50,000 ($25,000 _1998)
PROJECT SUMMARY
This synergy proposal describes a one-year effort to be conducted cooperatively by members of the
NSBRI Cardiovascular Alterations and Neurovestibular Adaptation Teams in collaboration with
NASA- Johnson Space Center (JSC) colleagues. The objectives of the proposed research are:
1. to investigate vestibular and visual influences on autonomic modulation of
cardiovascular regulatory mechanisms, and
2. to compare baroreflex changes as measured with a new Cardiovascular
System Identification (CSI) technique with those measured using a neck
barocuff.
Blunting of the carotid-cardiac baroreflex has been observed during and after space flight and
prolonged bed rest using the neck barocuff technique (Fritsch et aL, 1992; Fritsch-Yell et al.,
1994). Comparable barocuff response changes have recently been reported during yaw axis
vestibular stimulation and eye movements (Convertino et al., 1997; Convertino, 1998). It has
been suggested that vestibular pathways could play a significant role in changing the orthostatic
competence of astronauts and bedridden patients by inhibition of vagal withdrawal and elevation
of parasympathetic outflow. However, functional interpretation of neck barocuff data is
complicated because this method stimulates only the carotid baroreceptors. Interpretation would
be more straightforward if blunting during whole body rotation could be demonstrated using a
method like Cardiovascular System Identification (CSI) which provides a measure of overall
baroreflex responsiveness. Also, it is important to understand how the vestibular system
contributes to cardiovascular control during body tilt, as opposed to yaw rotation. This cannot
easily be done using actual body tilt, since the body's non-vestibular gravireceptors (e.g.
baroreceptors) are also stimulated. However, we have recently found compelling static tilt and
tumbling illusions in a majority of human subjects tested using a virtual reality head mounted
display system. We propose to look for baroreflex changes during real and illusory body rotation
and tilt using both the neck barocuff and CSI techniques.
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SYNERGY AREA: Human Performance' Immunology, Infection and Hematology -
Muscle Alterations
PRINCIPAL INVESTIGATOR: Janet M. Mullington, Ph,D.
ORGANIZATION: Hazard Medical School
PROJECT TITLE: Sustained Partial Sleep Deprivation: Effects on Immune Modulation
& Growth Factors
FUNDING: $50,000 ($25,000 FY1998)
PROJECT SUMMARY
While the endurance of public health maintenance and safety are important goals for
governments of advanced societies, these aims are prerequisite for the success of prolonged
space missions. The vulnerability to human performance errors or medical emergencies are
greatest in space where there are real limits to the availability or effectiveness of ground based
assistance. The Human Performance Factors, Sleep and Chronobiology Team (Dr. Czeisler,
Leader) has approached the problems associated with performance failure from the perspective of
optimizing performance capacity. They have developed integrated research projects aimed at
understanding the mechanisms involved in human adaptation to the space environment and the
associated behavioral factors lead to certain performance failure, notably insufficient sleep and
circadian rhythm disruption.
In long term space flight, the issue of immune suppression and possible reactivation of latent
viruses are risks that cannot be prevented by preflight quarantine. The possibility of reactivation
of latent viruses is a serious potential hazard for the success of long term space missions where
confined conditions increase the possibility of transmitting disease. Medical complications which
would not pose a serious problem on Earth may be disastrous if they emerged in space. The
Hematology, Immunology and Infection Team (Dr. Rudolph, Leader) is addressing issues of
immune regulation in space, to alterations in function produced by weightlessness and the
stresses associated with space flight and living in confined spaces. In addition to stress
modulation of immune function, recent research suggests that sleep is also involved. While we
all have the common experience of being sleepy when suffering from infection, and being
susceptible to infection when not getting enough sleep, the mechanisms involved in this process
are not understood and until recently have gone largely overlooked. We believe that the immune
function changes seen in spaceflight may also be related to the effects of partial cumulative sleep
deprivation.
The Human Performance Factors, Sleep and Chronobiology team project "Countermeasures to
Neurobehavioral Deficits from Cumulative Partial Sleep Deprivation During Space Flight" was
designed not only to test the efficacy of sleep-wake scheduling for the maintenance of optimal
performance during long term space flight but also to investigate the possible augmentation of
growth hormone by providing supplemental sleep episodes, or naps, positioned half way through
the waking period. The underlying hypothesis is that since >70% of total GH secretion occurs
during the nocturnal sleep period, that reduction of sleep time for prolonged periods may result in
a curtailment of 24 hour GH production, which may translate to reduced availability at the level
of the tissues. The Muscle Alterations and Atrophy team (Dr. Schwartz, Leader) are conducting a
series of studies to investigate the genetic expression of GH and insulin-like growth factors at the
level of the muscle, with a view to developing countermeasures for the known problems
associated with muscle fiber degeneration during prolonged space travel. It is anticipated that the
investigation of the GH-IGF-I axis during conditions of prolonged partial sleep deprivation will
help to develop countermeasures that can contribute to health maintenance and preventative
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strategies for use in space travel, and also to provide behavioral strategies that will be useful in
promoting GH and perhaps IGF-I availability to counteract degenerative processes in aging and
illness on Earth.
In order to synergize the aims of these three research teams we have chosen to investigate the
neuroendocrine and neuroimmune modulation of sustained partial sleep deprivation and furthermore
to test the influence of cumulative sleep loss on the reactivation of latent viruses, and the delayed
hypersensitivity response to cutaneously applied antigen testing. The results of this research will
integrate the teams and give them the opportunity to examine data using technologies and
methodologies that come from separate and distinct scientific methodologies, and bring them
together in a common protocol with a view to enhancing the potential of each team to take back
information which will help in the development and implementation of countermeasure strategies
and future scientific developmental plans.
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BIOGRAPHICAL SKETCH
Provide the following information for the key personnel in the order listed on Form Page 2.
Photocopythis page or follow this format for each person.
NAME POSITIONTITLE
William T. Shearer, M.D., Ph.D. Professor
CATION/I'RAINING (Begin with baccalaureate or other initial professional education, such as nursin{/, and include postdoctoral training).
INSTITUTION AND LOCATION DEGREE YEAR(s) FIELD OF STUDY
(if applicable)
IUniversity of Detroit, Detroit, MI B.S. 1960 Chemistry
Wayne State University, Detroit, MI Ph.D. 1966 Biochemistry
Washington University, St. Louis, MO M.D. 1970 Medicine
RESEARCH AND PROFESSIONAL EXPERIENCE: Concluding with present position, list, in chronological order, previous
employment, experience, and honors. Include present membership on any Federal Government public advisory committee.
List, in chronological order, the titles, all authors, and complete references to all publications during the past three years and
to representative earlier publications pertinent to this application. If the list of publications in the last three years exceeds two
pages, select the most pertinent publications. DO NOT EXCEED TWO PAGES. ...
Training:
63-66: Pre-doctoral Fellow in Biochemistry, Dept. Biochem., Wayne State Univ., Detroit, MI; 66-67: Post-doctoral
Fellow in Chemistry, Dept. Chem., Indiana Univ., Bloomington, IN; 70-71" Intern in Peds., St. Louis Children's
Hosp., St. Louis, MO; 71-72: Resident in Peds., St. Louis Children's Hosp.; 72-74: Resident in Immunol. in Peds.,
Barnes & St. Louis Children's Hospital, Washington University Medical Center.
Honors:
B.S. (Magna Cure Laude), Senior Biochemistry Award, Phi Larnbda Upsilon, Detroit News Fellowship, Sigma Xi,
St. Louis Pediatric Society Award, Alexander Berg Award, USPHS Special Fellowship, Research Scholar Award of
the Cystic Fibrosis Foundation, Faculty Research Award of the American Cancer Society, American Society for
Clinical Investigation, Myrtle Wreath Award of Hadassah, Special Recognition Award, American Academy of
Allergy and Immunology.
Certification:
National Board of Medical Examiners, 70; American Board of Pediatrics, 75, 81,86; American Board of Allergy and
Immunology 75, 77, 80, 83, 87, 89; Diagnostic Laboratory Immunology, American Boards of Internal Medicine,
Pediatrics, Allergy and Immunology, 86.
Appointments:
66-67: Research Associate in Chemistry, Dept. Chem., Indiana Univ., Bloomington, IN; 72-74: Special U.S. Public
Health Science Research Fellow in Medicine (Immunology) awarded by Natl. Inst. of Allergy & Infect. Dis., Dept.
Med., Washington Univ.; 74-78: Director of Div. of Allergy and Immunology, St. Louis Children's Hosp.; 76-78:
Associate Prof. of Peds., Washington Univ., St. Louis, MO; 78-78: Prof. of Peds., Washington Univ., St. Louis, MO;
78-: Chief, Allergy & Immunol. Service, Texas Children's Hosp., Houston, TX; 78-: Head, Sect. of Allergy &
Irnmunol., Dept. Peds., Baylor Col. of Med., Houston, TX; 78-: Prof. of Peds., Microbiol. & Irnmunol., Baylor Col. of
Med., Houston, TX; 91-: Director, Pediatric HIV Research Center, Baylor Col., of Med., Houston, TX.
Consultant:
AIDS Committee, St. Luke's and Texas Children's Hosp., Houston, "IX; AIDS Committee, Houston Independent
School District, Houston, TX; Ad Hoc Reviewer National Cooperative Drug Discovery Groups for AIDS; Review
Committee, Specialized Centers of Research in Transfusion Medicine, National Heart, Lung, and Blood Institute;
Consultant, Central Nervous System Aspects of HIV Infection and AIDS in Infants and Children, National Institute
of Mental Health; Review Committee, AIDS Related Research; Section Chair, NICHD Workshop, Early Diagnosis
of HIV Infection in Infants: Other Methods for HIV Detection; Consultant and Site Visitor, NHLBI Study of Heart and
Lung Complications of Pediatric HIV Infection; Ad Hoc Reviewer, AIDS and Related Research Study Section;
Member, Special Review Committee, Persons Affected by Chronic Granulomatous Disease, National Institutes of
Health; Chairman, Executive Committee of NICHD IVIG Trial in HIV-infected Children; member, Pediatric Core
Committee and Pediatric ACTG, Chair, Pediatric Immunology Committee and B2 Immunology Laboratory
Subcommittee, NIAID Pediatric ACTG; Vice-Chair, Pediatric Executive Committee, Pediatric ACTG; Chairman,
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Population Committee, NHLBI Study of Heart and Lung Complications of Pediatric AIDS; Member, AIDS Ad Hoc
Working Group; Member, Therapeutics Subcommittee, AIDS Advisory Research Committee, NIAID; Director and
Chair, American Board of Allergy and Immunology; Editorial Board, Journal of Allergy and Clinical Immunology,
Pediatric Asthma, Allergy and Immunology.
Publications (selected from over 215 full papers):
Kuruvilla A, Putcha G, Poulos E, Shearer WI-. Tyrosine phosphorylation of phospholipase C is essential for its
activation by platelet-activating factor in a human B cell line. J Immunol 151:637-648, 1993.
Dorenbaum A, Shearer WT, Abramson SL. Phagocytic cell superoxide production in children with HIV infection.
Pediatr AIDS HIV Infect 4:215-221, 1993.
Kline MW, Lewis DE, Hollinger FB, Reuben JM, Hanson IC, Kozinetz CA, Dimitrov DH, Rosenblatt HM, Shearer
W'I-. A comparative study of human immunodeficiency virus (HIV) culture, polymerase chain reaction, and anti-
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AGREEMENT OF AFFILIATION BETWEEN THE INSTITUTE OF AEROSPACE
MEDICINE OF THE GERMAN AEROSPACE CENTER
AND THE NATIONAL SPACE BIOMEDICAL RESEARCH INSTITUTE
This agreement is between the INSTITUTE OF AEROSPACE MEDICINE of the German
Aerospace Center (Deutsches Zentrum fttr Lufl- und Raumfahrt e.V., DLR) and the NATIONAL
SPACE BIOMEDICAL RESEARCH INSTITUTE (NSBRI) and is effective as of the date set forth
herein.
WHEREAS the INSTITUTE OF AEROSPACE MEDICINE of the German Aerospace
Center, Linder H6he, 51147 KNn, Germany, and the NATIONAL SPACE BIOMEDICAL
RESEARCH INSTITUTE, One Baylor Plaza, NA-425, Houston, Texas 77030-3498, U.S.A, share a
common interest in the human exploration and development of space and similar scientific, academic
and professional objectives; and
WHEREAS both institutions are desirous of increasing the human and scientific relations
which would contribute to the achievement of aims which both pursue.
1)
NOW, THEREFORE, the parties do agree as follows:
Because of their joint interest in the human exploration and development of space, the parties agree
to undertake specific activities from time to time aimed at furthering the following general
objectives:
(a) joint projects involving research, technological development, or education and outreach;
(b) exchange of life scientists;
(c) joint or coordinated organization of seminars, meetings and lectures on subjects of mutual
interest;
(d) reciprocal use of research and other published information;
(e) exchange of research and teaching materials and use of facilities;
(f) exchange of publications; and
(g) development of life-scientist related postgraduate, graduate and undergraduate student
exchange programs according to academic rules jointly adopted, but subject to legislation in
force in each country.
All such activities shall be subject to the budgetary resources available to, and any legal restrictions
applicable to the activities of, the parties.
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2) Each project created under this agreement must be reduced to a separate, formal, written agreement
which must be signed by authorized representatives of the parties before such a project can be
deemed in effect and, accordingly, binding on either party.
3) By means of the special agreements reduced to writing and signed by authorized persons, the
parties shall determine specific areas and programs of cooperation, as well as the terms, methods,
financial conditions and procedures of specific projects. As a governing principle for all such
agreements, and unless otherwise agreed to in writing, all costs and expenses related to
implementation of a project - direct or indirect costs and expenses, costs of equipment and
supplies, travel, etc. - and all expenses as are created pursuant to said agreements - travel, housing,
living expenses, stipends, benefits (including, but not limited to, health and life insurance),
licensure, malpractice insurance, etc. - will be paid by the sending party. Neither party will be
responsible for any costs and expenses incurred in any respect by the other party or its students,
residents or faculty unless expressly agreed to by separate written agreement signed by authorized
representatives of the parties.
4) The parties agree that, within the scope of this instrument and upon approval of the parties, other
qualified institutions may be invited to participate in the various projects envisioned by this
agreement.
5) The parties agree that, as an essential proposition to any cooperative endeavor, all individual
participants in projects created pursuant to this agreement will be selected with full respect for
equal opportunity for all persons in accordance with the policies of each party and without regard
to the race, sex, age, national origin or religious affiliation of participants or candidates for
participation.
6) The parties acknowledge that, due to the unique professional, institutional, and legal requirements
for registration, enrollment and certification applicable to each party, student participants in the
various projects envisioned by this agreement will be registered and/or enrolled in and will receive
certification and/or degrees from only the sending party. Accordingly, project participants will not
automatically be registered and/or enrolled in, nor will they receive degrees from the receiving
party, unless specifically accepted by the receiving institution and meeting their requirements.
7) While it is not contemplated that any projects implemented pursuant to this agreement will involve
the rendition of health care services by professionals out of their country, the parties acknowledge
that all physicians or other health care professionals who wish to participate in the rendition of
patient care shall be solely responsible, at their expense or the expense of the sending party, for
securing requisite licensure and all other authorization and any malpractice or other insurance
coverage as may be required by law or applicable institutional and hospital policies and
procedures.
8) This agreement will enter into force on January 21, 1998 and will continue in effect for five (5)
years from that date. It shall be renewed for equal periods, unless one of the parties notifies the
other in writing of its desire to terminate such agreement at least three (3) months prior to the date
of termination.
9) Entered into in the City of Krln, Germany, by means of the execution of two counterpart originals.
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FOR THE INSTITUTE OF AEROSPACE MEDICINE, DLR, KOLN, GERMANY
By:
Rupert Gerzer, Prof. Dr. med Date
Director, Institute of Aerospace Medicine, DLR
Approval:
By:
Walter Kr611, Prof. Dr. rer. nat
Chairman, Executive Board, DLR
Date
FOR THE NATIONAL SPACE BIOMEDICAL RESEARCH INSTITUTE, HOUSTON, TEXAS,
U.S.A.
By:
Laurence R. Young, Sc.D.
Director, NSBRI
Date
Approval:
By:
Bobby R. Alford, M.D. Date
Chairman of the Board and Chief Executive Officer, NSBRI
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Monday, June 8
8:00 a.m.
8:10
8:45
9:00
10:00
10:30
11:30
12:30 p.m.
1:30
3:00
6:00
8:00
10:00
National Space Biomedical Research Institute
RETREAT
June 8-11, 1998
Del Lago Conference Center
Montgomery, Texas
AGENDA
PLENARY SESSION - TEJAS BALLROOM I
Welcome
Purposes & Objectives of Retreat
NSBRI Activities: March 1997-June 1998
June-October 1998
NASA Greetings
Critical Path Roadmap for Human
Exploration Missions - Overview
BREAK
Team Report: Bone Loss
Team Report: Immunology, Infection & Hematology
LUNCH
POSTER SESSION: TEJAS BALLROOM II
Bone Loss & Immunology Team Posters
FREE DISCUSSION TIME
BUFFET DINNER
PLENARY SESSION - TEJAS BALLROOM I
Critical Path Roadmap for Human
Exploration Missions
• Reports from Risk Area Teams
• Assignment for Workshop
ADJOURN
B. Alford
L. Young
J. Rummel
C. Sawin
J. Shapiro
W. Shearer
Project Investigators
C. Sawin
J. Charles
L. Leveton
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Tuesday, June 9
8:00 a.m.
9:00
10:00
10:30
11:30
12:30 p.m.
1:30
3:00
5:00
6:00
8:00
10:00
PLENARY SESSION - TEJAS BALLROOM I
Team Report: Cardiovascular Alterations
Team Report: Radiation Effects
BREAK
Team Report: Muscle Alterations & Atrophy
Team Report: Neurovestibular Adaptation
LUNCH
POSTER SESSION: TEJAS BALLROOM II
Cardiovascular, Radiation, Muscle & Neurovestibular
Team Posters
FREE DISCUSSION TIME
PLENARY SESSION - TEJAS BALLROOM I
Education & Outreach Program
BUFFET DINNER
ROUND TABLE DISCUSSIONS
• TEJAS BALLROOM I
NASA Flight Opportunities &
Experiment Integration
• SAM HOUSTON I
Education & Outreach: Connecting
NSBRI to Communities & Schools
• SAM HOUSTON II
Use of Crescendo (MK0677) and Growth
Hormone Releasing Factor
• MONTGOMERY I
Remote and In Situ Biomedicine
• MONTGOMERY lI
Stem Cells in Space
ADJOURN
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R. Cohen
J. Dicello
R. Schwartz/F. Booth
C. Oman
Project Investigators
M. MacLeish
C. Sawin
M. MacLeish
R. Schwartz
H. Pien
W. Shearer
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Wednesday, June 10
PLENARY SESSION - TEJAS BALLROOM I
8:00 a.m.
9:00
10:00
10:30
12:30 p.m.
1:30
3:00
5:00
6:00
8:00
10:00
Appendix E
Team Report: Human Performance
Team Report: Technology Development
BREAK
International Space Station Capability
and Industry Partnership
LUNCH
POSTER SESSION: TEJAS BALLROOM H
Human Performance & Technology Development
Team Posters
FREE DISCUSSION TIME
PLENARY SESSION - TEJAS BALLROOM I
NSBRI Data Archive Project
BUFFET DINNER
ROUND TABLE DISCUSSIONS
• TEJAS BALLROOM I
Microbiological Characterization of
Closed Systems: Potential Impacts &
Countermeasures
• SAM HOUSTON I
Technology Development: How Industry
And Academia Collaborate
ADJOURN
C. Czeisler
V. Pisacane
J. Buchli
Project Investigators
L. Suther
M. Wilson
J. Kerwin
SPECIAL INTEREST GROUP MEETING
SAM HOUSTON II
Institute Data Archive System V. Pisacane
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Thursday, June 11
PLENARY SESSION - TEJAS BALLROOM I
8:00 a.m.
10:30
10:45
11:15
11:30
12:00 p.m.
I:00
Critical Path Roadmap for Human J. Charles
Exploration Missions
• Final Reports from Risk Area Teams - Discussion by All
BREAK
FINAL REMARKS
ADJOURN
LUNCH
TEAM LEADERS ONLY
MEETING ROOM: LONGHORN
Team Leaders Meeting - Post Retreat Discussions
Where Do We Go From Here?
ADJOURN
Appendix E
B. Alford & L. Young
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NATIONAL SPACE BIOMEDICAL RESEARCH INSTITUTE
INDUSTRY FORUM CHARTER
Establishment and Authority
The National Space Biomedical Research Institute (NSBRI) Administration, having determined
that it is in the public interest in connection with the accomplishment of the major mission of the
Institute, as well as to foster strong interaction between Industry and the Institute, hereby
establishes the NSBRI Industry Forum.
Membership
The Industry Forum membership will consist of representatives from 11 charter companies,
including: Boeing Space Systems; Veridian; Merck Pharmaceuticals; Lockheed-Martin; Draper
Labs; Wyle Laboratories; Payload Systems; Raytheon; Southwestern Bell Communications;
Silicon Graphics; and Information Dynamics. This ensures the inclusion of consensus leaders in
the aerospace industry who have experience in partnering with NASA in the commercial
development of technologies adapted from the space program.
Purpose and Duties
The Industry Forum will strive to partner with the Institute by:
• identifying technologies in development by research teams that have the potential for
commercialization;
• providing new technologies for use by the research teams and through direct financial
support to the research teams;
• identifying operational problems of space flight that have relevance to space-based
research enterprises;
• contributing to cost-sharing; and
• assisting in leveraging Federal support to the Institute through cooperative activities.
Meetings
The Industry Forum will convene at least semi-annually, with teleconferences offset 3 months
from each of these meetings. NSBRI Administration will be notified well in advance of
upcoming Industry Forum activities.
Administrative Provisions
The Industry Forum will be an independent body that will interact with, but not be governed by,
NSBRI. Leadership of the forum is by majority election of a member company representative to
a one year term as Executive Secretary. Administrative support for the Executive Secretary will
be provided by the elected individual's company, and will be considered in-kind support. The
forum will receive no operating budget from NSBRI, with the exception of use of the NSBRI
headquarters conference room facility for semi-annual meetings as deemed appropriate by the
forum representatives. Representatives to the forum will serve at the discretion of the member
companies who employ them; NSBRI administration will play no role in the selection of
representatives. Member companies may use the Institute logo at their discretion, and may
identify themselves as NSBRI Forum members in correspondence.
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APPLICATION FOR MEMBERSHIP IN THE
NATIONAL SPACE BIOMEDICAL RESEARCH INSTITUTE
INDUSTRY FORUM
Introduction
As a preamble to this document it should be clearly stated that the aim of the Industry
Forum is to expand by only a few members companies, since the intended purpose of this
group is to form a limited number of productive partnerships with Institute research
teams. Were the Industry Forum to become a large group, any competitive advantage
gained by member companies as a result of having invested resources into partnering
would be diluted, likely to a level that would not justify continued participation.
Mission Statement for the Industry Forum
The mission of the NSBRI Industry Forum is to work together with the administration
and research teams of the Institute to make possible the transfer and dissemination of
biomedical advances in knowledge and technology acquired through living and working
in space to the benefit of mankind in space and on Earth.
Application Procedure
Companies interested in membership in the Industry Forum should prepare a letter
addressed to the Executive Secretary. This document should include the following:
• Identification of the management level at which approval for application for
membership has received writte____n_napproval;
• A brief description of the company;
• Identification of the individual within the company who will serve as the point of
contact with the Industry Forum, together with a brief discussion of the role
played by that person within the company;
• A statement identifying how the company, through membership in the Industry
Forum, can contribute to accomplishing the missions of both the Industry Forum
and the Institute; and
• A quantitative per annum estimate of the direct and/or in-kind support to be
provided by the company to the Industry Forum and to the Institute
Industry Forum Consideration of Applications
A simple majority vote of the Industry Forum companies is required in order to
recommend an applicant company for membership. This recommendation is forwarded to
the Institute's Board of Directors for approval. It is expected that applications will be
handled expeditiously by the Industry Forum, however applicant companies should be
aware that the Institute Board of Directors may consider such matters infrequently (once
or twice per year).
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PROPOSAL FOR PARTNERING AND INITIATIVES
NATIONAL SPACE BIOMEDICAL RESEARCH INSTITUTE
INDUSTRY FORUM
INTRODUCTION
The National Space Biomedical Research Institute (NSBRI) Industry Forum (IF) held an
Executive Session meeting on June 9, 1998 during the NSBRI Workshop at Del Lago
Conference Center in Conroe, Texas. All Industry Forum members present expressed the need to
develop partnering and initiatives with NSBRI research programs to successfully fulfill the IF
mission, increase Institute impact, and improve Industry's return on investment in the Institute.
As stated in the NSBRI Industry Forum mission statement, and as detailed in the Industry Forum
Charter, the Industry Forum will strive to partner with the Institute in a variety of ways (See
Industry Forum Charter). It is our belief that Industry Forum involvement in the development of
critical path technology roadmaps and research directions, development of research proposals,
and peer review of Institute research proposals is critical to mission implementation and success.
PLAN FOR PARTNERING
We believe that the first step for improved interaction between the IF and Institute is to develop a
formal process to solicit and integrate critical path technologies from industry engineers and
scientists and Institute research teams. The Industry Forum membership includes companies
with expertise in aerospace, biomedicine, pharmaceuticals, biotechnology, and telemedicine, to
name several. The integration of applied industrial research with basic academic research will
ensure quantitative critical path research prioritization, improve technology transfer, and leverage
government and industry co-funding. Information concerning critical path technologies should
be updated annually and provided to researchers prior to requests for proposals.
Secondly, Industry participation in the development of research proposals for the Institute is one
of the most important criteria for improving industry interaction between forum scientists and
engineers and Institute research teams. Members of the Industry Forum should be included on
distribution lists for NSBRI research announcements and requests for proposals. Industry has
had limited success coordinating and communicating with research teams through roundtables
and other means at NSBRI meetings. Incentives should be developed to encourage teaming of
industry and academic scientists. We suggest the establishment of experience tours or
sabbaticals for professors, postdoctoral fellows and/or graduate students to utilize industry
facilities to further the Institute research effort. Also, Industry co-investigators could spend a
sabbatical at the associated university performing basic and applied research on critical projects
benefiting both Industry and the Institute. Cooperative research will provide a greater return on
investment for the Institute and Industry by: supporting cost sharing; facilitating educational
outreach; and improving technology transfer.
Last, the Industry Forum requests input into the peer review process for Institute proposal
selection and research progress reports. We are not suggesting that industry should be involved
in evaluating the quality of research: rather we feel that the t he Industry Forum could play an
important role in assessing whether ongoing and proposed research projects satisfy the
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requirements of the critical path technologies and NASA requirements. The membership of the
Industry Forum possesses the knowledge and experience to relate operational problems of space
flight to research needs.
SUMMARY
We, the members of the Industry Forum of the National Space Biomedical Research Institute,
look forward to increased involvement with and support of, the Institute in 1999. In this
document, we have made suggestions designed to assist the Institute in: development of critical
path technology roadmaps and research directions: formulation of new research proposals: and
review Institute research proposals. Our unanimous opinion is that adding these responsibilities
will be critical to improving the functionality of the Industry Forum. We request that NSBRI
Administration work together with us to develop these formal processes in order to assist the
Institute in meeting its future goals, increase cost sharing for critical path research projects, and
better transition technologies for use in space and on Earth.
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NATIONAL SPACE BIOMEDICAL RESEARCH INSTITUTE
Investigator List
Andersen Consulting: Carpenter-Smith, T.R.; Australian Antarctic Division: Lugg, D. J.;
Baylor College of Medicine: Abdellatif, M. M., Alfrey, C. P., Appel, S. H., Butel, J. S., Cohen,
H. S., Conner, M. E., Demayo, F. J., Epstein, H. F., Goldberg, J., Hamilton, S. L., LeBlanc, A.,
Lednickey, J. A., Ling, P. D., Medina, D., Mosier, D. R., O'Malley, B. W., Overbeek, P. A.,
Reid, M. B., Rice, L., Rosenblatt, H. M., Schneider, M. D., Schwartz, R. J., Shearer, W. T.,
Smith, C. L., Smith, C. W., Smith, E. O., Smolen, J. E., Trial, J., Weigel, N. L., and Wood, S.;
Brookhaven National Laboratory: Sutherland, B. M.; Brooklyn College: Raphan, T.;
Dartmouth College: Taube, J. S.; Harvard Medical School: Bonventre, J. V., Brown, E. M.,
Brown, E. N., Cajochen, C., Czeisler, C. A., Dijk, D., Goldberg, A. L., Jewett, M. E., Khalsa, S.
B., Krebs, D. E., Kronauer, R. E., Lorell, B. H., Luithardt, H. H., Mullen, T. J., Mullington, J.
M., Oden, Z. M., Ramsdell, C. R., Ronda, J. M., Rosenthal, N. A., Wall, C. C., Williams, G. H.,
and Wright, K. P.; Loma Linda University Medical Center: Gridley, D. S.; Massachusetts
Institute of Technology: Beall, A. C., Cohen, R. J., Karnm, R. D., Mark, R. G., Natapoff, A.,
Newman, D. J., Oman, C. M., Szolovits, P., and Young, L. R.; Mayo Clinic: Turner, R. T.;
Morehouse School of Medicine: Ofili, Elizabeth, and Thierry-Palmer, M.; NASA Johnson
Space Center: Bloomberg, J. J., Cucinotta, F. A., Paloski, W. H., Pierson, D. L., Sams, C.,
Shackelford, L., Yang, T., and Yelle, J. M.; SmithKline Beecham Pharmaceuticals: Suva, L.
J.; Texas A&M University: Armstrong, R. B., Bloomfield, S. A., Braby, L. A., Delp, M. D.,
Hogan, H. A., Shebilske, W. L., and Sinden, R. R.; The Johns Hopkins University: Beck, T.
J., Berkowitz, D., Bryden, W. A., Charles, H. K. Jr., Cotter, R. J., Dicello, J. F., Fainchtein, R.,
Fedarko, N. S., Feldmesser, H. S., Gold, R. E., Goldsten, J. O., Griffin, C. A., Helzlsouer, K. J.,
Huso, D. L., Jones, R. J., Kessler, P., Kinnison, J. D., Maurer, R. H., Minor, L. B., Novak, G. R.,
O'Malley, B. W. Jr., Piantadosi, S., Pisacane, V. L., Potember, R. S., Risby, T. H., Roth, D. R.,
Ruff, C. B., Schultheis, L. W., Shelhamer, M. J., Shoukas, A. A., Strandberg, J. D., Williams, J.
R., Zee, D. S., and Zhang, Y.; Uniformed Services University of the Health Sciences:
Shapiro, J. R.; University of Caifornia, Irvine: Baldwin, K. M.; University of Florida:
Byrne, B. J.; University of Houston: Fox, G. E., and Willson, R. C.; University of
Pennsylvania: Dinges, D. F., Maislin, G., and Van Dongen, H. P.; University of Texas Health
Science Center at Houston: Booth, F. W.; University of Texas M. D. Anderson Cancer
Center: Reuben, J. M.; University of Washington: Ochs, H. D., University of Wisconsin:
Howard, S. P.; York University: Howard, I. P.
G-1
Appendix H
NIDCD-NSBRI PROGRAM FOR THE SUPPORT OF VESTIBULAR RESEARCH
Release Date: June 16, 1998
PA NUMBER: PAS-98-081
P.T,
National Institute on Deafness and Other Communication Disorders
National Space Biomedical Research Institute
Application Receipt Date: September 28, 1998
PURPOSE
The National Institute on Deafness and Other Communication Disorders (NIDCD) of the
National Institutes of Health (NIH) and the National Space Biomedical Research Institute
(NSBRI) invite research project applications for the support of ground-based research on the
dynamic adaptation of central vestibular functions. The purpose of this initiative is to promote
the application of cellular and molecular biologic approaches and advanced systems-level
approaches to the understanding of vestibular adaptation. This research shall contribute to one or
both of the following goals: 1) understand the neural basis of the autonomic responses that
accompany acute vestibular dysfunction, motion sickness and responses to altered gravitational
environments, and 2) facilitate the development of targeted approaches for the management of
balance and vestibular disorders, motion sickness and adaptation to altered gravitational
environments.
HEALTHY PEOPLE 2000
The Public Health Service (PHS) is committed to achieving the health promotion and disease
prevention objectives of"Healthy People 2000," a PHS-led national activity for setting priority
areas. This Program Announcement (PA), NIDCD-NSBRI Program for the Support of
Vestibular Research, is related to the priority areas of physical activity fitness, educational and
community-based programs, unintentional injuries, occupational safety and health, diabetes and
chronic disabling diseases, clinical prevention services and human resource development.
Potential applicants may obtain a copy of"Healthy People 2000" (Full Report: Stock No. 017-
001-00474-0 or Summary Report: Stock No. 017-001-00473-1) through the Superintendent of
Documents, Government Printing Office, Washington, DC 20402-9325 (telephone 202-512-
1800).
ELIGIBILITY REQUIREMENTS
Applications may be submitted by domestic and foreign, for-profit and non-profit organizations,
public and private, such as universities, colleges, hospitals, laboratories, units of state and local
governments, and eligible agencies of the Federal government. Applications from minority
individuals, women and individuals with disabilities are encouraged.
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MECHANISM OF SUPPORT
The mechanism of support shall be the individual investigator-initiated research grant (R01)
award. Although a scored application responsive to this initiative may be awarded by either the
NIDCD or the NSBRI, individual grant awards will not be cofunded. Hence, the grant awards
made by the NIDCD and the NSBRI will be separate and mutually exclusive. Upon
authorization from the applicant investigator and the applicant institution (see "SPECIAL
REQUIREMENTS"), the grant application, the summary statement and related materials will be
released to the NSBRI. The NIDCD and the NSBRI will both employ the same criteria in the
award of applications for this program (see "AWARD CRITERIA") and confer during this
process to ensure that there is no overlap in funding.
FUNDS AVAILABLE
The NIDCD has committed up to $400,000 total costs [direct cost plus facilities and
administrative allowance (indirect cost)] to this initiative for FY99 (Year One). The NSBRI has
committed up to $400,000 total costs for FY99, as well. It is anticipated that a total of three to
six awards of up to five years each will be made in FY99. Those awards made by the NIDCD
shall be administered according to current NIH policy.
RESEARCH OBJECTIVES
Background
Changes in vestibular function play a key role in numerous clinical disorders of balance and
spatial orientation on Earth and in the spatial orientation and motor performance of space
travelers during and after flight. However, the mechanisms responsible for vestibular adaptive
changes are not well understood. The cellular and subcellular properties of many neurons within
the vestibular system have been characterized anatomically and physiologically, and there is
evidence implicating the involvement of both excitatory amino acid and peptide
neurotransmitters in vestibular function. However, there have been no comprehensive studies of
the neurochemical organization of the vestibular nuclear complex and the central vestibular
pathways, nor has there been sufficient application of systems approaches and models to relate
stimulus parameters and behavior to vestibular adaptation. These studies are needed in order to
understand the recovery of vestibular function following injury (vestibular compensation) and
the adaptation of the vestibular system to altered gravitational environments, including
microgravity and centrifugation.
The NIDCD signed a Memorandum of Understanding with the NSBRI on June 6, 1997 for the
joint support of ground-based research in the vestibular system relevant to the research missions
of both the NIDCD and the NSBRI. This research shall be applicable to the health of space
travelers and to vestibular disorders on Earth. The NSBRI was established by the National
Aeronautics and Space Administration at the Baylor College of Medicine in April 1997 as a
consortium of seven institutions for the conduct of biomedical research necessary to support
human health in the exploration and development of space. Further information on the mission
and the research components of the NSBRI is available on the World Wide Web at
http://www.nsbri.org.
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Scope
Changes in vestibular function, through modifications of the processes of learning and adaptive
plasticity, underlie both treatment approaches to vestibular disorders and adaptation to altered
gravitational environments. These changes take place through a combination of cellular and
integrated neural network modifications. Very little is known about the cellular- and molecular-
level processing of signals from the vestibular and nonvestibular motion sensors in the central
vestibular pathways, about the changing roles of neural circuits during and following adaptation,
and about the integrated neural network modifications that lead to a new adapted state. It is now
possible to identify specific relay neurons in vitro and to determine how their cellular properties
contribute to the processing of vestibular and visual information and how this processing is
modified by cerebellar or brain stem inhibitory mechanisms. It is also possible to use advanced
systems approaches to model integrated neural network responses. Knowledge of the key
cellular- and systems-level events underlying vestibular compensation and dynamic adaptation
will provide a solid basis for the improved rehabilitation of patients with balance disorders and
for management of the sensorimotor and perceptual difficulties associated with space travel,
particularly during long-duration space missions.
The purpose of this initiative is to promote the application of cellular and molecular biologic
approaches and advanced systems-level approaches to the understanding of adaptive functions
(e.g., learning and adaptive plasticity) within the central vestibular pathways. This will afford the
opportunity to merge and maximize the efforts of cellular and systems neuroscience.
Applications submitted in response to this PA may either encompass a continuum of approaches
from reductionistic to systems-level and integrated systems-levels, or may focus on one level of
analysis. Applicants shall define how their proposed research will contribute to one or both of
the following goals: 1) understand the neural basis of the autonomic manifestations that
accompany acute vestibular dysfunction, motion sickness and responses to altered gravitational
environments, and 2) facilitate the development of targeted pharmacotherapeutic, physical
rehabilitative and/or behavioral approaches for the management of balance and vestibular
disorders, motion sickness and adaptation to altered gravitational environments.
SPECIAL REQUIREMENTS
Annual Meetings
The principal investigators (PIs) supported through this initiative shall meet annually for one day
with the Neurovestibular Adaptation Team of the NSBRI and with program officials of the
NSBRI and the NIDCD to review the progress and to discuss the future plans of their research
projects. The Neurovestibular Adaptation Team is headquartered in the Boston area at the present
time. In addition, the PIs shall participate in an annual three- to four-day NSBRI-sponsored
workshop/retreat or symposium which will usually be held in the Houston, TX area. These
events will facilitate communication and collaborative interactions among the investigators
supported through this initiative and the investigators comprising the Neurovestibular Adaptation
Team and the other research teams of the NSBRI. Budget requests for travel should reflect the
costs associated with these two annual meetings and should include a statement indicating that
this travel is a special requirement of this PA.
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Letter of Authorization
In order for an application to be considered for funding by the NSBRI, the applicant must submit
a brief letter of authorization, co-signed by the Principal Investigator and the official signing for
the applicant institution, authorizing the NIDCD to release the application, the summary
statement and all related materials to the NSBRI. These materials will be shared with the NSBRI
when available. Applications without such authorization will not be considered for funding by
the NSBRI.
INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN
SUBJECTS
It is the policy of NIH that women and members of minority groups and their subpopulations
must be included in all NIH supported biomedical and behavioral research projects involving
human subjects, unless a clear and compelling rationale and justification is provided that
inclusion is inappropriate with respect to the health of the subjects or the purpose of the research.
This policy results from the NIH Revitalization Act of 1993 (Section 492B of Public Law 103-
43). All investigators proposing research involving human subjects should read the "NIH
Guidelines For Inclusion of Women and Minorities as Subjects in Clinical Research", which
have been published in the Federal Register of March 28, 1994 (FR 59 14508-14513), and in the
NIH Guide for Grants and Contracts, Volume 23, Number 11, March 18, 1994. Investigators
may obtain copies from these sources or from the program staff or contact person listed under
INQUIRIES. Program staff will, on request, provide additional relevant information concerning
the policy.
APPLICATION PROCEDURES
Applications are to be submitted on the grant application form PHS 398 (rev. 5/95). These forms
are available at most institutional offices of sponsored research, from the NIDCD program
administrator listed under INQUIRIES, as well as from the Office of Extramural Outreach and
Information Resources, National Institutes of Health, 6701 Rockledge Drive, MSC 7910,
Bethesda, MD 20892-7910, telephone 301/435-0714, FAX 301/480-0525, email:
ASKNIH@ODROCKM1 .OD.NIH.GOV. The PHS 398 form is also available electronically on
the NIH Home Page at http://www.nih.gov/grants/phs3981
The PA title and number (NIDCD-NSBRI Program for the Support of Vestibular Research, PAS-
98-081) must be typed in Section 2 of the face page of the application form and the "Yes" box
must be checked. Instructions for completing the application are found in the PHS 398 form.
Submit the signed, original application and five exact photocopies and five collated sets of
appendix materials, in one package to:
CENTER FOR SCIENTIFIC REVIEW
NATIONAL INSTITUTES OF HEALTH
6701 ROCKLEDGE DRIVE, ROOM 1040- MSC 7710
BETHESDA, MD 20892-7710
BETHESDA, MD 20817 (for express/courier service)
There will be only one receipt date for this PA. Applications must be postmarked by the receipt
date of September 28, 1998.
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If the application submitted in response to this PA is substantially similar to a grant application
already submitted to the NIH for review, but not yet reviewed, the applicant will be asked to
withdraw either the pending application or the new one. Simultaneous submission of identical
applications will not be allowed, nor will essentially identical applications be reviewed by
different review committees. This does not preclude the submission of substantial revisions of
applications already reviewed, but such applications must include an introduction addressing the
previous critique.
REVIEW CONSIDERATIONS
Applications will be evaluated for scientific and technical merit by an appropriate peer review
group convened by the Center for Scientific Review in accordance with NIH peer review
procedures. As part of the initial merit review, all applications will receive a written critique and
undergo a process in which only those applications deemed to have the highest scientific merit,
generally the top half of applications under review, will be discussed, assigned a priority score
and receive a second-level review by the National Deafness and Other Communication Disorders
Advisory Council and the NSBRI.
Review Criteria
o Significance: Does this study address an important problem relevant to this PA? If the aims of
the application are achieved, how will scientific knowledge be advanced? What will be the
effect of these studies on the concepts or methods that drive this field?
o Approach: Are the conceptual framework, design, methods, and analyses adequately
developed, well-integrated, and appropriate to the aims of the project? Does the applicant
acknowledge potential problem areas and consider alternative tactics?
o Innovation: Does the project employ novel concepts, approaches or method? Are the aims
original and innovative? Does the project challenge existing paradigms or develop new
methodologies or technologies?
o Investigator: Is the investigator appropriately trained and well suited to carry out this work? Is
the work proposed appropriate to the experience level of the principal investigator and other
researchers (if any)?
o Environment: Does the scientific environment in which the work will be done contribute to the
probability of success? Do the proposed experiments take advantage of unique features of the
scientific environment or employ useful collaborative arrangements? Is there evidence of
institutional support?
o Appropriateness of the proposed budget and duration in relation to the proposed research.
o For Studies Involving Human Subjects: Adequacy of plans to include both genders and
minorities and their subgroups as appropriate for the scientific goals of the research. Plans for
the recruitment and retention of subjects will also be evaluated.
The initial review group will also examine the provisions for the protection of human and animal
subjects, and the safety of the research environment.
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A WARD CRITERIA
Up to a total of six research grants will be awarded separately by NIDCD and NSBRI in response
to this PA. The anticipated date of award is August 1, 1999. The following criteria will be
considered by both the NIDCD and the NSBRI in making their funding decisions:
o Responsiveness of the proposed project to the purpose of this PA;
o Quality of the proposed project, as determined by peer review;
o Program priorities of the NIDCD and the NSBRI within the research purview of this PA; and
o Availability of funds for this initiative.
INQUIRIES
Inquiries concerning this PA are encouraged. The opportunity to clarify any issues and to
respond to questions from potential applicants is welcome.
Direct inquiries regarding programmatic issues to:
Daniel A. Sklare, Ph.D.
Health Scientist Administrator
Hearing and Balance/Vestibular Sciences Branch
Division of Human Communication
National Institute on Deafness and Other Communication Disorders
6120 Executive Boulevard, Room 400-C - MSC 7180
Bethesda, MD 20892-7180
Rockville, MD 20852 (for express/courier service)
Telephone: (301) 496-1804
FAX: (301) 402-6251
Email: daniel_sklare@nih.gov
or to:
Ronald J. White, Ph.D.
Associate Director
National Space Biomedical Research Institute
One Baylor Plaza, NA-425
Houston, TX 77030
Telephone: (713) 798-7412
FAX: (713) 798-7413
Email: rwhite@bcm.tmc.edu
Direct inquiries regarding fiscal matters to:
Sharon Hunt
Chief, Grants Management Branch
Division of Extramural Activities
National institute on Deafness and Other Communication Disorders
Executive Plaza South
6120 Executive Boulevard, Room 400-B - MSC 7180
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Bethesda, MD 20892-7180
Rockville, MD 20852 (for express/courier service)
Telephone: (301) 402-0909
FAX: (301) 402-1758
Email: sh79f@nih.gov
AUTHORITY AND REGULATIONS
This program is described in the Catalog of Federal Domestic Assistance No. 93.173. Awards
are made under the authority of the Public Health Service Act, Title IV, Part A (Public Law 78-
410, as amended by Public Law 99-158, 42 USC 241 and 285) and administered under PHS
grant policies and Federal Regulations at 42 CFR 52 and 45 CFR Part 74. This program is not
subject to the intergovernmental review requirements of Executive Order 12372 or Health
Systems Agency review.
The PHS strongly encourages all grant and contract recipients to provide a smoke-free workplace
and promote the non-use of all tobacco products. In addition, Public Law 103-227, the Pro-
Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a
facility) in which regular or routine education, library, day care, health care or early childhood
development services are provided to children. This is consistent with the PHS
mission to protect and advance the physical and mental health of the American people.
H-7
